Allergic conjunctivitis

H7_ALLERGICCONJUNCTIVITIS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

30848

6. Filter based on genotype QC (FinnGen only)

30848

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 239320 148884 89699
Only index persons 227459 143511 83948
Unadjusted period prevalence (%)
Whole population 3.59 4.26 2.51
Only index persons 4.51 5.28 3.20
Median age at first event (years)
Whole population 26.84 34.62 13.85
Only index persons 27.33 34.76 14.64

-FinnGen-

Key figures

All Female Male
Number of individuals 30848 23409 7439
Unadjusted period prevalence (%) 6.85 7.98 3.28
Median age at first event (years) 36.97 37.80 34.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
27126
Matched controls
267919
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H04.10
ICD-10 Finland
Dry eye syndrome
3.3
323.0
3739
12319
R06AE09
ATC
levocetirizine; oral
4.2
323.0
7484
22518
J45
ICD-10 Finland
Asthma
2.8
323.0
3401
12989
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
323.0
4035
17598
R01AD05
ATC
budesonide; nasal
4.4
323.0
3739
9372
R06AE07
ATC
cetirizine; oral
4.8
323.0
18866
86603
C01CA24
ATC
epinephrine; parenteral
4.5
323.0
3233
7880
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.6
323.0
9867
48774
H10.4
ICD-10 Finland
Chronic conjunctivitis
13.7
323.0
586
431
XQ800
NOMESCO Finland
Prick test
2.8
323.0
2956
11087
R06AX26
ATC
fexofenadine; oral
4.9
323.0
3685
8280
E000001
ATC
NA
2.3
323.0
6911
34091
R01AD01
ATC
beclometasone; nasal
3.5
323.0
6499
22303
R03AC03
ATC
terbutaline; inhalant
3.0
323.0
5439
20743
L20.0
ICD-10 Finland
Besnier prurigo
3.4
323.0
3057
9738
D07AA02
ATC
hydrocortisone; topical
2.6
323.0
5002
21277
S01GX02
ATC
levocabastine; ophthalmic
16.2
323.0
6670
5288
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.5
323.0
3331
14371
S01GX06
ATC
emedastine; ophthalmic
18.0
323.0
1095
625
H02AB06
ATC
prednisolone; systemic
2.1
323.0
13031
82552
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.7
323.0
6496
27760
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
7.1
323.0
868
1241
J02AC01
ATC
fluconazole; systemic
1.7
323.0
12069
86179
R06AX22
ATC
ebastine; oral
4.9
323.0
9409
26243
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
16.6
323.0
2337
1516
R03AC02
ATC
salbutamol; inhalant
2.8
323.0
17405
105478
S01GX01
ATC
cromoglicic acid; ophthalmic
94.7
323.0
24434
23419
R01AD11
ATC
triamcinolone; nasal
2.9
323.0
3246
11978
E000002
ATC
NA
2.7
323.0
4225
17081
R01AD12
ATC
fluticasone furoate; nasal
2.4
323.0
10798
57389
R01AC02
ATC
levocabastine; nasal
7.1
323.0
1800
2645
V01AA05
ATC
tree pollen; parenteral
17.8
323.0
609
345
J30.19
ICD-10 Finland
Pollen allergy UNS
5.6
323.0
1571
2922
H02AB07
ATC
prednisone; oral
2.2
323.0
3958
18921
R01AC01
ATC
cromoglicic acid; nasal
7.7
323.0
2853
4033
R03BA05
ATC
fluticasone; inhalant
2.5
323.0
6384
28929
E0000UV
ATC
NA
2.5
323.0
13317
73807
R01BA52
ATC
pseudoephedrine, combinations; oral
2.5
323.0
10302
53237
R06AX27
ATC
desloratadine; oral
4.2
323.0
13303
49855
R03AK07
ATC
formoterol and budesonide; inhalant
2.4
323.0
6193
29897
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
323.0
5578
25556
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
323.0
8006
47771
J01FA10
ATC
azithromycin; systemic
1.9
323.0
17561
130761
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
7.3
323.0
4020
6265
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.6
323.0
8068
37386
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.3
323.0
14200
66309
R03BA02
ATC
budesonide; inhalant
2.9
323.0
6628
26683
R06AX13
ATC
loratadine; oral
4.9
323.0
8765
23880
R01AD08
ATC
fluticasone; nasal
3.5
323.0
12010
49607
R06AX11
ATC
astemizole; oral
4.4
323.0
1438
3388
R03BA01
ATC
beclometasone; inhalant
2.5
323.0
4515
19579
D07AC13
ATC
mometasone; topical
1.9
323.0
8003
47954
S01GX04
ATC
nedocromil; ophthalmic
20.9
323.0
1661
835
R03DC03
ATC
montelukast; oral
3.4
323.0
6965
24465
S01GX05
ATC
lodoxamide; ophthalmic
28.9
323.0
1385
498
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.3
323.0
4367
11429
Z51.6
ICD-10 Finland
Desensitization to allergens
12.6
323.0
1014
820
R01AD09
ATC
mometasone; nasal
3.1
323.0
16531
89883
S01GX08
ATC
ketotifen; ophthalmic
16.9
323.0
3800
2563
D07AB08
ATC
desonide; topical
2.4
323.0
3274
14415
R06AX12
ATC
terfenadine; oral
5.0
323.0
2392
5081
S01GX09
ATC
olopatadine; ophthalmic
19.4
323.0
2668
1498
J01AA02
ATC
doxycycline; systemic
1.7
319.5
19872
165359
J30.3
ICD-10 Finland
Other allergic rhinitis
3.8
319.1
1468
3987
R06AX18
ATC
acrivastine; oral
4.6
317.1
1176
2612
J01FA09
ATC
clarithromycin; systemic
1.7
313.9
8854
59157
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
309.9
6091
36254
D07AC01
ATC
betamethasone; topical
1.7
303.0
8557
57047
A02BC05
ATC
esomeprazole; systemic
1.7
299.0
10115
70903
Z2221
NOMESCO Finland
Medical doctor
1.7
298.1
7545
48626
H02AB04
ATC
methylprednisolone; systemic
2.1
297.4
3962
20313
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
3.9
295.0
1292
3357
J01FA06
ATC
roxithromycin; oral
1.6
294.6
10502
74576
R96
ICPC
Asthma
2.4
277.1
2521
10781
E000007
ATC
NA
2.8
275.5
1949
7218
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
273.5
3041
14353
Z3231
NOMESCO Finland
Registered nurse
1.7
266.8
6767
43348
R03AC13
ATC
formoterol; inhalant
3.2
264.7
1519
4888
R97
ICPC
Allergic rhinitis
4.9
246.8
855
1763
R03AC12
ATC
salmeterol; inhalant
3.4
245.4
1283
3848
J01DA01
ATC
[U] cefalexin; systemic
1.5
244.3
16220
131727
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.0
241.5
3451
18069
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
238.0
9370
67154
D11AH01
ATC
tacrolimus; topical
8.2
236.5
551
674
R03BC01
ATC
cromoglicic acid; inhalant
5.3
231.1
751
1442
E000006
ATC
NA
2.4
230.8
2123
9091
N05BB01
ATC
hydroxyzine; systemic
2.5
227.4
1969
8163
R03BC03
ATC
nedocromil; inhalant
2.4
227.4
2062
8762
M03BX02
ATC
tizanidine; oral
1.5
227.1
16041
130974
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
227.0
5554
34916
M02AA07
ATC
piroxicam; topical
1.6
223.6
8354
58861
A02BC02
ATC
pantoprazole; systemic
1.5
218.9
15438
125481
H01.0
ICD-10 Finland
Blepharitis
2.6
217.5
1703
6671
M01AE02
ATC
naproxen; oral, rectal
1.5
216.4
14927
120604
R03BA08
ATC
ciclesonide; inhalant
2.2
212.8
2325
10811
A92
ICPC
Allergy/allergic reaction NOS
3.5
211.3
1078
3167
J01DB01
ATC
cefalexin; oral
1.6
209.8
21361
187579
S01KA02
ATC
hypromellose; ophthalmic
5.2
207.7
676
1299
J01DA06
ATC
[U] cefuroxime; systemic
1.8
207.4
3898
22453
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
3.2
207.1
1178
3754
R4110
NOMESCO Finland
Physiotherapy
1.6
204.8
6186
41074
WQ000
NOMESCO Finland
Hyposensibilisation
11.2
204.4
399
355
ZXE00
NOMESCO Finland
One hour or less
1.5
197.5
9854
73692
D02AE01
ATC
carbamide; topical
2.3
193.0
1885
8291
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
2.5
191.7
1578
6344
D02AX
ATC
Other emollients and protectives
3.1
190.2
1116
3632
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
189.5
3858
22751
Z3226
NOMESCO Finland
Physiotherapist
1.7
189.2
4430
27289
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
186.4
9971
75406
D06BX01
ATC
metronidazole; topical
1.9
184.7
2827
15085
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
182.9
6634
45907
D11AX14
ATC
[U] tacrolimus; topical
11.5
182.8
352
305
D07CC01
ATC
betamethasone and antibiotics; topical
1.8
176.4
3251
18515
E000003
ATC
NA
2.6
175.6
1350
5215
S01XA18
ATC
ciclosporin; ophthalmic
12.6
174.5
322
255
A02BC03
ATC
lansoprazole; oral
1.6
174.5
6492
45107
T78.4
ICD-10 Finland
Allergy, unspecified
2.5
173.9
1490
6113
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
173.6
13192
106503
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.8
173.0
3418
19910
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.9
172.2
1119
3898
R05FB02
ATC
cough suppressants and expectorants
1.5
171.7
8623
64031
L20
ICD-10 Finland
Atopic dermatitis
3.2
168.4
959
3051
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.7
166.6
3612
21648
A02BA02
ATC
ranitidine; systemic
1.7
164.5
4162
26102
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.8
164.3
1162
4268
J01AA04
ATC
lymecycline; systemic
1.7
163.6
3654
22086
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
163.6
12199
97685
A02BC01
ATC
omeprazole; systemic
1.5
160.4
6120
42621
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
159.4
7044
50698
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
156.6
6013
41898
J01AA07
ATC
tetracycline; systemic
1.6
155.4
4218
26928
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.3
155.0
1557
6918
R03DA04
ATC
theophylline; systemic, rectal
2.8
155.0
1089
3982
M01AH05
ATC
etoricoxib; oral
1.4
152.9
14277
118500
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
149.9
2040
10357
H10
ICD-10 Finland
Conjunctivitis
2.1
148.6
1753
8383
N02BE01
ATC
paracetamol; systemic, rectal
1.5
147.0
21546
193633
N02AX02
ATC
tramadol; systemic, rectal
1.4
146.2
9039
69371
H10.5
ICD-10 Finland
Blepharoconjunctivitis
4.1
144.0
590
1435
D11AH02
ATC
pimecrolimus; topical
12.1
142.6
268
221
XQ802
NOMESCO Finland
Epicutan test
2.5
141.8
1243
5149
S01CA03
ATC
hydrocortisone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
5.8
141.3
418
717
M01AB05
ATC
diclofenac; systemic, rectal
1.4
137.6
16095
137659
J01MA02
ATC
ciprofloxacin; systemic
1.4
137.3
8104
61456
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
136.5
10774
86128
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
133.0
1970
10315
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
132.8
5573
39373
R03CC02
ATC
salbutamol; systemic
2.0
130.4
1926
10068
R03BB04
ATC
tiotropium bromide; inhalant
2.0
128.7
1712
8591
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
128.5
8069
61715
J45.8
ICD-10 Finland
Mixed asthma
2.9
127.2
838
2940
J01CA04
ATC
amoxicillin; systemic
1.4
127.1
21410
193598
J02AC02
ATC
itraconazole; systemic
1.6
127.1
4277
28684
N03AX16
ATC
pregabalin; oral
1.5
126.7
5143
36013
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
126.2
8163
62721
S01AX11
ATC
[U] ofloxacin; ophthalmic
2.8
125.8
848
3018
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
4.3
125.1
489
1138
R03AK08
ATC
formoterol and beclometasone; inhalant
2.6
125.0
990
3879
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
124.1
4103
27381
M01AH01
ATC
celecoxib; oral (coxibs)
1.6
123.3
3902
25757
J05AB01
ATC
aciclovir; systemic
1.5
121.9
5034
35339
F29
ICPC
Eye symptom/complaint other
1.9
121.0
1979
10730
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
120.4
6871
51483
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.1
119.6
1529
7541
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.5
118.3
1013
4138
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
118.0
2332
13471
N06AX11
ATC
mirtazapine; oral
1.4
117.9
7325
55712
A03CA02
ATC
clidinium and psycholeptics; oral
2.2
115.5
1268
5855
WX002
NOMESCO Finland
Sedation and analgesia
1.5
115.2
4065
27498
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
113.6
6758
50920
J01FF01
ATC
clindamycin; systemic
1.4
113.4
6032
44496
R06.0
ICD-10 Finland
Dyspnoea
1.5
113.0
5009
35617
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.4
112.9
1065
4575
A01AB09
ATC
miconazole; local oral
1.8
112.8
2015
11254
J05AB11
ATC
valaciclovir; oral
1.6
112.1
3085
19606
J01FA01
ATC
erythromycin; systemic
1.5
111.7
3875
26086
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.7
111.5
2402
14237
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
110.8
2759
17056
M25.5
ICD-10 Finland
Pain in joint
1.4
110.2
6767
51223
D10AF01
ATC
clindamycin; topical
2.0
107.9
1436
7192
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
5.0
107.3
359
712
N05CF01
ATC
zopiclone; oral
1.4
106.9
6623
50158
Z71.8
ICD-10 Finland
Other specified counselling
1.4
106.6
5819
43050
V01AA02
ATC
grass pollen; systemic
11.3
106.3
206
182
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.0
106.1
1521
7843
A03FA02
ATC
cisapride; oral, rectal
1.9
105.7
1633
8660
M01AC06
ATC
meloxicam; systemic, rectal
1.4
105.2
8106
63702
J01DA08
ATC
[U] cefaclor; oral
1.6
104.8
3270
21430
C07AA05
ATC
propranolol; systemic
1.5
104.5
4756
33927
D10AX03
ATC
azelaic acid; topical
1.7
103.9
2186
12854
R03DC01
ATC
zafirlukast; oral
3.8
102.2
461
1222
N05CF02
ATC
zolpidem; oral
1.5
101.9
4108
28548
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
101.7
10088
82370
D07AD01
ATC
clobetasol; topical
1.6
101.1
3369
22418
J46
ICD-10 Finland
Status asthmaticus
2.7
101.1
713
2608
J01MA06
ATC
norfloxacin; oral
1.6
100.2
3032
19698
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
100.1
3778
25864
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
99.4
1597
8586
D06BB03
ATC
aciclovir; topical
2.1
99.1
1239
6047
ZXA10
NOMESCO Finland
Bilateral
1.5
98.5
3827
26363
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
97.9
8598
68789
M79.6
ICD-10 Finland
Pain in limb
1.4
97.5
8047
63745
C05AA08
ATC
fluocortolone; rectal, topical
1.6
96.3
2997
19594
R01AC07
ATC
nedocromil; nasal
7.6
96.3
233
304
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
95.4
5662
42396
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
95.0
6419
49162
S01AA13
ATC
fusidic acid; ophthalmic
2.4
94.8
861
3625
J01FA15
ATC
telithromycin; oral
1.7
94.3
2339
14407
N06AX21
ATC
duloxetine; oral
1.6
94.1
2554
16120
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
93.9
3896
27189
S01AD03
ATC
aciclovir; ophthalmic
2.4
93.3
877
3754
F03
ICPC
Eye discharge
1.9
93.1
1496
8035
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.6
93.0
745
2931
D11AX15
ATC
[U] pimecrolimus; topical
12.5
92.9
171
136
N05BA01
ATC
diazepam; systemic, rectal
1.6
92.4
2814
18285
R05
ICD-10 Finland
Cough
1.5
91.6
4183
29760
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
6.2
91.5
255
407
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
90.7
2911
19156
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
90.7
5709
43132
D07AC14
ATC
methylprednisolone aceponate; topical
2.1
90.6
1130
5504
ZXA00
NOMESCO Finland
Right side
1.4
89.8
5267
39283
R02
ICPC
Shortness of breath/dyspnoea
1.6
89.5
2451
15495
M01AX17
ATC
nimesulide; oral
1.4
88.9
4775
35038
R01BA01
ATC
phenylpropanolamine; oral
2.0
88.8
1288
6659
J30.1
ICD-10 Finland
Allergic rhinitis due to pollen
13.0
87.3
158
121
D07BC01
ATC
betamethasone and antiseptics; topical
1.6
86.6
2479
15847
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.9
86.2
1273
6625
R03BB01
ATC
ipratropium bromide; inhalant
2.6
85.7
669
2596
ZXA05
NOMESCO Finland
Left side
1.4
83.8
4887
36346
R06AE08
ATC
NA
4.3
83.7
322
740
N05BA04
ATC
oxazepam; oral
1.4
83.3
5524
42008
M02AA10
ATC
ketoprofen; topical
1.5
83.3
3257
22393
A01AB04
ATC
amphotericin B; local oral
2.1
82.6
982
4687
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
3.0
81.9
511
1730
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
80.4
1768
10504
M01AH02
ATC
rofecoxib; oral
1.6
80.1
2486
16196
G47.3
ICD-10 Finland
Sleep apnoea
1.4
79.2
3857
27710
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
77.8
1853
11256
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
77.7
3911
28264
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
77.4
1679
9931
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
77.0
8335
68117
A98
ICPC
Health maint/preventive medicine
1.7
77.0
25980
249022
3023
Kela drug reimbursment
Allergen extract of birch pollen (adults)
11.8
76.8
145
122
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
2.8
76.2
512
1817
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
76.2
2679
17963
R01AD04
ATC
flunisolide; nasal
5.1
75.5
247
480
ZXD20
NOMESCO Finland
Day surgery
1.5
74.3
2847
19450
L27.2
ICD-10 Finland
Dermatitis due to ingested food
4.1
74.2
306
751
N03AX12
ATC
gabapentin; oral
1.5
73.5
3126
21825
N06AA09
ATC
amitriptyline; systemic
1.6
73.4
2019
12743
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
73.3
3675
26509
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.7
72.9
518
1901
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
72.9
4464
33378
N06AB04
ATC
citalopram; systemic
1.4
72.8
4737
35787
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
1.7
72.4
1504
8774
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
70.3
3312
23591
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
70.2
5441
42237
A07AA02
ATC
nystatin; oral
1.8
70.1
1223
6749
P01AB01
ATC
metronidazole; oral, rectal
1.3
69.9
9274
77581
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
69.1
2029
13016
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
9.1
69.1
149
162
A06AC51
ATC
ispaghula, combinations; systemic
1.9
68.6
1050
5532
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
68.6
1382
7986
R03AK11
ATC
formoterol and fluticasone; inhalant
2.5
68.4
580
2355
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
3.5
68.1
330
931
G44.2
ICD-10 Finland
Tension-type headache
1.4
68.1
3112
22021
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.9
67.6
1008
5261
49300
ICD-8 Finland
Asthma, bronchiale
2.6
66.5
499
1894
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
66.4
2115
13835
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
66.1
5582
43837
G01AF05
ATC
econazole; vaginal
1.6
65.6
1991
12871
C09CA06
ATC
candesartan; oral
1.4
65.2
4156
31219
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.6
64.7
1675
10392
364
Kela drug reimbursment
Allergen extract of birch pollen and allergen extract of grass pollen
24.6
64.5
92
37
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
64.1
1786
11299
E000004
ATC
NA
2.5
64.0
529
2120
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
63.9
8102
67186
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
4.0
63.6
265
658
L01
ICPC
Neck symptom/complaint
1.4
62.7
3029
21638
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.0
62.6
834
4169
R51.80
ICD-10 Finland
Headache
1.4
62.4
3470
25441
A07DA03
ATC
loperamide; oral
2.2
62.2
662
3006
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
61.9
23268
219132
J01DC02
ATC
cefuroxime; systemic
1.7
61.9
1306
7647
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.5
61.4
2710
19018
J30
ICD-10 Finland
Vasomotor and allergic rhinitis
2.8
60.5
418
1510
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
59.9
1951
12817
L17
ICPC
Foot/toe symptom/complaint
1.3
58.9
5158
40608
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.6
58.8
1759
11322
D07XB05
ATC
dexamethasone, combinations; topical
2.2
58.7
604
2702
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.6
58.7
1688
10759
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
58.0
2693
19072
D07AB01
ATC
clobetasone; topical
2.1
57.9
720
3502
A02BC04
ATC
rabeprazole; oral
1.6
57.8
1778
11518
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
57.5
4379
33763
M79.7
ICD-10 Finland
Fibromyalgia
1.9
57.5
833
4299
C07AB07
ATC
bisoprolol; oral
1.3
57.4
8006
66938
S01EE05
ATC
tafluprost; ophthalmic
2.3
57.2
557
2428
N02CC04
ATC
rizatriptan; oral
1.6
57.0
1473
9129
E0001A1
ATC
NA
2.3
56.7
574
2547
R53
ICD-10 Finland
Malaise and fatigue
1.3
56.6
4194
32193
G03DB01
ATC
dydrogesterone; oral
1.4
56.1
3370
24998
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
56.0
1983
13269
D07XC01
ATC
betamethasone, combinations; topical
1.5
56.0
2189
14968
N06AX16
ATC
venlafaxine; oral
1.4
55.9
3211
23634
M01AX05
ATC
glucosamine; oral
1.4
55.8
3366
24984
N02CC03
ATC
zolmitriptan; nasal, oral
1.7
55.5
1359
8297
S01BC03
ATC
diclofenac; ophthalmic
2.4
55.5
488
2022
J20
ICD-10 Finland
Acute bronchitis
1.5
55.2
1938
12941
M79.1
ICD-10 Finland
Myalgia
1.4
55.2
2817
20296
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.0
54.9
784
4025
K07.60
ICD-10 Finland
Snapping jaw
1.7
54.8
1225
7291
R01AC03
ATC
azelastine; nasal
5.6
54.8
164
289
R83
ICPC
Respiratory infection other
1.3
54.7
6225
50702
R05
ICPC
Cough
1.3
54.7
4856
38259
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.4
54.6
2512
17743
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
3.2
54.2
298
928
R74
ICPC
Upper respiratory infection acute
1.3
54.1
7309
60782
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
54.1
1928
12918
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.9
53.9
862
4611
SPAT1267
SPAT
Desensitisation
8.2
53.5
122
147
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
53.1
1285
7821
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
53.0
3651
27675
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
52.8
4461
34872
A06AD11
ATC
lactulose; oral
1.5
52.7
2209
15315
A02BA04
ATC
nizatidine; systemic
1.6
52.3
1305
8010
SPAT1324
SPAT
Screening procedure
0.7
52.2
2986
38300
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
2.7
52.0
372
1376
N06AB10
ATC
escitalopram; oral
1.3
51.8
4775
37771
D01AE16
ATC
amorolfine; topical
1.5
51.7
2072
14227
N05CD07
ATC
temazepam; oral
1.5
51.5
1952
13251
F71
ICPC
Conjunctivitis allergic
6.1
50.9
143
233
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.9
50.9
776
4084
N05BA12
ATC
alprazolam; oral
1.5
50.8
2088
14415
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
50.8
1052
6121
J01MA14
ATC
moxifloxacin; systemic
1.6
50.7
1584
10289
C05AA01
ATC
hydrocortisone; rectal, topical
1.8
50.0
938
5292
M01AB55
ATC
diclofenac, combinations; oral
1.7
50.0
1199
7277
S01GA51
ATC
naphazoline, combinations; ophthalmic
8.3
49.6
112
133
S29
ICPC
Skin symptom/complaint other
1.4
49.3
3256
24489
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
6.1
49.1
138
225
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
49.1
1782
11980
S87
ICPC
Dermatitis/atopic eczema
2.2
49.0
536
2467
J01MA12
ATC
levofloxacin; systemic
1.4
48.9
3132
23435
M54.5
ICD-10 Finland
Low back pain
1.2
48.7
7257
60864
R01AX03
ATC
ipratropium bromide; nasal
2.5
48.5
410
1666
N06AB06
ATC
sertraline; oral
1.4
48.3
2456
17659
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.5
48.1
1831
12432
R06AX25
ATC
mizolastine; oral
6.4
48.0
130
202
J01EA01
ATC
trimethoprim; systemic
1.3
47.6
5557
45261
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
47.5
4768
38089
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
47.1
2930
21813
N02CC06
ATC
eletriptan; oral
1.8
47.1
872
4902
S01EC04
ATC
brinzolamide; ophthalmic
2.1
47.0
551
2615
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
3.5
46.6
230
661
M54
ICD-10 Finland
Dorsalgia
1.4
46.6
2396
17260
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.7
46.5
1083
6520
G01AF04
ATC
miconazole; vaginal
1.6
46.4
1147
7019
XG410
NOMESCO Finland
Flow-volume spirometry
1.9
46.3
750
4032
Z2446
NOMESCO Finland
Social worker
1.6
45.9
1331
8490
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
2.5
45.1
370
1481
J30.0
ICD-10 Finland
Vasomotor rhinitis
2.1
45.0
526
2494
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
44.9
2733
20262
F02
ICPC
Red eye
1.8
44.7
852
4833
114
Kela drug reimbursment
Glaucoma
1.6
44.7
1177
7326
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
44.6
2317
16712
M01AC01
ATC
piroxicam; systemic, rectal
1.4
44.6
2353
17021
S01EE01
ATC
latanoprost; ophthalmic
1.8
44.4
855
4865
S01XA02
ATC
retinol; ophthalmic
4.9
44.2
149
302
N06AB03
ATC
fluoxetine; oral
1.4
44.0
2644
19552
R06.2
ICD-10 Finland
Wheezing
1.7
43.8
878
5058
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
43.7
3168
24143
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.5
43.2
1812
12547
K30
ICD-10 Finland
Functional dyspepsia
1.4
42.7
2103
15012
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
4.4
42.6
159
358
A01AC01
ATC
triamcinolone; local oral
2.5
42.6
339
1332
R42
ICD-10 Finland
Dizziness and giddiness
1.3
42.6
3928
30978
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.8
42.4
724
3961
H03AA01
ATC
levothyroxine sodium; systemic
1.3
42.3
5085
41470
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
42.3
2320
16884
M48.0
ICD-10 Finland
Spinal stenosis
1.5
42.3
1751
12087
L71.8
ICD-10 Finland
Other rosacea
2.6
42.2
313
1185
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
41.8
6644
55918
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
41.8
3317
25607
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
41.7
1188
7542
Z01.7
ICD-10 Finland
Laboratory examination
1.4
41.5
2151
15499
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.6
41.4
1014
6188
L03
ICPC
Low back symptom/complaint
1.3
41.1
5141
42109
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
40.9
3349
25961
EB1AA
SPAT
NA
1.7
40.6
967
5859
S01CB01
ATC
dexamethasone; ophthalmic (corticosteroids/antiinfectives/mydriatics in comb.)
4.5
40.5
147
323
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
40.4
1569
10688
N03AE01
ATC
clonazepam; systemic
1.6
40.3
1089
6818
G03HB01
ATC
cyproterone and estrogen; systemic
1.4
40.2
2553
19041
H92.0
ICD-10 Finland
Otalgia
1.6
40.1
1098
6901
XKD00
NOMESCO Finland
Uroflowmetry
1.5
40.0
1566
10688
L12
ICPC
Hand/finger symptom/complaint
1.3
39.8
2922
22285
R49.08
ICD-10 Finland
Other specified dysphonia
2.1
39.7
442
2052
WX110
SPAT
NA
1.6
39.7
960
5839
S21
ICPC
Skin texture symptom/complaint
1.4
39.6
2277
16702
H57.1
ICD-10 Finland
Ocular pain
1.8
39.6
680
3728
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
39.6
3836
30422
D01AC02
ATC
miconazole; topical
1.5
39.3
1265
8268
DHB50
NOMESCO Finland
Turbinoplasty
2.0
39.2
534
2697
XCK00
NOMESCO Finland
Perimetry
1.6
39.0
1104
6995
F01
ICPC
Eye pain
1.9
38.9
584
3058
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
3.7
38.9
174
464
S01ED01
ATC
timolol; ophthalmic
2.0
38.8
505
2503
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
38.8
1626
11249
R4120
NOMESCO Finland
Occupational therapy
1.6
38.7
1153
7398
M01AX01
ATC
nabumetone; oral
1.7
38.5
780
4509
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.5
38.3
1430
9659
H16.2
ICD-10 Finland
Keratoconjunctivitis
3.5
38.3
183
515
D10BA01
ATC
isotretinoin; oral
1.5
38.0
1602
11097
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
37.9
1619
11240
L71
ICD-10 Finland
Rosacea
2.1
37.8
418
1936
J01
ICD-10 Finland
Acute sinusitis
1.6
37.8
1081
6869
G04CA01
ATC
alfuzosin; oral
1.6
37.8
966
5965
R05DA01
ATC
ethylmorphine; oral
1.5
37.7
1529
10507
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
37.7
2426
18119
H10.8
ICD-10 Finland
Other conjunctivitis
3.1
37.6
216
695
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.5
37.6
1296
8603
L82
ICD-10 Finland
Seborrhoeic keratosis
1.3
37.5
2612
19748
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
37.4
2649
20086
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
37.4
1332
8906
L28
ICPC
Limited function/disability (L)
1.3
37.2
2445
18323
UJH02
NOMESCO Finland
Anoscopy
1.7
37.2
776
4525
G04BD12
ATC
mirabegron; oral
1.5
37.1
1507
10357
R01AD
ATC
Corticosteroids
2.8
37.1
247
877
A01
ICPC
Pain general/multiple sites
1.5
36.9
1421
9658
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
2.2
36.8
368
1630
R49.01
ICD-10 Finland
Functional dysphonia
1.9
36.8
594
3189
L13
ICPC
Hip symptom/complaint
1.3
36.8
2731
20851
SPAT1325
SPAT
Vaccination
1.2
36.6
6594
56073
H02.3
ICD-10 Finland
Blepharochalasis
1.6
36.5
1005
6326
A02BX02
ATC
sucralfate; oral
1.8
36.3
660
3689
N02CC07
ATC
frovatriptan; oral
1.6
36.2
997
6272
A02BA03
ATC
famotidine; systemic
1.9
36.0
584
3143
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.9
36.0
544
2855
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
35.9
1372
9310
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.8
35.8
675
3817
R5599
NOMESCO Finland
Other rehabilitation service
1.9
35.6
524
2725
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.8
35.5
657
3693
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.6
35.4
1043
6677
R35
ICD-10 Finland
Polyuria
1.6
35.3
883
5418
L02
ICPC
Back symptom/complaint
1.4
35.3
1902
13787
S01BC05
ATC
ketorolac; ophthalmic
1.9
35.3
548
2903
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.5
35.3
1345
9123
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
35.0
1390
9508
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.8
35.0
593
3239
S01ED02
ATC
betaxolol; ophthalmic
3.4
35.0
172
496
U13
ICPC
Bladder symptom/complaint other
1.9
34.9
553
2950
L71.9
ICD-10 Finland
Rosacea, unspecified
2.0
34.9
441
2163
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.5
34.4
1166
7710
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.6
34.4
1047
6754
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
34.3
1728
12377
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
2.7
34.3
248
928
D01AC03
ATC
econazole; topical
1.6
34.0
979
6231
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.4
33.9
1667
11880
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
3.4
33.9
171
503
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.6
33.8
901
5621
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
33.8
2525
19281
D01
ICPC
Abdominal pain/cramps general
1.3
33.7
2301
17331
H04.2
ICD-10 Finland
Epiphora
3.4
33.7
171
506
R52.2
ICD-10 Finland
Other chronic pain
1.8
33.6
629
3548
R05DB20
ATC
other cough suppressants - combinations
1.5
33.6
1135
7498
G01AA10
ATC
clindamycin; vaginal
1.3
33.5
3590
28781
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
1.7
33.3
751
4479
50708
ICD-8 Finland
Hay fever, Alia definita
3.8
33.3
145
379
H02.4
ICD-10 Finland
Ptosis of eyelid
2.0
33.2
444
2226
J30.2
ICD-10 Finland
Other seasonal allergic rhinitis
4.8
33.0
113
235
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
33.0
4173
34118
S02CA02
ATC
flumetasone and antiinfectives; otic
1.6
32.9
989
6357
H16.0
ICD-10 Finland
Corneal ulcer
1.6
32.9
874
5451
J34.2
ICD-10 Finland
Deviated nasal septum
1.6
32.9
870
5418
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.6
32.7
955
6101
A04
ICPC
Weakness/tiredness general
1.3
32.6
2505
19202
N01
ICPC
Headache
1.3
32.5
2441
18651
N95.1
ICD-10 Finland
Menopausal and female climacteric states
1.4
32.5
2039
15157
EB1SA
SPAT
NA
1.7
32.4
769
4652
S18
ICPC
Laceration/cut
1.2
32.2
8008
69978
Z01.2
ICD-10 Finland
Dental examination
1.2
32.2
9635
85542
S01AA30
ATC
combinations of different antibiotics; ophthalmic
2.8
32.0
208
729
R2110
NOMESCO Finland
Giving the first information
1.4
32.0
1473
10371
U02
ICPC
Urinary frequency/urgency
1.3
32.0
2617
20240
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.5
31.9
259
1036
L20.8
ICD-10 Finland
Other atopic dermatitis
2.6
31.8
240
921
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.2
31.8
174
545
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
2.2
31.7
322
1438
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
31.7
1854
13619
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.6
31.7
796
4894
D19
ICPC
Teeth/gum symptom/complaint
1.2
31.6
5807
49342
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.7
31.6
693
4102
UKC02
NOMESCO Finland
Cystoscopy
1.3
31.5
2044
15269
WX320
NOMESCO Finland
Spinalanesthesy
1.2
31.5
4121
33795
UJF32
NOMESCO Finland
Coloscopy
1.2
31.5
4467
36960
S01ED51
ATC
timolol, combinations; ophthalmic
1.6
31.5
951
6120
H10.2
ICD-10 Finland
Other acute conjunctivitis
2.3
31.5
286
1210
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.4
31.4
1465
10339
L15
ICPC
Knee symptom/complaint
1.2
31.3
4011
32813
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
3.8
31.3
136
355
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
1.8
31.2
594
3368
Z2445
NOMESCO Finland
Psychologist
1.6
31.2
859
5406
N03AX11
ATC
topiramate; oral
1.8
31.2
568
3180
L08
ICPC
Shoulder symptom/complaint
1.3
31.1
3410
27391
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
31.1
1426
10035
J01MA01
ATC
ofloxacin; systemic
1.4
31.0
1307
9051
-60
ICPC
Result test/procedure
1.5
30.9
1056
6995
H01.9
ICD-10 Finland
Inflammation of eyelid, unspecified
2.5
30.9
251
1003
S01AA02
ATC
chlortetracycline; ophthalmic
3.4
30.8
155
456
N04BC05
ATC
pramipexole; oral
1.5
30.8
1170
7930
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.3
30.7
2095
15768
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
30.6
2762
21646
L50.0
ICD-10 Finland
Allergic urticaria
1.8
30.5
534
2949
N06AG02
ATC
moclobemide; oral
1.6
30.2
782
4844
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
30.0
2325
17837
L29
ICPC
Musculoskeletal sympt/complt other
1.4
29.9
1351
9478
J35.0
ICD-10 Finland
Chronic tonsillitis
1.4
29.9
1251
8647
D01AE15
ATC
terbinafine; topical
1.5
29.8
1069
7156
G04BD04
ATC
oxybutynin; oral, transdermal
1.6
29.8
875
5595
K58
ICD-10 Finland
Irritable bowel syndrome
1.8
29.8
509
2792
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.5
29.7
970
6360
P06
ICPC
Sleep disturbance
1.3
29.5
1944
14549
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.4
29.5
1321
9250
S01GX07
ATC
azelastine; ophthalmic
13.6
29.5
51
37
D01BA02
ATC
terbinafine; oral; topical
1.2
29.3
4275
35450
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.2
29.3
4177
34557
H26.4
ICD-10 Finland
After-cataract
1.5
29.2
1161
7943
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.5
28.9
1093
7399
A11
ICPC
Chest pain NOS
1.5
28.8
1181
8131
ZXC60
NOMESCO Finland
Application of heat
2.2
28.7
300
1358
K59.0
ICD-10 Finland
Constipation
1.5
28.7
871
5616
G43
ICD-10 Finland
Migraine
1.5
28.6
1071
7238
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.4
28.5
1288
9034
C10AA07
ATC
rosuvastatin; oral
1.2
28.5
3682
30120
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.3
28.4
1879
14074
N05AH04
ATC
quetiapine; oral
1.2
28.4
3408
27649
P01BA02
ATC
hydroxychloroquine; oral
1.4
28.3
1582
11531
D09AB01
ATC
zinc bandage without supplements; topical
2.1
28.3
327
1548
4224
FHL
Endonasal anthrostomy
2.6
28.2
217
841
N02CC05
ATC
almotriptan; oral
1.5
28.2
919
6022
G03DC02
ATC
norethisterone; oral
1.3
28.1
2284
17629
XCH05
NOMESCO Finland
Eye pressure longterm registration
3.0
28.0
168
560
N17
ICPC
Vertigo/dizziness
1.3
28.0
1906
14334
N06AA12
ATC
doxepin; systemic
1.5
28.0
871
5648
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.4
27.9
1429
10255
J02AB02
ATC
ketoconazole; oral
1.7
27.9
567
3286
F70
ICPC
Conjunctivitis infectious
1.8
27.9
473
2587
N06AB05
ATC
paroxetine; oral
1.4
27.9
1212
8438
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
27.7
1631
11987
R07.0
ICD-10 Finland
Pain in throat
1.4
27.4
1263
8890
G50.1
ICD-10 Finland
Atypical facial pain
2.0
27.3
348
1717
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
27.2
2282
17689
A97
ICPC
No disease
1.3
27.2
2850
22738
R06.5
ICD-10 Finland
Mouth breathing
1.4
27.2
1423
10253
B02AA02
ATC
tranexamic acid; systemic
1.2
27.2
3240
26253
G04CA02
ATC
tamsulosin; oral
1.4
27.1
1707
12684
D07CB01
ATC
triamcinolone and antibiotics; topical
1.9
27.0
376
1920
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.4
27.0
1271
8983
D07XB02
ATC
triamcinolone, combinations; topical
2.3
27.0
260
1136
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
26.9
9327
83403
S01EX03
ATC
NA
2.3
26.9
261
1143
H01
ICPC
Ear pain/earache
1.3
26.8
2250
17440
N03AX09
ATC
lamotrigine; oral
1.5
26.8
1006
6801
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.3
26.8
2046
15650
J37.0
ICD-10 Finland
Chronic laryngitis
1.7
26.7
538
3107
WX402
NOMESCO Finland
General anaesthesia
1.2
26.7
3226
26180
N06AA06
ATC
trimipramine; systemic
1.8
26.6
439
2383
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.7
26.6
606
3632
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.4
26.5
1545
11340
3007
Kela drug reimbursment
Erenumab and fremanezumab
2.3
26.4
260
1146
R60.0
ICD-10 Finland
Localized oedema
1.3
26.4
1697
12653
EMB10
NOMESCO Finland
Tonsillectomy
1.4
26.3
1359
9769
R13
ICD-10 Finland
Dysphagia
1.5
26.2
974
6571
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.4
26.1
1361
9796
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.5
26.1
792
5107
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
1.6
26.0
773
4959
G01AF01
ATC
metronidazole; vaginal
1.3
25.9
2053
15789
TUPEI
NOMESCO Finland
NA
1.5
25.9
799
5171
L57.0
ICD-10 Finland
Actinic keratosis
1.4
25.9
1176
8260
J01CE02
ATC
phenoxymethylpenicillin; oral
1.1
25.8
16869
157668
H02.1
ICD-10 Finland
Ectropion of eyelid
3.3
25.7
134
407
U01
ICPC
Dysuria/painful urination
1.4
25.7
1495
10966
G04BD08
ATC
solifenacin; oral
1.5
25.6
970
6572
D06
ICPC
Abdominal pain localized other
1.4
25.6
1600
11878
R20.2
ICD-10 Finland
Paraesthesia of skin
1.4
25.5
1272
9082
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.4
25.5
1190
8402
H02AB09
ATC
hydrocortisone; systemic
1.8
25.3
427
2334
D11
ICPC
Diarrhoea
1.3
25.2
2396
18876
N06AA10
ATC
nortriptyline; systemic
1.8
25.2
407
2194
H29
ICPC
Ear symptom/complaint other
1.3
25.0
1690
12695
F13
ICPC
Eye sensation abnormal
1.8
24.9
471
2671
WX140
NOMESCO Finland
Parabulbar anesthesy
1.7
24.9
560
3343
CG2T4
NOMESCO Finland
Topography assessment of cornea
2.8
24.9
158
550
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
24.8
1260
9029
SBB10
NOMESCO Finland
Teeth copy
1.4
24.8
1342
9725
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.4
24.7
1186
8417
ZXE20
NOMESCO Finland
More than three and less than five hours
1.3
24.6
2212
17297
A01AB10
ATC
natamycin; local oral
1.7
24.6
528
3109
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
24.6
1165
8246
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
1.7
24.6
538
3187
D10AD01
ATC
tretinoin; topical
1.7
24.4
468
2664
S01EE03
ATC
bimatoprost; ophthalmic
2.0
24.4
310
1530
S01EC03
ATC
dorzolamide; ophthalmic
2.5
24.4
194
770
R21
ICPC
Throat symptom/complaint
1.2
24.4
4827
41151
H02BX01
ATC
methylprednisolone, combinations; systemic
1.5
24.3
767
4995
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
1.9
24.2
351
1823
R05DB05
ATC
pentoxyverine; oral, rectal
1.6
24.2
621
3844
R51
ICD-10 Finland
Headache
1.4
24.2
1059
7387
X58
ICD-10 Finland
Exposure to other specified factors
1.3
24.1
2615
20933
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
3.2
24.1
129
400
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.3
24.1
1588
11879
H40.0
ICD-10 Finland
Glaucoma suspect
1.4
24.0
1132
8002
F73
ICPC
Eye infection/inflammation other
1.9
23.9
362
1907
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.4
23.8
1475
10928
S01EC01
ATC
acetazolamide; systemic
2.0
23.8
320
1614
N06AX03
ATC
mianserin; oral
1.5
23.8
782
5136
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
23.7
8074
71930
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
1.7
23.6
455
2596
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
23.6
1351
9881
M01AG01
ATC
mefenamic acid; oral
1.7
23.5
516
3060
395
Kela drug reimbursment
Dupilumab
10.3
23.5
46
44
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.6
23.3
556
3374
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
23.3
5242
45175
N30
ICD-10 Finland
Cystitis
1.3
23.1
1502
11212
G02BA03
ATC
plastic IUD with progestogen
1.2
23.1
2722
21996
S01AX12
ATC
[U] norfloxacin; ophthalmic
3.5
23.1
110
313
XF402
NOMESCO Finland
ECG with work load test
1.3
23.1
1563
11743
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.3
23.0
1891
14613
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
2.3
22.9
215
929
Z50.1
ICD-10 Finland
Other physical therapy
1.5
22.9
887
6037
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.2
22.9
2646
21333
E03
ICD-10 Finland
Other hypothyroidism
1.4
22.8
1074
7593
WX110
NOMESCO Finland
Local anesthesy
1.1
22.8
16598
155517
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.5
22.8
927
6372
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.3
22.8
1482
11066
A60
ICPC
General and Unspecified, Result test/procedure
1.5
22.8
723
4712
E66.8
ICD-10 Finland
Other obesity
1.4
22.7
1026
7198
GD1AA
SPAT
NA
1.4
22.7
1332
9785
N02CD03
ATC
fremanezumab; systemic
2.7
22.5
152
550
M01AH03
ATC
valdecoxib; oral
1.4
22.5
1046
7376
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
22.5
2582
20803
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.4
22.5
987
6888
N06AX12
ATC
bupropion; oral
1.4
22.5
1298
9508
A07EB01
ATC
cromoglicic acid; oral
9.9
22.5
45
45
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.5
22.4
736
4833
M77.4
ICD-10 Finland
Metatarsalgia
1.4
22.4
1019
7160
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.3
22.3
1966
15328
N06AX05
ATC
trazodone; oral
1.7
22.2
472
2772
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
22.2
3247
26860
G03DB02
ATC
megestrol; oral (pregnadien derivatives)
1.5
22.1
709
4634
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
3.5
22.1
104
294
H93.1
ICD-10 Finland
Tinnitus
1.4
22.1
1052
7457
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
22.1
6655
58677
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.6
22.1
545
3343
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.5
22.0
667
4302
U07
ICPC
Urine symptom/complaint other
1.4
22.0
906
6248
A03CA05
ATC
glycopyrronium bromide and psycholeptics; systemic
2.4
21.9
193
809
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
1.7
21.9
503
3023
C08DA01
ATC
verapamil; systemic
1.6
21.8
599
3770
SPAT1058
SPAT
PEF monitoring instruction
1.3
21.8
1422
10618
H16.9
ICD-10 Finland
Keratitis, unspecified
1.9
21.8
300
1529
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.6
21.6
505
3050
M03BB52
ATC
chlormezanone, combinations excl. psycholeptics; oral, rectal
1.9
21.6
323
1697
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
21.6
6545
57711
R12
ICD-10 Finland
Heartburn
1.4
21.6
1273
9359
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.8
21.5
390
2186
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.1
21.5
12360
113853
R08
ICPC
Nose symptom/complaint other
1.6
21.5
603
3817
J04.0
ICD-10 Finland
Acute laryngitis
1.5
21.5
676
4398
C10AC01
ATC
colestyramine; oral
1.7
21.5
447
2612
G04BD07
ATC
tolterodine; oral
1.5
21.4
716
4722
H15.1
ICD-10 Finland
Episcleritis
2.0
21.4
277
1377
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.5
21.3
833
5678
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.5
21.3
691
4526
R09
ICPC
Sinus symptom/complaint
1.3
21.3
1643
12577
R07.3
ICD-10 Finland
Other chest pain
1.3
21.3
1511
11430
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
2.7
21.2
149
554
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
1.9
21.1
309
1609
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
21.1
6335
55795
R00.2
ICD-10 Finland
Palpitations
1.3
21.1
1353
10079
N02CX04
ATC
NA
1.8
21.1
394
2229
D01AA02
ATC
natamycin; topical
1.8
21.1
362
1993
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
1.7
21.1
471
2811
Z00.0
ICD-10 Finland
General medical examination
1.2
21.1
3470
29038
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
21.0
2615
21251
M54.2
ICD-10 Finland
Cervicalgia
1.4
21.0
1282
9472
DM1QA
SPAT
NA
1.7
21.0
416
2395
K08.80
ICD-10 Finland
Toothache NOS
1.3
21.0
1594
12176
G01AF02
ATC
clotrimazole; vaginal
1.5
21.0
727
4834
D11AH05
ATC
dupilumab; topical
11.3
20.9
39
34
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
2.4
20.9
181
755
R52.9
ICD-10 Finland
Pain, unspecified
1.3
20.8
1475
11153
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.3
20.8
1471
11118
ZXC20
NOMESCO Finland
Use of chemical agents
2.0
20.8
252
1220
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.6
20.8
517
3177
M03AX01
ATC
botulinum toxin; parenteral
2.1
20.7
245
1177
R05CA10
ATC
expectorants - combinations
1.8
20.7
360
1991
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.4
20.7
1268
9380
B00.10
ICD-10 Finland
Herpes simplex facialis
2.4
20.7
177
734
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.4
20.6
847
5832
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.2
20.6
6896
61205
SPAT1193
SPAT
Pap smear
0.8
20.6
1518
18995
R05DA09
ATC
dextromethorphan; oral
1.9
20.4
280
1426
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.2
20.2
5070
44011
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.3
20.1
1782
13897
G43.3
ICD-10 Finland
Complicated migraine
1.8
20.1
348
1925
ZY010
NOMESCO Finland
Hospital outpatient
1.4
20.1
988
7042
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
2.0
20.0
251
1238
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
2.1
20.0
227
1072
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
3.1
19.9
110
351
R1250
NOMESCO Finland
Evaluation of functional capability
1.8
19.9
357
1993
M09AX01
ATC
hyaluronic acid; parenteral
1.5
19.9
656
4313
G03CA04
ATC
estriol; systemic, vaginal
1.4
19.9
1052
7593
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.2
19.9
2592
21171
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.7
19.8
380
2168
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.3
19.8
1689
13110
C08DB01
ATC
diltiazem; oral
1.6
19.8
568
3620
R29
ICPC
Respiratory symptom/complaint other
1.4
19.7
1102
8029
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.3
19.6
1439
10938
H52.1
ICD-10 Finland
Myopia
1.5
19.6
652
4300
L30.8
ICD-10 Finland
Other specified dermatitis
1.7
19.6
374
2131
H00.1
ICD-10 Finland
Chalazion
1.5
19.6
605
3925
N02CC02
ATC
naratriptan; oral
1.7
19.5
379
2170
H18.6
ICD-10 Finland
Keratoconus
2.8
19.5
126
446
N05AB04
ATC
prochlorperazine; systemic, rectal
1.8
19.5
359
2027
SPAT1336
SPAT
Request for examination
1.5
19.4
623
4073
H16.8
ICD-10 Finland
Other keratitis
4.2
19.4
74
175
N07CA01
ATC
betahistine; oral
1.4
19.3
1076
7838
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
2.1
19.3
227
1090
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
19.2
619
4051
L71.0
ICD-10 Finland
Perioral dermatitis
1.9
19.2
303
1625
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
2.6
19.1
136
510
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
1.7
19.1
361
2051
N06AX26
ATC
vortioxetine; oral
1.4
19.1
1106
8104
N02CD01
ATC
erenumab; parenteral
2.2
19.1
189
842
ZXD35
NOMESCO Finland
Usual procedure
1.6
19.1
526
3321
S01AA03
ATC
neomycin; ophthalmic (antibiotics)
2.7
19.0
134
498
R07
ICPC
Sneezing/nasal congestion
1.3
19.0
1358
10283
A91
ICPC
Abnormal result investigation NOS
1.5
19.0
648
4295
F16
ICPC
Eyelid symptom/complaint
1.4
19.0
813
5649
UJD02
NOMESCO Finland
Gastroscopy
1.5
18.9
705
4765
RD210
NOMESCO Finland
NA
1.8
18.9
339
1898
S01EA03
ATC
apraclonidine; ophthalmic
2.6
18.8
134
503
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.4
18.8
936
6688
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
2.9
18.7
112
378
D22
ICD-10 Finland
Melanocytic naevi
1.4
18.7
868
6127
A28
ICPC
Limited function/disability NOS
1.3
18.6
1817
14349
A99
ICPC
Disease/condition unspecnature/site
1.3
18.6
1285
9681
G03AC03
ATC
levonorgestrel; systemic
1.2
18.5
2404
19620
OAB95
SPAT
NA
1.4
18.5
1017
7390
SAA03
NOMESCO Finland
Extended examination of mouth
1.1
18.5
8839
80225
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.3
18.5
1956
15599
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.5
18.4
671
4514
X57
ICD-10 Finland
Unspecified privation
1.7
18.4
356
2037
M01AE52
ATC
naproxen and esomeprazole; oral
1.5
18.4
565
3658
TQW40
NOMESCO Finland
Remowal of suture of skin
1.3
18.3
1159
8615
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.5
18.3
629
4179
M15
ICD-10 Finland
Polyarthrosis
1.5
18.3
683
4618
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
18.2
830
5833
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.4
18.2
936
6722
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.2
18.2
2387
19498
L16
ICPC
Ankle symptom/complaint
1.3
18.2
1877
14923
B37.0
ICD-10 Finland
Candidal stomatitis
2.2
18.2
190
867
M05BA04
ATC
alendronic acid; oral
1.3
18.2
1158
8619
N89
ICPC
Migraine
1.5
18.2
695
4722
N30.0
ICD-10 Finland
Acute cystitis
1.2
18.2
2644
21839
R49.0
ICD-10 Finland
Dysphonia
1.9
18.1
282
1506
H02
ICPC
Hearing complaint
1.3
18.1
1589
12377
M54.6
ICD-10 Finland
Pain in thoracic spine
1.3
17.9
1241
9353
L60.0
ICD-10 Finland
Ingrowing nail
1.5
17.9
712
4877
H60
ICD-10 Finland
Otitis externa
1.4
17.9
814
5721
R49.03
ICD-10 Finland
Atrophic dysphonia
2.6
17.9
131
500
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
2.4
17.9
146
593
EB1HA
SPAT
NA
2.3
17.8
160
679
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
17.8
5288
46443
H60.8
ICD-10 Finland
Other otitis externa
1.6
17.8
456
2826
L50.9
ICD-10 Finland
Urticaria, unspecified
1.5
17.8
676
4590
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.7
17.8
339
1933
K80
ICPC
Cardiac arrhythmia NOS
1.3
17.7
1126
8376
R4190
NOMESCO Finland
Nutritional therapy
1.5
17.7
577
3788
F32
ICD-10 Finland
Depressive episode
1.4
17.7
1056
7775
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
4.1
17.7
69
167
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
1.6
17.7
492
3114
L50.8
ICD-10 Finland
Other urticaria
1.7
17.7
335
1905
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.4
17.7
990
7219
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.5
17.6
649
4377
J01DC04
ATC
cefaclor; oral
1.9
17.6
259
1357
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.2
17.5
2030
16357
S01GA55
ATC
phenylephrine, combinations; ophthalmic
5.7
17.5
50
87
L50.3
ICD-10 Finland
Dermatographic urticaria
1.8
17.4
320
1806
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.6
17.4
419
2556
-62
ICPC
Administrative procedure
1.6
17.4
469
2948
N62
ICD-10 Finland
Hypertrophy of breast
1.4
17.3
785
5513
XF404
NOMESCO Finland
Ambulatory ECG
1.3
17.3
1324
10122
N76.0
ICD-10 Finland
Acute vaginitis
1.3
17.3
1272
9673
R03BA07
ATC
mometasone; inhalant
2.2
17.2
170
756
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.2
17.2
1986
16001
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
2.2
17.2
178
812
U05
ICPC
Urination problems other
1.5
17.1
573
3784
T86
ICPC
Hypothyroidism/myxoedema
1.5
17.1
676
4622
XX9CW
NOMESCO Finland
Submitting image material and/or investigation material to patient
2.3
17.1
158
679
D02
ICPC
Abdominal pain epigastric
1.4
17.1
1036
7648
G03CX01
ATC
tibolone; oral
1.6
17.1
485
3083
H66.9
ICD-10 Finland
Otitis media, unspecified
1.3
17.1
1165
8759
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
17.1
3138
26494
I84
ICD-10 Finland
Hemorrhoids
1.6
17.1
456
2856
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
17.1
1702
13474
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.4
17.0
965
7053
R75
ICPC
Sinusitis acute/chronic
1.4
17.0
884
6368
J01DB05
ATC
cefadroxil; oral
1.4
17.0
758
5311
S02AA30
ATC
antiinfectives, combinations; otic
1.4
17.0
879
6326
A13
ICPC
Concern/fear medical treatment
1.9
16.9
246
1283
A03BA03
ATC
hyoscyamine; oral
2.4
16.9
139
566
R51.81
ICD-10 Finland
Facial pain NOS
1.6
16.9
395
2391
CBB30
NOMESCO Finland
Excision of lesion of eyelid
1.6
16.8
406
2477
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.3
16.8
1746
13888
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
2.0
16.8
201
973
A12
ICPC
ALLERGY/ALLERGIC REACTION
3.1
16.8
91
289
N06AB08
ATC
fluvoxamine; oral
1.6
16.7
454
2857
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.4
16.7
865
6225
F34.1
ICD-10 Finland
Dysthymia
1.5
16.7
659
4509
K59.01
ICD-10 Finland
Constipation outlet obstruction type
2.1
16.7
196
941
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
16.7
3272
27781
K59.1
ICD-10 Finland
Functional diarrhoea
1.4
16.7
816
5812
C10AX09
ATC
ezetimibe; oral
1.3
16.7
1354
10439
TKC20
NOMESCO Finland
Catheterisation of bladder
1.4
16.6
845
6062
H01.89
ICD-10 Finland
Other specified inflammation of eyelids
2.6
16.6
120
457
D07AC03
ATC
desoximetasone; topical
1.8
16.6
269
1461
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
2.8
16.5
106
374
286
Kela drug reimbursment
Ciclosporin eye drop
10.2
16.5
32
31
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.4
16.4
841
6039
M01AB01
ATC
indometacin; systemic, rectal
1.4
16.4
856
6170
L30
ICD-10 Finland
Other dermatitis
1.7
16.3
338
1981
50709
ICD-8 Finland
Hay fever, Unspecified
2.6
16.3
114
426
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.3
16.2
1162
8799
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
1.7
16.2
316
1817
Z3232
NOMESCO Finland
Midwife
1.2
16.2
1816
14577
S06.0
ICD-10 Finland
Concussion
1.2
16.2
1831
14713
H01.1
ICD-10 Finland
Noninfectious dermatoses of eyelid
2.8
16.2
102
358
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.1
16.1
8847
80785
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.2
16.1
2347
19380
HA1RA
SPAT
NA
1.6
16.0
460
2937
L91
ICPC
Osteoarthrosis other
1.8
16.0
256
1382
CG2S4
NOMESCO Finland
Photography of cornea
3.3
16.0
81
245
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
2.0
16.0
197
965
J01CA08
ATC
pivmecillinam; oral
1.1
15.9
9653
88623
D93
ICPC
Irritable bowel syndrome
1.9
15.9
221
1136
H00.00
ICD-10 Finland
Hordeolum
1.4
15.9
678
4709
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
1.5
15.9
574
3857
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.6
15.9
435
2746
F32.1
ICD-10 Finland
Moderate depressive episode
1.3
15.9
1117
8442
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
1.5
15.9
511
3352
C10AA05
ATC
atorvastatin; oral
1.1
15.8
5404
47880
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
15.8
1699
13573
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.3
15.8
1114
8425
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.3
15.7
1098
8288
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
1.7
15.7
334
1969
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.7
15.7
329
1934
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
1.6
15.7
363
2194
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.2
15.7
2144
17587
N02AC04
ATC
dextropropoxyphene; oral
1.6
15.7
436
2764
D06BB10
ATC
imiquimod; topical
1.4
15.6
773
5519
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.2
15.6
1740
13959
S88
ICPC
Dermatitis contact/allergic
1.7
15.6
343
2043
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
1.9
15.6
216
1109
K03.80
ICD-10 Finland
Irradiated enamel
1.4
15.6
885
6474
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.4
15.5
852
6193
R50.9
ICD-10 Finland
Fever, unspecified
1.2
15.5
2392
19858
M54.1
ICD-10 Finland
Radiculopathy
1.5
15.5
601
4100
C08CA13
ATC
lercanidipine; oral
1.2
15.5
1735
13923
M01AB08
ATC
etodolac; oral
1.3
15.5
1226
9422
R23
ICPC
Voice symptom/complaint
1.6
15.4
390
2412
4239
FHL
Other measure in this category
2.9
15.4
93
318
RS221
NOMESCO Finland
NA
1.8
15.4
249
1349
XCH00
NOMESCO Finland
Eye pressure measurement
1.5
15.4
534
3558
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.3
15.4
1157
8827
G03FB08
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.3
15.3
1143
8710
TQW80
NOMESCO Finland
Local dermatologic skincare
1.6
15.3
387
2396
A03DA02
ATC
pitofenone and analgesics; systemic
1.7
15.3
286
1627
D07AB09
ATC
triamcinolone; topical
2.6
15.3
108
406
CFA20
NOMESCO Finland
Biopsy of conjunctiva
4.1
15.3
59
143
F33
ICD-10 Finland
Recurrent depressive disorder
1.6
15.2
383
2368
N06AX18
ATC
reboxetine; oral
2.0
15.2
201
1016
R03AC04
ATC
fenoterol; inhalant
3.3
15.2
75
223
L86
ICPC
Back syndrome with radiating pain
1.4
15.2
911
6719
TQW99
NOMESCO Finland
Other minor procedure on skin
1.4
15.2
671
4694
U72
ICPC
Urethritis
1.6
15.2
405
2541
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
1.3
15.2
1084
8211
J47
ICD-10 Finland
Bronchiectasis
1.9
15.0
230
1225
Z58.8
ICD-10 Finland
Other problems related to physical environment
4.6
15.0
51
109
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.3
14.9
1215
9370
S01
ICPC
Pain/tenderness of skin
1.4
14.9
666
4670
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
1.8
14.9
260
1446
ZXD05
NOMESCO Finland
Urgent procedure
1.1
14.9
6146
55102
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
14.9
371
2288
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.3
14.9
1057
7999
M54.3
ICD-10 Finland
Sciatica
1.3
14.9
936
6956
G03DC05
ATC
[U] tibolone; oral
1.4
14.8
693
4901
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
14.8
880
6482
K04
ICPC
Palpitations/awareness of heart
1.4
14.8
836
6109
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.2
14.8
2208
18270
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.3
14.8
1001
7522
M05BA06
ATC
ibandronic acid; systemic
1.7
14.8
279
1592
TPH04
NOMESCO Finland
Cathetrisation of vein
1.2
14.7
3458
29784
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
14.7
669
4706
WX780
NOMESCO Finland
Remote monitoring CPAP
1.5
14.7
558
3792
S01EE04
ATC
travoprost; ophthalmic
1.8
14.7
251
1387
M76.6
ICD-10 Finland
Achilles tendinitis
1.4
14.7
705
5006
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
1.6
14.7
382
2380
K07.61
ICD-10 Finland
Cracking jaw joint
1.6
14.7
364
2239
N06AX22
ATC
agomelatine; oral
1.6
14.7
398
2508
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.6
14.7
393
2471
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.3
14.6
906
6719
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.4
14.6
587
4035
VALMI
NOMESCO Finland
NA
1.1
14.6
5497
48996
AA1AD
NOMESCO Finland
CT of head and brain
1.2
14.5
3563
30796
N81.6
ICD-10 Finland
Rectocele
1.3
14.5
1121
8588
M03BX01
ATC
baclofen; systemic
1.7
14.5
269
1525
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
2.8
14.5
91
320
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
2.8
14.5
90
314
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.2
14.4
1953
16001
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
4.1
14.4
55
132
A27
ICPC
Fear of other disease NOS
1.4
14.4
673
4759
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
1.9
14.4
223
1193
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.5
14.4
434
2806
D03
ICPC
Heartburn
1.5
14.4
520
3500
C08CA01
ATC
amlodipine; oral
1.1
14.4
5061
44894
F61.0
ICD-10 Finland
Mixed personality disorders
1.7
14.4
321
1925
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
2.4
14.4
125
525
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
1.7
14.3
319
1911
N05BA02
ATC
chlordiazepoxide; systemic
1.7
14.3
310
1840
-44
ICPC
Preventive immunization/medic
1.3
14.3
1270
9908
L04
ICPC
Chest symptom/complaint
1.3
14.3
949
7109
A08
ICPC
Swelling
1.4
14.3
568
3897
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.4
14.3
622
4345
G04AC01
ATC
NA
1.5
14.3
493
3286
L11
ICPC
Wrist symptom/complaint
1.3
14.3
1493
11889
M35.7
ICD-10 Finland
Hypermobility syndrome
1.7
14.2
283
1641
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.6
14.2
385
2426
L08
ICD-10 Finland
Other local infections of skin and subcutaneous tissue
1.8
14.2
261
1476
H19.3
ICD-10 Finland
Keratitis and keratoconjunctivitis in other diseases classified elsewhere
4.7
14.2
47
98
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.5
14.2
532
3609
J32
ICD-10 Finland
Chronic sinusitis
2.3
14.2
125
531
M77.1
ICD-10 Finland
Lateral epicondylitis
1.3
14.2
1318
10344
Z37.0
ICD-10 Finland
Single live birth
1.2
14.1
1921
15744
C07AB12
ATC
nebivolol; oral
1.6
14.1
404
2581
J32.4
ICD-10 Finland
Chronic pansinusitis
1.8
14.1
226
1224
N06BA04
ATC
methylphenidate; oral
1.5
14.0
463
3055
K03.08
ICD-10 Finland
Other wear and tear of the teeth
1.6
14.0
381
2403
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
2.6
14.0
100
379
OAB48
SPAT
NA
1.2
14.0
1835
14980
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.5
14.0
506
3407
D07XA01
ATC
hydrocortisone, combinations; topical
3.1
14.0
77
249
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
1.6
14.0
382
2413
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
1.5
14.0
418
2698
T93
ICPC
Lipid disorder
1.4
14.0
735
5311
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
4.1
14.0
53
127
EAV
NOMESCO Finland
NA
1.7
13.9
313
1879
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
1.6
13.9
336
2056
ZX120
NOMESCO Finland
Intravenous
1.3
13.9
1473
11746
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
2.1
13.9
154
726
M54.8
ICD-10 Finland
Other dorsalgia
1.4
13.9
672
4784
L20
ICPC
Joint symptom/complaint NOS
1.4
13.8
586
4073
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.4
13.8
719
5188
R30.0
ICD-10 Finland
Dysuria
1.4
13.8
570
3942
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.3
13.8
1421
11297
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.8
13.8
1602
19095
A29
ICPC
General symptom/complaint other
1.2
13.7
1749
14235
B60
ICPC
Blood and Immunity, Result test/procedure
1.9
13.7
187
958
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
2.0
13.7
162
783
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
1.5
13.7
430
2808
WX203
NOMESCO Finland
Infraclavicular plexus blockade
1.6
13.6
356
2222
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
2.2
13.6
132
586
S01EC54
ATC
brinzolamide, combinations; ophthalmic
2.1
13.6
145
672
Z76
ICD-10 Finland
Persons encountering health services in other circumstances
1.6
13.6
320
1946
K96
ICPC
Haemorrhoids
1.5
13.6
411
2661
TAB00
NOMESCO Finland
Lumbar puncture
1.4
13.6
751
5471
F51
ICD-10 Finland
Nonorganic sleep disorders
1.4
13.5
631
4462
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.0
13.5
159
770
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
13.5
3853
33673
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
2.0
13.4
158
764
K11.2
ICD-10 Finland
Sialoadenitis
1.5
13.4
506
3435
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
1.6
13.4
331
2041
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.3
13.4
845
6288
H40.11
ICD-10 Finland
Low pressure glaucoma
1.7
13.4
248
1408
SAA02
NOMESCO Finland
Basic examination of mouth
1.1
13.4
15822
149850
N03AF01
ATC
carbamazepine; oral, rectal
1.4
13.4
734
5340
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.3
13.4
894
6711
S80.0
ICD-10 Finland
Contusion of knee
1.3
13.4
1164
9065
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.3
13.4
1001
7640
J33.0
ICD-10 Finland
Polyp of nasal cavity
1.6
13.3
367
2323
A62
ICPC
General and Unspecified, Administrative procedure
1.6
13.3
373
2373
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.6
13.3
313
1904
M43.1
ICD-10 Finland
Spondylolisthesis
1.4
13.3
594
4168
S12
ICPC
Insect bite/sting
1.3
13.3
1166
9089
WX290
SPAT
NA
1.5
13.3
485
3275
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.2
13.2
127
563
T78.3
ICD-10 Finland
Angioneurotic oedema
1.8
13.2
222
1224
R03AA01
ATC
epinephrine; inhalant
7.6
13.2
30
39
CFW99
NOMESCO Finland
Other operation on conjunctiva
4.3
13.2
48
111
R05CB01
ATC
acetylcysteine; inhalant, oral
1.9
13.1
190
993
H04.1
ICD-10 Finland
Other disorders of lacrimal gland
11.3
13.1
24
21
104
Kela drug reimbursment
Thyroid insufficiency
1.3
13.1
1238
9733
M19.8
ICD-10 Finland
Other specified arthrosis
1.5
13.1
466
3129
D01AC08
ATC
ketoconazole; topical
1.9
13.0
201
1074
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.4
13.0
745
5460
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
1.6
13.0
351
2211
N05BE01
ATC
buspirone; oral
1.5
13.0
446
2971
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.6
13.0
349
2198
UDM02
NOMESCO Finland
Sinoscopy
1.6
13.0
346
2176
J05AH02
ATC
oseltamivir; oral
2.2
13.0
132
599
N02BA71
ATC
acetylsalicylic acid, combinations with psycholeptics; systemic
1.6
13.0
326
2018
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.2
13.0
1576
12769
XF600
NOMESCO Finland
Bloodpressure measurement
1.3
12.9
924
7005
L88
ICPC
Rheumatoid/seropositive arthritis
1.4
12.9
615
4371
D12
ICPC
Constipation
1.5
12.9
434
2879
SPAT1216
SPAT
Assessment of functional ability
1.2
12.8
2167
18141
D02BB01
ATC
betacarotene; oral
3.1
12.8
70
226
R60.9
ICD-10 Finland
Oedema, unspecified
1.4
12.8
663
4782
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
1.6
12.7
359
2289
SPAT1057
SPAT
Peak expiratory flow measurement
1.6
12.7
349
2210
F90.0
ICD-10 Finland
Disturbance of activity and attention
1.4
12.7
559
3914
RS222
NOMESCO Finland
NA
1.9
12.7
184
963
L29
ICD-10 Finland
Pruritus
1.8
12.7
206
1123
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.6
12.7
352
2237
SAA01
NOMESCO Finland
Simple examination of mouth
1.1
12.7
17115
162919
WX722
NOMESCO Finland
PEEP
1.4
12.6
550
3844
M20.2
ICD-10 Finland
Hallux rigidus
1.5
12.6
446
2992
A02BX05
ATC
bismuth subcitrate; oral
2.0
12.6
161
807
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.2
12.6
1398
11210
H40
ICD-10 Finland
Glaucoma
2.1
12.6
133
617
C10AA04
ATC
fluvastatin; oral
1.3
12.5
971
7443
R11
ICD-10 Finland
Nausea and vomiting
1.2
12.5
1363
10905
K02.0
ICD-10 Finland
Caries limited to enamel
1.2
12.5
3006
25919
OAB43
SPAT
NA
1.1
12.5
3786
33207
XX9XE
NOMESCO Finland
Other ultrasound examination
2.0
12.5
158
789
HA1AE
SPAT
NA
1.6
12.5
353
2251
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
2.0
12.5
153
754
D01AC07
ATC
tioconazole; topical
1.5
12.5
485
3319
S83.2
ICD-10 Finland
Tear of meniscus, current
1.3
12.4
1084
8441
M75
ICD-10 Finland
Shoulder lesions
1.4
12.4
647
4670
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
1.4
12.4
604
4307
XCD10
NOMESCO Finland
Electrophysiological examination of eye
1.6
12.4
338
2138
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
2.1
12.4
143
687
S02
ICPC
Pruritus
1.4
12.4
555
3900
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
2.3
12.4
110
471
NH3AA
SPAT
NA
1.4
12.4
528
3679
R05CB02
ATC
bromhexine; systemic
1.8
12.4
205
1125
N04BB01
ATC
amantadine; oral
1.7
12.3
231
1317
M50.3
ICD-10 Finland
Other cervical disc degeneration
1.6
12.3
337
2132
R01AB01
ATC
phenylephrine; inhalant, nasal
2.1
12.3
142
680
A09
ICPC
Sweating problem
1.9
12.2
174
908
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.4
12.2
591
4215
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.5
12.2
394
2593
RK110
NOMESCO Finland
NA
2.2
12.2
116
512
R04.0
ICD-10 Finland
Epistaxis
1.3
12.2
859
6502
F72
ICPC
Blepharitis/stye/chalazion
1.6
12.1
319
2000
M23.8
ICD-10 Finland
Other internal derangements of knee
1.4
12.1
612
4397
ELA30
NOMESCO Finland
Biopsy of salivary gland
3.3
12.1
59
176
C08CA05
ATC
nifedipine; systemic
1.3
12.1
824
6207
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
1.8
12.1
197
1077
Z01.9
ICD-10 Finland
Special examination, unspecified
1.3
12.0
846
6405
S02CA06
ATC
dexamethasone and antiinfectives; otic
2.0
12.0
140
677
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
1.7
12.0
224
1278
4740A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Chronic tonsillitis
1.4
11.9
547
3861
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
1.5
11.9
376
2463
R02AD02
ATC
lidocaine; local oral
1.5
11.9
368
2399
K07.6
ICD-10 Finland
Temporomandibular joint disorders
1.9
11.9
163
837
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.3
11.9
1019
7921
K85
ICPC
Elevated blood pressure
1.2
11.9
2071
17388
H33.3
ICD-10 Finland
Retinal breaks without detachment
1.5
11.8
439
2974
J01XC01
ATC
fusidic acid; systemic
1.8
11.8
208
1164
130
Kela drug reimbursment
Malignant tumour
0.7
11.8
546
7266
H33.0
ICD-10 Finland
Retinal detachment with retinal break
1.6
11.8
306
1914
Z50.5
ICD-10 Finland
Speech therapy
1.8
11.8
206
1152
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
1.5
11.8
422
2839
J01X
ATC
OTHER ANTIBACTERIALS
2.3
11.8
109
477
F38
ICPC
Eye, Other laboratory test NEC
2.8
11.8
73
254
L50
ICD-10 Finland
Urticaria
1.6
11.8
269
1625
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
11.8
1970
16477
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
2.0
11.8
139
677
G54.0
ICD-10 Finland
Brachial plexus disorders
1.5
11.7
430
2909
F60.5
ICD-10 Finland
Anankastic personality disorder
1.8
11.7
201
1116
CGG99
NOMESCO Finland
Other reconstructive operations on cornea and sclera
7.8
11.7
26
33
A85
ICPC
Adverse effect medical agent
2.0
11.7
149
747
H52.2
ICD-10 Finland
Astigmatism
1.7
11.7
251
1494
TKD00
NOMESCO Finland
Dilatation of urethra
2.1
11.6
135
651
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
2.2
11.6
116
526
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.3
11.6
966
7481
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.2
11.6
2650
22759
XQ801
NOMESCO Finland
Intracutantest
2.5
11.6
85
330
H26.02
ICD-10 Finland
Presenil cataract
1.5
11.6
367
2407
WX723
NOMESCO Finland
CPAP therapy
1.4
11.6
487
3385
EMAK
NOMESCO Finland
NA
1.4
11.5
652
4770
R23.3
ICD-10 Finland
Spontaneous ecchymoses
1.6
11.5
267
1623
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.3
11.5
706
5235
XKD03
NOMESCO Finland
Urethral pressure profilometry
1.5
11.5
348
2258
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
1.9
11.5
164
855
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.4
11.5
635
4633
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.4
11.4
569
4080
E000008
ATC
NA
3.0
11.4
66
221
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.3
11.4
1091
8598
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.2
11.4
1216
9709
K57
ICD-10 Finland
Diverticular disease of intestine
1.6
11.4
282
1743
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.6
11.4
133
2319
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
1.8
11.4
195
1085
C10AA03
ATC
pravastatin; oral
1.3
11.4
798
6037
H01
ICD-10 Finland
Other inflammation of eyelid
2.5
11.4
88
352
G57.6
ICD-10 Finland
Lesion of plantar nerve
1.5
11.4
325
2082
N05CD08
ATC
midazolam; nasal, systemic
1.6
11.3
286
1775
SPAT1359
SPAT
Use of symptom diary
1.5
11.3
364
2394
H11.0
ICD-10 Finland
Pterygium
2.4
11.3
96
402
XKC03
NOMESCO Finland
Water cystometry
1.4
11.3
446
3063
L29.9
ICD-10 Finland
Pruritus, unspecified
1.5
11.3
356
2334
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.3
11.2
1018
7968
RJ512
NOMESCO Finland
NA
4.2
11.2
41
96
H40.9
ICD-10 Finland
Glaucoma, unspecified
1.8
11.2
184
1010
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.2
11.2
1485
12142
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
1.4
11.2
550
3936
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.2
11.2
1789
14905
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.2
11.2
1539
12637
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
1.8
11.1
172
926
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
1.6
11.1
274
1690
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
1.7
11.1
209
1196
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.3
11.1
936
7261
K03.00
ICD-10 Finland
Approximal wear
1.3
11.1
829
6325
U71
ICPC
Cystitis/urinary infection other
1.3
11.1
1075
8487
SXC05
NOMESCO Finland
Other oral or dental procedure
1.3
11.1
1081
8538
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
1.4
11.1
513
3632
N01BB20
ATC
amides - combinations; parenteral
1.9
11.1
165
877
M01AC02
ATC
tenoxicam; systemic, rectal
1.4
11.1
643
4727
IBA03
NOMESCO Finland
Psychotherapy evaluation
1.9
11.1
159
835
G04BD11
ATC
fesoterodine; oral
1.5
11.0
373
2482
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
1.7
11.0
238
1418
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.3
11.0
900
6951
S01AA12
ATC
tobramycin; ophthalmic
3.4
11.0
52
152
G43.8
ICD-10 Finland
Other migraine
1.6
11.0
268
1650
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
1.3
11.0
645
4752
R15
ICD-10 Finland
Faecal incontinence
1.5
11.0
371
2468
R23
ICD-10 Finland
Other skin changes
1.9
11.0
168
898
C03DA01
ATC
spironolactone; oral
1.2
11.0
1283
10349
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
1.6
11.0
287
1801
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
2.4
11.0
86
348
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
1.6
10.9
264
1622
M22.4
ICD-10 Finland
Chondromalacia patellae
1.4
10.9
566
4086
S01EB01
ATC
pilocarpine; ophthalmic
2.5
10.9
82
324
N02BE51
ATC
paracetamol, combinations excl. psycholeptics; systemic
1.9
10.9
153
794
XJH00
NOMESCO Finland
Transanal ultrasonography
1.4
10.9
435
2995
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.1
10.9
3716
32843
C03AA03
ATC
hydrochlorothiazide; oral
1.2
10.8
1199
9615
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
2.3
10.8
94
400
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.4
10.8
430
2956
D07BB01
ATC
flumetasone and antiseptics; topical
2.2
10.8
102
451
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
10.8
1179
9441
V01AA11
ATC
animals
7.3
10.8
25
34
M01AE11
ATC
tiaprofenic acid; oral, rectal
1.4
10.8
517
3684
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
1.8
10.8
168
905
G01AF08
ATC
tioconazole; vaginal
1.5
10.8
338
2215
R05CB03
ATC
carbocisteine; oral
1.6
10.8
305
1949
C05AA05
ATC
betamethasone; rectal, topical
2.2
10.7
107
486
S22
ICPC
Nail symptom/complaint
1.3
10.7
840
6457
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
1.5
10.7
340
2230
X15
ICPC
Vaginal symptom/complaint other
1.3
10.7
686
5125
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.6
10.7
126
2192
M19.9
ICD-10 Finland
Arthrosis, unspecified
1.4
10.7
496
3513
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.3
10.7
692
5177
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.2
10.7
2324
19884
R52.1
ICD-10 Finland
Chronic intractable pain
1.9
10.6
141
720
R52.0
ICD-10 Finland
Acute pain
1.4
10.6
506
3599
SPAT1342
SPAT
Referral to specialised care
1.8
10.6
184
1028
L14
ICPC
Leg/thigh symptom/complaint
1.2
10.6
1111
8856
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
1.6
10.6
252
1543
B02
ICD-10 Finland
Zoster [herpes zoster]
1.4
10.6
507
3613
P01
ICPC
Feeling anxious/nervous/tense
1.2
10.5
2323
19889
WW200
SPAT
NA
0.8
10.5
1380
16269
CBA10
NOMESCO Finland
Biopsy of eyelid
2.1
10.5
115
543
RS121
NOMESCO Finland
NA
2.1
10.5
110
510
WX892
NOMESCO Finland
Monitored bed care
1.3
10.5
990
7794
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
1.8
10.5
181
1009
E78
ICD-10 Finland
Disorders of lipoprotein metabolism and other lipidaemias
1.5
10.5
395
2689
XA800
NOMESCO Finland
Neuropsychological investigation
1.3
10.4
617
4554
A07EA06
ATC
budesonide; oral, local oral
1.4
10.4
550
3986
L07
ICPC
Jaw symptom/complaint
1.7
10.4
206
1199
N41.1
ICD-10 Finland
Chronic prostatitis
1.7
10.4
188
1065
T82
ICPC
Obesity
1.3
10.4
643
4777
A02BD02
ATC
lansoprazole, tetracycline and metronidazole; systemic
1.5
10.4
323
2113
KAY40
NOMESCO Finland
NA
1.4
10.4
529
3811
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.2
10.4
1255
10163
C03CA01
ATC
furosemide; systemic
1.1
10.3
3415
30106
P76
ICPC
Depressive disorder
1.2
10.3
1216
9819
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
1.8
10.3
172
948
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.1
10.3
5527
50144
H25.0
ICD-10 Finland
Senile incipient cataract
1.3
10.3
661
4937
4741B
ICD-9 Finland
Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]
1.5
10.3
306
1980
P72
ICPC
Schizophrenia
0.5
10.3
106
1911
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.3
10.3
1016
8045
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
1.3
10.3
617
4565
R39.1
ICD-10 Finland
Other difficulties with micturition
1.5
10.3
312
2031
6931A
ICD-9 Finland
Dermatitis due to substances taken internally, Due to food
7.6
10.2
23
30
50499
ICD-8 Finland
Deflected nasal septum
1.8
10.2
158
853
EBA00
NOMESCO Finland
Extraction of tooth
0.9
10.2
5780
61737
A07EC02
ATC
mesalazine; oral, rectal
1.3
10.2
898
7008
N95
ICD-10 Finland
Menopausal and other perimenopausal disorders
1.4
10.2
400
2745
KCV04
NOMESCO Finland
Distension of bladder with fluid
1.9
10.2
143
743
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
1.5
10.1
373
2529
I49
ICD-10 Finland
Other cardiac arrhythmias
1.6
10.1
238
1456
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.2
10.0
1452
11979
K60.1
ICD-10 Finland
Chronic anal fissure
1.5
10.0
344
2297
Z04
ICD-10 Finland
Examination and observation for other reasons
1.6
10.0
228
1383
A06AX04
ATC
linaclotide; oral
2.7
10.0
64
231
RK320
NOMESCO Finland
NA
2.1
10.0
106
494
F27
ICPC
Fear of eye disease
1.9
10.0
136
703
S94
ICPC
Ingrowing nail
1.6
10.0
231
1408
Z94.7
ICD-10 Finland
Corneal transplant status
2.8
10.0
63
225
R68.2
ICD-10 Finland
Dry mouth, unspecified
2.1
10.0
111
530
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.5
9.9
328
2174
CCC00
NOMESCO Finland
Occlusion of lacrimal punctum or canaliculus
6.8
9.9
24
35
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
2.0
9.9
122
604
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.3
9.9
977
7729
C09CA01
ATC
losartan; oral
1.1
9.9
3447
30486
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.2
9.9
1215
9857
A06AC07
ATC
triticum (wheat fibre); oral
2.8
9.9
60
210
S02.51
ICD-10 Finland
Fracture of tooth, open
1.2
9.9
1675
14025
SBA10
NOMESCO Finland
Measurement of excretion of saliva
1.8
9.9
161
884
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
2.6
9.9
69
263
G03DA04
ATC
progesterone; systemic, rectal, vaginal
1.3
9.9
642
4811
G03CB01
ATC
dienestrol; oral, vaginal
1.5
9.9
342
2293
J33.8
ICD-10 Finland
Other polyp of sinus
1.6
9.8
270
1718
WZB00
SPAT
NA
1.3
9.8
974
7717
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
1.9
9.8
136
708
F2680
NOMESCO Finland
NA
4.1
9.8
36
86
Z71.9
ICD-10 Finland
Counselling, unspecified
1.3
9.8
908
7137
L04AA01
ATC
[U] ciclosporin; systemic
1.6
9.8
220
1330
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
1.5
9.8
289
1870
J06
ICD-10 Finland
Acute upper respiratory infections of multiple and unspecified sites
1.3
9.7
590
4374
H20.1
ICD-10 Finland
Chronic iridocyclitis
1.8
9.7
169
949
G04CB02
ATC
dutasteride; oral
1.5
9.7
325
2161
M76.0
ICD-10 Finland
Gluteal tendinitis
1.6
9.7
262
1661
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
4.5
9.7
33
73
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.4
9.7
419
2934
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.1
9.7
3694
32862
F60.9
ICD-10 Finland
Personality disorder, unspecified
1.6
9.7
247
1541
S08
ICPC
Skin colour change
1.3
9.7
671
5076
G44.0
ICD-10 Finland
Cluster headache syndrome
1.7
9.6
181
1040
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
1.4
9.6
478
3428
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.5
9.6
348
2353
TMA00
NOMESCO Finland
Episiotomy
1.3
9.6
567
4183
D06BB04
ATC
podophyllotoxin; topical
1.2
9.6
1035
8279
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.2
9.6
1945
16543
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
1.4
9.6
399
2772
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
1.6
9.6
230
1416
WZA90
NOMESCO Finland
Other doctors statement
1.1
9.6
4637
41822
L84
ICD-10 Finland
Corns and callosities
1.4
9.6
448
3182
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
1.7
9.6
196
1155
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
1.3
9.6
690
5249
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
1.6
9.6
251
1581
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.4
9.6
393
2725
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.2
9.5
1846
15639
I10
ICD-10 Finland
Essential (primary) hypertension
1.1
9.5
9007
83926
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
1.4
9.5
453
3224
H52.4
ICD-10 Finland
Presbyopia
1.5
9.5
361
2466
J01XE01
ATC
nitrofurantoin; oral
1.5
9.5
291
1899
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.2
9.5
990
7892
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
1.7
9.5
172
977
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.7
9.5
291
4124
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.2
9.5
1334
10978
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
1.5
9.4
329
2206
ZX112
NOMESCO Finland
Subcutaneous
1.5
9.4
279
1806
-64
ICPC
Encounter/prob initiated by provider
1.6
9.4
230
1424
KMAK
NOMESCO Finland
NA
1.1
9.4
12065
113850
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
1.4
9.4
385
2668
50701
ICD-8 Finland
Hay fever, Vernalis
5.9
9.4
25
42
D23
ICD-10 Finland
Other benign neoplasms of skin
1.5
9.4
312
2075
K07
ICPC
Swollen ankles/oedema
1.4
9.3
490
3548
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.3
9.3
629
4740
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
1.5
9.3
298
1965
S71
ICPC
Herpes simplex
1.9
9.3
132
691
M67.4
ICD-10 Finland
Ganglion
1.2
9.3
1089
8793
SDA02
NOMESCO Finland
Parodonthologic therapy
1.1
9.3
6899
63579
F43
ICPC
Eye, Other diagnostic procedure
1.6
9.3
217
1328
L73.8
ICD-10 Finland
Other specified follicular disorders
1.8
9.3
140
751
CHD00
NOMESCO Finland
Laser trabeculoplasty
1.9
9.3
138
737
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.3
9.3
700
5361
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
1.6
9.3
220
1351
R61.9
ICD-10 Finland
Hyperhidrosis, unspecified
1.7
9.3
170
971
I78.1
ICD-10 Finland
Naevus, non-neoplastic
1.4
9.3
356
2438
S82
ICPC
Naevus/mole
1.2
9.2
2149
18477
D18
ICPC
Change in faeces/bowel movements
1.5
9.2
292
1918
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
1.6
9.2
213
1298
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.3
9.2
788
6133
RK220
NOMESCO Finland
NA
2.4
9.2
73
298
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.3
9.2
537
3963
G50.0
ICD-10 Finland
Trigeminal neuralgia
1.6
9.2
248
1574
J35.1
ICD-10 Finland
Hypertrophy of tonsils
1.5
9.1
330
2232
OAA65
SPAT
NA
1.2
9.1
1943
16588
CCD50
NOMESCO Finland
Dacryocystorhinostomy with insertion of tube
2.9
9.1
53
180
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.3
9.1
749
5801
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
3.7
9.1
38
102
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.4
9.1
391
2734
-50
ICPC
Medication/prescr/renewal
1.3
9.1
580
4338
D25
ICPC
Abdominal distension
1.5
9.1
284
1865
CS2P4
NOMESCO Finland
Optic nerve head imaging
2.3
9.1
81
350
R4130
NOMESCO Finland
Speech therapy
1.5
9.0
267
1728
EKA10
NOMESCO Finland
Biopsy of cheek
1.5
9.0
284
1866
J38.4
ICD-10 Finland
Oedema of larynx
2.2
9.0
89
402
B37.08
ICD-10 Finland
Other candidal stomatitis
2.0
9.0
104
504
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
2.1
9.0
97
457
R25.2
ICD-10 Finland
Cramp and spasm
1.5
9.0
318
2138
CBG99
NOMESCO Finland
Other operation for trichiasis
6.6
9.0
22
33
R41.3
ICD-10 Finland
Other amnesia
1.5
9.0
294
1949
R03BB02
ATC
oxitropium bromide; inhalant
2.7
9.0
61
227
CHD35
NOMESCO Finland
Laser goniopuncture
2.8
9.0
54
189
N01BB02
ATC
lidocaine; parenteral
1.8
9.0
143
780
A69.2
ICD-10 Finland
Lyme disease
1.3
9.0
716
5521
ND2AA
SPAT
NA
1.4
9.0
476
3457
H81
ICPC
Excessive ear wax
1.2
9.0
2104
18107
J05AB09
ATC
famciclovir; oral
2.1
9.0
96
451
B01AB05
ATC
enoxaparin; parenteral
1.1
8.9
5100
46386
KAY20
NOMESCO Finland
NA
1.4
8.9
407
2880
G03FA12
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.3
8.9
880
6972
M05BA07
ATC
risedronic acid; oral
1.4
8.9
408
2888
L19
ICPC
Muscle symptom/complaint NOS
1.4
8.9
360
2489
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.3
8.9
607
4585
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
1.4
8.9
445
3203
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.3
8.9
817
6419
N05CD05
ATC
triazolam; oral, sublingual
1.8
8.9
146
806
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
1.5
8.9
268
1745
C07AB02
ATC
metoprolol; systemic
1.1
8.9
2737
24013
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.3
8.9
844
6658
K07.4
ICD-10 Finland
Malocclusion, unspecified
1.5
8.8
277
1819
G01AG02
ATC
terconazole; vaginal
1.7
8.8
177
1039
UJD10
SPAT
NA
1.7
8.8
192
1152
XQ820
NOMESCO Finland
Exposure to medicinal substance
2.3
8.8
77
331
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
1.5
8.8
306
2058
H61.2
ICD-10 Finland
Impacted cerumen
1.3
8.8
756
5891
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
2.0
8.8
100
485
UJF32
SPAT
NA
1.6
8.7
226
1419
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.8
8.7
151
849
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.3
8.7
576
4330
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
1.5
8.7
304
2041
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.2
8.7
1168
9565
H00
ICD-10 Finland
Hordeolum and chalazion
1.8
8.7
137
744
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
1.4
8.7
429
3079
3AX01
NOMESCO Finland
NA
2.3
8.7
76
325
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
1.5
8.7
286
1898
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
1.6
8.7
191
1149
M13.9
ICD-10 Finland
Arthritis, unspecified
1.2
8.7
1096
8923
JG1JB
NOMESCO Finland
Defekography with X-ray
1.9
8.7
127
673
S04
ICPC
Lump/swelling localized
1.2
8.7
1572
13242
R03DX05
ATC
omalizumab; parenteral
4.4
8.7
30
68
ZX114
NOMESCO Finland
Intramuscular
1.6
8.7
222
1391
S01EA02
ATC
dipivefrine; ophthalmic
3.1
8.6
45
144
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.3
8.6
587
4430
NB1AT
NOMESCO Finland
Puncture of shoulder with ultrasound guidance
2.1
8.6
97
468
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
1.6
8.6
202
1239
NG1BG
SPAT
NA
1.5
8.6
304
2047
LCA06
NOMESCO Finland
Biopsy of endometrium
1.1
8.6
2366
20598
B00.5
ICD-10 Finland
Herpesviral ocular disease
2.6
8.6
57
213
RT272
NOMESCO Finland
NA
2.4
8.6
69
284
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
2.4
8.6
69
284
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
1.3
8.5
515
3819
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
1.8
8.5
138
760
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.3
8.5
665
5117
RD211
NOMESCO Finland
NA
1.3
8.5
656
5037
K05.0
ICD-10 Finland
Acute gingivitis
1.4
8.5
401
2853
4222
FHL
Endonasal etmoidectomy
2.0
8.5
100
489
WW200
NOMESCO Finland
Immunization
1.4
8.5
398
2830
S92.3
ICD-10 Finland
Fracture of metatarsal bone
1.3
8.5
547
4097
F05
ICPC
Visual disturbance other
1.4
8.5
363
2541
MAX99
NOMESCO Finland
Assistance to normal delivery
1.2
8.5
1763
15029
E61.1
ICD-10 Finland
Iron deficiency
1.5
8.4
287
1920
M01AE51
ATC
ibuprofen, combinations; systemic
1.6
8.4
211
1313
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
1.5
8.4
284
1898
S15
ICPC
Foreign body in skin
1.2
8.4
873
6959
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
1.5
8.4
249
1616
N03
ICPC
Pain face
1.8
8.4
127
684
B00.11
ICD-10 Finland
Herpes simplex labialis
1.6
8.4
230
1464
H26.2
ICD-10 Finland
Complicated cataract
1.7
8.4
160
924
R06
ICD-10 Finland
Abnormalities of breathing
1.8
8.4
140
777
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
1.5
8.4
249
1618
EBA00
SPAT
NA
1.5
8.4
300
2029
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
2.1
8.4
87
404
H81.3
ICD-10 Finland
Other peripheral vertigo
1.4
8.4
367
2580
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
1.7
8.4
167
979
N05CD02
ATC
nitrazepam; oral
1.6
8.4
186
1126
SPAT1281
SPAT
Other administrative function
1.2
8.4
1312
10916
P25
ICPC
Phase of life problem adult
1.3
8.3
753
5902
P58
ICPC
Psychological, Therapeutic counselling/listening
1.5
8.3
286
1919
N39.3
ICD-10 Finland
Stress incontinence
1.2
8.3
1229
10165
S01BA09
ATC
clobetasone; ophthalmic
5.5
8.3
23
41
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
1.5
8.3
254
1663
JN1AE
SPAT
NA
1.4
8.3
346
2409
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
1.6
8.3
203
1259
L09
ICPC
Arm symptom/complaint
1.3
8.3
684
5305
RJ411
NOMESCO Finland
NA
2.2
8.3
81
366
N06AX17
ATC
milnacipran; oral
1.6
8.3
180
1084
R33
ICD-10 Finland
Retention of urine
1.3
8.3
614
4694
N64.9
ICD-10 Finland
Disorder of breast, unspecified
1.7
8.3
171
1013
H53.2
ICD-10 Finland
Diplopia
1.4
8.3
389
2772
H60.3
ICD-10 Finland
Other infective otitis externa
1.4
8.2
311
2128
L95
ICPC
Osteoporosis
1.4
8.2
386
2750
K05.09
ICD-10 Finland
Acute gingivitis, UNS
1.6
8.2
214
1348
B07.9
ICD-10 Finland
Verruca simplex
1.3
8.2
541
4064
L21
ICD-10 Finland
Seborrhoeic dermatitis
1.6
8.2
196
1208
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
1.5
8.2
274
1828
M53.2
ICD-10 Finland
Spinal instabilities
1.8
8.2
123
660
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.3
8.2
646
4981
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.2
8.2
880
7046
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
1.8
8.2
136
755
CCD30
NOMESCO Finland
Reconstruction of lacrimal canaliculus
4.5
8.2
27
59
J01XX01
ATC
fosfomycin; systemic
1.4
8.1
330
2289
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
1.7
8.1
175
1049
L01
ICD-10 Finland
Impetigo
1.6
8.1
213
1345
M70.7
ICD-10 Finland
Other bursitis of hip
1.4
8.1
341
2382
C07AG02
ATC
carvedilol; oral
1.3
8.1
620
4759
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.5
8.1
84
1505
62550
ICD-8 Finland
NA
2.0
8.1
101
505
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.2
8.1
1283
10684
L84
ICPC
Back syndrome without radiat pain
1.3
8.1
663
5136
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.1
8.1
10779
101652
R5110
SPAT
NA
1.4
8.1
309
2120
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.3
8.1
520
3897
H53.8
ICD-10 Finland
Other visual disturbances
1.7
8.0
160
939
R05DA05
ATC
opium alkaloids with morphine; systemic
1.9
8.0
109
565
L26
ICD-10 Finland
Exfoliative dermatitis
3.4
8.0
36
104
RK420
NOMESCO Finland
NA
3.4
8.0
36
104
CBN99
NOMESCO Finland
Other operation on eyelid for malposition
2.6
8.0
56
216
ZX101
NOMESCO Finland
Sublingual
6.7
8.0
19
28
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
1.5
7.9
272
1823
I49.1
ICD-10 Finland
Atrial premature depolarization
1.4
7.9
424
3089
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
1.7
7.9
143
813
TCG10
NOMESCO Finland
Removal of sutures from cornea
2.4
7.9
65
271
N64.4
ICD-10 Finland
Mastodynia
1.3
7.9
473
3504
L05
ICPC
Flank/axilla symptom/complaint
1.3
7.9
780
6186
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
1.5
7.9
267
1788
L04AB01
ATC
etanercept; parenteral
1.5
7.9
241
1575
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.2
7.9
1014
8279
RT271
NOMESCO Finland
NA
2.7
7.9
50
180
M19
ICD-10 Finland
Other arthrosis
1.5
7.8
265
1774
OAA80
SPAT
NA
0.8
7.8
515
6522
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.4
7.8
352
2489
R31
ICD-10 Finland
Unspecified haematuria
1.2
7.8
968
7872
134
Kela drug reimbursment
General erythroderma
2.5
7.8
56
220
SXC03
NOMESCO Finland
Other oral or dental procedure
1.7
7.8
158
934
N03AG01
ATC
valproic acid; systemic, rectal
1.2
7.8
984
8022
J00
ICD-10 Finland
Acute nasopharyngitis [common cold]
1.4
7.7
352
2496
CBB00
NOMESCO Finland
Excision of chalazion
1.6
7.7
176
1075
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
1.5
7.7
248
1642
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
1.5
7.7
233
1524
R49.09
ICD-10 Finland
Unspecified dysphonia
1.7
7.7
143
825
344
Kela drug reimbursment
Omalizumab
3.6
7.7
32
87
E66
ICD-10 Finland
Obesity
1.3
7.7
700
5500
K07.68
ICD-10 Finland
Other disorders of the jaw joint
1.8
7.7
122
667
SPAT1360
SPAT
Extensive global examination
1.2
7.6
1086
8952
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
1.8
7.6
130
730
N05AF01
ATC
flupentixol; systemic
1.5
7.6
220
1421
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
3.1
7.6
39
124
C01DA14
ATC
isosorbide mononitrate; oral
1.2
7.6
1322
11099
B05CB01
ATC
sodium chloride; irrigating solution
2.7
7.6
47
169
D09
ICPC
Nausea
1.2
7.6
783
6239
R03
ICPC
Wheezing
1.7
7.6
151
885
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
1.4
7.6
330
2320
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
1.7
7.6
142
817
A07EA02
ATC
hydrocortisone; rectal
1.4
7.6
334
2353
R61
ICD-10 Finland
Hyperhidrosis
1.8
7.6
126
702
S81.0
ICD-10 Finland
Open wound of knee
1.5
7.6
241
1592
J01.8
ICD-10 Finland
Other acute sinusitis
2.0
7.6
95
477
Z12.4
ICD-10 Finland
Special screening examination for neoplasm of cervix
0.7
7.6
228
3234
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.2
7.6
1251
10461
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
1.3
7.6
585
4498
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.3
7.6
429
3155
R55
ICD-10 Finland
Syncope and collapse
1.2
7.6
1400
11819
M81.5
ICD-10 Finland
Idiopathic osteoporosis
2.0
7.6
97
492
4452
FHL
Tonsil surgery
1.3
7.6
581
4467
50704
ICD-8 Finland
Hay fever, Conjunctivitis allergica
5.5
7.6
21
38
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.2
7.5
1754
15085
W84
ICD-10 Finland
Unspecified threat to breathing
2.6
7.5
53
205
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
3.3
7.5
35
104
G03CC04
ATC
estrone; systemic
1.4
7.5
400
2912
SBA00
NOMESCO Finland
Microbiological examinations
1.4
7.5
341
2415
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
1.7
7.5
152
898
CJ2M4
NOMESCO Finland
Scans and measurement printouts for intraocular lens power calculation
1.8
7.5
117
637
S44
ICPC
Skin, Preventive immunization/medic
1.5
7.5
246
1637
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.1
7.5
1988
17262
36009
ICD-8 Finland
Conjunctivitis and ophthalmia, Unspecified
4.7
7.5
24
51
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.3
7.5
513
3879
G03AA10
ATC
gestodene and ethinylestradiol; systemic (progestogens and estrogens, fixed comb.)
1.6
7.5
198
1254
LCB98
NOMESCO Finland
Other transluminal endoscopic excision of lesion of uterus
1.6
7.5
162
975
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
1.4
7.5
324
2278
CG2Z4
NOMESCO Finland
Specialised imaging of cornea
3.6
7.5
32
89
U60
ICPC
Urological, Result test/procedure
2.0
7.5
88
434
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
1.9
7.5
97
498
S16
ICPC
Bruise/contusion
1.4
7.5
403
2943
N02CD02
ATC
galcanezumab; parenteral
2.7
7.5
46
166
O99.80
ICD-10 Finland
The fear of childbirth
1.2
7.4
871
7043
V07AB
ATC
Solvents and diluting agents, incl. irrigating solutions
4.0
7.4
28
70
R06AE02
ATC
NA
5.3
7.4
21
39
DMB10
NOMESCO Finland
Radical maxillary antrotomy
2.2
7.4
71
322
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
1.7
7.4
154
917
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
1.8
7.4
129
728
R22
ICD-10 Finland
Localized swelling, mass and lump of skin and subcutaneous tissue
1.4
7.4
339
2407
S06
ICPC
Rash localized
1.2
7.4
807
6476
TGC00
NOMESCO Finland
Bronchial lavation
1.4
7.4
284
1954
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.2
7.4
1352
11410
H40.1
ICD-10 Finland
Primary open-angle glaucoma
2.8
7.4
44
155
C09DA06
ATC
candesartan and diuretics; oral
1.2
7.4
908
7381
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.1
7.4
5090
46682
C02AC05
ATC
moxonidine; oral
1.3
7.4
465
3476
-1
NOMESCO Finland
NA
1.1
7.4
7419
69148
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
1.3
7.4
412
3026
B00.0
ICD-10 Finland
Eczema herpeticum
2.0
7.3
87
431
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.3
7.3
471
3531
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
1.4
7.3
349
2496
R19.4
ICD-10 Finland
Change in bowel habit
1.4
7.3
310
2171
R04
ICPC
Breathing problem other
1.3
7.3
463
3467
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.2
7.3
1043
8609
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.3
7.3
625
4876
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
1.6
7.3
158
953
J03
ICD-10 Finland
Acute tonsillitis
1.3
7.3
436
3238
JGC01
NOMESCO Finland
Laparoscopic rectopexy
1.8
7.3
117
646
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
1.4
7.3
278
1911
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.4
7.3
305
2133
D07AB10
ATC
alclometasone; topical
2.1
7.3
75
352
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
1.8
7.3
113
617
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.3
7.3
623
4860
B00.1
ICD-10 Finland
Herpesviral vesicular dermatitis
1.8
7.2
126
712
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
1.9
7.2
101
531
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
1.5
7.2
232
1536
L18
ICPC
Muscle pain
1.3
7.2
571
4407
N48.1
ICD-10 Finland
Balanoposthitis
1.5
7.2
198
1265
C09CA07
ATC
telmisartan; oral
1.2
7.2
883
7176
ZXX06
NOMESCO Finland
Extent of procedure, 6 units
2.9
7.2
42
145
XQ899
NOMESCO Finland
Other assessment of skin
2.1
7.2
74
345
K03.2
ICD-10 Finland
Erosion of teeth
1.4
7.2
307
2151
N92.5
ICD-10 Finland
Other specified irregular menstruation
1.3
7.2
482
3637
OAB47
SPAT
NA
0.7
7.2
217
3076
H66
ICD-10 Finland
Suppurative and unspecified otitis media
1.4
7.2
381
2774
K64.9
ICD-10 Finland
Haemorrhoids, unspecified
1.4
7.2
366
2646
H13.1*B00.5
ICD-10 Finland
Herpesviral conjunctivitis
3.3
7.2
34
103
SPAT1131
SPAT
Colonoscopy
1.3
7.2
417
3083
E23.03
ICD-10 Finland
Lack of ACTH
3.0
7.1
38
125
TND34
NOMESCO Finland
Custom moulded functional brace, wrist or hand
1.9
7.1
104
554
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
1.5
7.1
237
1583
C09CA03
ATC
valsartan; oral
1.2
7.1
1047
8665
6918C
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]
3.6
7.1
30
83
H53.3
ICD-10 Finland
Other disorders of binocular vision
2.0
7.1
80
386
J31
ICD-10 Finland
Chronic rhinitis, nasopharyngitis and pharyngitis
1.7
7.1
146
867
R3110
NOMESCO Finland
Psychosocial training
1.5
7.1
251
1699
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
1.6
7.1
158
962
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
1.4
7.1
305
2143
M89.0
ICD-10 Finland
Algoneurodystrophy
1.7
7.1
142
838
K90.0
ICD-10 Finland
Coeliac disease
1.3
7.1
435
3243
QBJ00
NOMESCO Finland
Liposuction in trunk
1.9
7.0
95
493
A23
ICPC
Risk factor NOS
1.2
7.0
1466
12502
A10BX01
ATC
guar gum; systemic
1.3
7.0
415
3075
SPAT1252
SPAT
Overall medication plan or its review
1.2
7.0
839
6802
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
1.6
7.0
185
1174
R30.1
ICD-10 Finland
Vesical tenesmus
1.5
7.0
225
1492
H19.8*E85.80
ICD-10 Finland
Reticular keratitis in Meretoja's patients
6.5
7.0
17
26
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.2
7.0
872
7101
E03.89
ICD-10 Finland
Other specified hypothyroidism
1.3
7.0
521
3993
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
2.4
7.0
53
214
L04AX01
ATC
azathioprine; systemic
1.2
7.0
696
5532
U04
ICPC
Incontinence urine
1.3
7.0
550
4246
L01BC06
ATC
capecitabine; oral
0.7
7.0
233
3243
HA1AA
NOMESCO Finland
X-ray mammography
1.2
7.0
1282
10823
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.2
7.0
1353
11474
K03.28
ICD-10 Finland
Other erosion of teeth
1.5
7.0
215
1414
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
1.4
6.9
316
2241
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
1.8
6.9
114
633
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.1
6.9
1872
16277
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.8
6.9
920
10822
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
1.6
6.9
168
1045
F41.8
ICD-10 Finland
Other specified anxiety disorders
1.3
6.9
459
3458
F43.8
ICD-10 Finland
Other reactions to severe stress
1.4
6.9
369
2689
J38.7
ICD-10 Finland
Other diseases of larynx
2.0
6.9
86
435
49099
ICD-8 Finland
Bronchitis, unspecified
1.7
6.9
139
823
M75.5
ICD-10 Finland
Bursitis of shoulder
1.4
6.9
307
2172
CD2S4
NOMESCO Finland
Photography of eye
2.1
6.9
70
327
A02BB01
ATC
misoprostol; oral
2.0
6.9
77
374
CGD10
NOMESCO Finland
Laser keratoplasty for error of refraction
2.1
6.9
74
352
H15.0
ICD-10 Finland
Scleritis
2.3
6.9
61
266
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.2
6.9
1035
8587
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.2
6.9
752
6041
H04.0
ICD-10 Finland
Dacryoadenitis
2.4
6.8
53
218
A07EC01
ATC
sulfasalazine; oral, rectal
1.2
6.8
1301
11019
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
1.8
6.8
104
566
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
1.6
6.8
178
1127
R05DB03
ATC
clobutinol; systemic
3.5
6.8
29
81
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
2.6
6.8
45
169
R48
ICPC
Respiratory, Clarification/discussion RFE/demand
1.8
6.8
107
585
M04AA01
ATC
allopurinol; systemic
1.2
6.8
1202
10117
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
1.2
6.8
1569
13488
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.2
6.8
1263
10674
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.1
6.8
4608
42210
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.4
6.8
300
2120
N30.2
ICD-10 Finland
Other chronic cystitis
1.7
6.8
122
699
1CD02
NOMESCO Finland
NA
1.7
6.8
122
699
SPAT1229
SPAT
Assessment of need for aid
1.2
6.8
990
8191
RK250
NOMESCO Finland
NA
2.2
6.8
66
302
SPAT1257
SPAT
Teaching of medicine inhalation technique
1.3
6.8
442
3325
TEA00
NOMESCO Finland
Biopsy of lip
1.7
6.8
125
719
W19
ICD-10 Finland
Unspecified fall
1.2
6.8
1386
11810
L04AB04
ATC
adalimumab; parenteral
1.4
6.8
305
2163
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.3
6.8
543
4202
R03DA05
ATC
aminophylline; systemic, rectal
2.1
6.8
71
336
WX704
NOMESCO Finland
Intubation
0.8
6.7
784
9332
K05.08
ICD-10 Finland
Another acute gingivitis
1.3
6.7
389
2872
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
1.3
6.7
439
3304
R25.1
ICD-10 Finland
Tremor, unspecified
1.4
6.7
332
2390
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.4
6.7
303
2147
IGY99
NOMESCO Finland
Other psychiatric treatment contact
1.4
6.7
310
2209
PA6AM
NOMESCO Finland
Simple MRI examination of neck vasculature with 3 Tesla magnet
2.8
6.7
40
142
L04AA13
ATC
leflunomide; oral
1.3
6.7
371
2726
SJB60
NOMESCO Finland
External device grinding and adaptation
1.4
6.7
253
1736
4451
FHL
Guitar cutting
1.2
6.7
661
5251
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
1.6
6.7
160
993
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.2
6.7
1206
10174
RP210
NOMESCO Finland
NA
2.7
6.6
41
149
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
1.5
6.6
190
1229
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
1.6
6.6
150
916
N05AH02
ATC
clozapine; systemic
0.7
6.6
152
2261
L10
ICPC
Elbow symptom/complaint
1.2
6.6
676
5389
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.3
6.6
477
3639
EP1AE
SPAT
NA
1.5
6.6
229
1545
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
1.8
6.6
104
573
WQ007
NOMESCO Finland
NA
2.9
6.6
38
130
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
1.4
6.6
319
2290
H68
ICD-10 Finland
Eustachian salpingitis and obstruction
2.4
6.6
51
210
TCB10
NOMESCO Finland
Simple epilation of cilia
4.8
6.6
20
41
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
2.5
6.5
47
186
ZX070
NOMESCO Finland
Intensity modified radiotherapy
0.6
6.5
80
1369
-59
ICPC
Other therap proced/minor surg NEC
1.4
6.5
360
2640
CBG10
NOMESCO Finland
Cryotherapy for trichiasis
5.8
6.5
17
29
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.3
6.5
479
3668
H18.4
ICD-10 Finland
Corneal degeneration
2.2
6.5
61
273
DM1AA
SPAT
NA
1.8
6.5
110
618
S02AA03
ATC
boric acid; otic
1.7
6.5
128
753
K05
ICPC
Irregular heartbeat other
1.4
6.5
353
2584
4453
FHL
Other and tonsil surgery
1.4
6.5
252
1739
WYA30
SPAT
NA
1.9
6.5
83
426
J01CF02
ATC
cloxacillin; systemic
1.4
6.5
276
1936
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
1.9
6.5
85
440
I45.0
ICD-10 Finland
Right fascicular block
2.1
6.5
69
329
ZYC01
NOMESCO Finland
Remote contact by phone
1.2
6.5
707
5682
K64.0
ICD-10 Finland
First degree haemorrhoids
1.5
6.5
197
1291
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
1.3
6.5
370
2732
NBL22
NOMESCO Finland
Myotomy, tenotomy or excision of tendon of upper arm
1.6
6.5
171
1089
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
2.2
6.5
61
275
ENC30
NOMESCO Finland
Plastic operation of pharynx
1.6
6.5
140
848
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.3
6.5
460
3508
M76.7
ICD-10 Finland
Peroneal tendinitis
1.7
6.5
115
656
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
1.5
6.5
234
1593
S90.1
ICD-10 Finland
Contusion of toe(s) without damage to nail
1.4
6.4
298
2126
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
2.6
6.4
44
170
BA1AE
SPAT
NA
1.7
6.4
122
708
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
2.5
6.4
47
188
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.2
6.4
1141
9605
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.3
6.4
380
2817
PH2AE
SPAT
NA
1.5
6.4
175
1120
L30.4
ICD-10 Finland
Erythema intertrigo
1.6
6.4
156
972
B00.9
ICD-10 Finland
Herpesviral infection, unspecified
1.9
6.4
88
461
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
1.5
6.4
225
1524
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.2
6.4
658
5251
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.2
6.4
903
7448
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
1.3
6.4
559
4375
F20.5
ICD-10 Finland
Residual schizophrenia
0.3
6.4
11
390
JHC60
NOMESCO Finland
Transanal submucous or intersphincteric injection
3.3
6.4
30
91
N80.0
ICD-10 Finland
Endometriosis of uterus
1.3
6.4
373
2763
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
4.1
6.4
23
56
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
1.4
6.4
308
2214
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.3
6.4
408
3062
G04BD09
ATC
trospium; oral
1.4
6.4
309
2220
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.2
6.4
1597
13816
SPB10
NOMESCO Finland
Production of temporary crone to tooth
1.7
6.4
118
683
XQ817
NOMESCO Finland
NA
3.2
6.4
31
97
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
1.4
6.3
267
1870
X23
ICPC
Fear sexually transm dis female
1.2
6.3
965
8015
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.1
6.3
2392
21254
G72.9
ICD-10 Finland
Myopathy, unspecified
1.8
6.3
99
541
RJ412
NOMESCO Finland
NA
2.8
6.3
37
129
SXA10
NOMESCO Finland
Epithel biopsy of mouth
1.6
6.3
150
928
4211
FHL
Transeptal septal resection and reconstruction
1.8
6.3
101
557
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.2
6.3
1191
10080
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.2
6.3
729
5892
JHB00
NOMESCO Finland
Hemorrhoidectomy
1.3
6.3
442
3360
B80
ICPC
Iron deficiency anaemia
1.4
6.3
278
1966
J39.3
ICD-10 Finland
Upper respiratory tract hypersensitivity reaction, site unspecified
2.5
6.3
45
176
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
1.4
6.3
244
1686
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
2.4
6.3
48
194
S76
ICPC
Skin infection other
1.2
6.3
676
5423
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.2
6.3
1154
9747
H43.3
ICD-10 Finland
Other vitreous opacities
1.6
6.3
159
999
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
2.4
6.3
51
213
CBF99
NOMESCO Finland
Other operation for ectropion
3.4
6.3
28
82
L30.3
ICD-10 Finland
Infective dermatitis
1.3
6.3
445
3389
5301A
ICD-9 Finland
Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]
2.0
6.3
68
328
R06
ICPC
Nose bleed/epistaxis
1.4
6.3
229
1564
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
1.7
6.3
110
628
S09
ICPC
Infected finger/toe
1.3
6.2
411
3098
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
1.5
6.2
227
1546
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
1.5
6.2
173
1113
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
1.8
6.2
95
519
WF003
NOMESCO Finland
Adjuvant radiotherapy
0.7
6.2
262
3513
EB1CA
SPAT
NA
1.9
6.2
80
409
XG405
NOMESCO Finland
Education on PEF monitoring
1.5
6.2
191
1256
D82.4
ICD-10 Finland
Hyperimmunoglobulin E [IgE] syndrome
17.8
6.2
9
5
R32
ICD-10 Finland
Unspecified urinary incontinence
1.3
6.2
354
2615
L85.3
ICD-10 Finland
Xerosis cutis
1.7
6.2
115
667
J02
ICD-10 Finland
Acute pharyngitis
1.3
6.2
449
3429
H02.9
ICD-10 Finland
Disorder of eyelid, unspecified
2.4
6.2
49
205
69109
ICD-8 Finland
Infantile eczema and related conditions, Unspecified
4.1
6.2
22
53
D68.0
ICD-10 Finland
Von Willebrand disease
2.1
6.2
64
300
S70.0
ICD-10 Finland
Contusion of hip
1.3
6.2
401
3019
R23.4
ICD-10 Finland
Changes in skin texture
1.7
6.2
127
759
A09AA02
ATC
multienzymes (lipase, protease etc.)
1.5
6.2
210
1412
C01CA01
ATC
etilefrine; systemic
1.9
6.2
88
468
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
1.4
6.2
266
1872
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
1.7
6.2
123
726
CFD10
NOMESCO Finland
Repair of conjunctiva
3.9
6.2
23
58
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.4
6.2
317
2304
NA3BG
SPAT
NA
1.4
6.2
310
2243
DPA30
NOMESCO Finland
Sphenotomy
1.9
6.2
82
427
P01AB02
ATC
tinidazole; oral, rectal
1.3
6.2
438
3342
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
1.6
6.1
140
860
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
2.7
6.1
37
133
RK520
NOMESCO Finland
NA
2.1
6.1
61
281
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
1.3
6.1
375
2798
H19.2*B30.0
ICD-10 Finland
Epidemic keratoconjunctivitis
2.9
6.1
33
111
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.3
6.1
436
3327
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
1.4
6.1
278
1979
F31.8
ICD-10 Finland
Other bipolar affective disorders
1.4
6.1
308
2230
P74
ICPC
Anxiety disorder/anxiety state
1.2
6.1
688
5549
K03.19
ICD-10 Finland
Abrasion of the teeth UNS
1.6
6.1
128
770
RL210
NOMESCO Finland
NA
2.0
6.1
68
329
S63.5
ICD-10 Finland
Sprain and strain of wrist
1.3
6.1
543
4265
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
1.4
6.1
251
1756
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
1.4
6.1
321
2343
A04AD01
ATC
scopolamine; systemic (antiemetics)
1.8
6.1
91
492
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
1.5
6.1
206
1388
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.2
6.1
1066
8974
R5120
NOMESCO Finland
Preparation of an aid
1.4
6.1
266
1881
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.3
6.1
552
4347
G03FB01
ATC
norgestrel and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.4
6.1
232
1602
RJ425
NOMESCO Finland
NA
3.2
6.0
29
90
Z29.9
ICD-10 Finland
Prophylactic measure, unspecified
1.8
6.0
93
509
N94.5
ICD-10 Finland
Secondary dysmenorrhoea
1.3
6.0
338
2490
WVA20
NOMESCO Finland
Medicine administration
1.4
6.0
267
1889
G03FB09
ATC
levonorgestrel and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.4
6.0
323
2364
G57.5
ICD-10 Finland
Tarsal tunnel syndrome
2.2
6.0
53
233
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
1.4
6.0
224
1534
L04AD01
ATC
ciclosporin; systemic
1.4
6.0
257
1810
J38.3
ICD-10 Finland
Other diseases of vocal cords
1.6
6.0
127
765
C01BC04
ATC
flecainide; systemic
1.3
6.0
356
2645
59504
ICD-8 Finland
Cystitis, Interstitialis (Hunner)
2.8
6.0
36
129
K03.18
ICD-10 Finland
Other abrasion of the teeth
1.5
6.0
199
1332
A07DA01
ATC
diphenoxylate; oral
2.5
6.0
43
169

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
1701
5836
2.98
307.65
1.1
1.1
u/ml
1.6
1.9
0.30
873
2236
(3003888) Timothy IgE Ab [Units/volume] in Serum
1648
5176
3.25
307.65
1.1
1.1
u/ml
7.2
5.5
3.39
1163
2457
(3008401) Mugwort IgE Ab [Units/volume] in Serum
1493
4969
3.06
307.65
1.1
1.1
u/ml
1.4
1.0
1.44
895
1932
(3010726) Horse dander IgE Ab [Units/volume] in Serum
1587
4862
3.33
307.65
1.1
1.1
u/ml
2.8
2.2
0.92
495
1145
(3014133) Dog dander IgE Ab [Units/volume] in Serum
1248
4222
2.99
267.67
1.1
1.1
u/ml
5.2
4.5
0.48
636
1567
(3023430) Cat dander IgE Ab [Units/volume] in Serum
1144
3975
2.90
233.46
1.1
1.1
u/ml
5.2
5.4
0.12
642
1549
(3005322) IgE [Units/volume] in Serum or Plasma
3163
17371
1.88
218.07
1.5
1.3
u/ml
457.2
198.0
7.67
3000
16026
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
994
3426
2.92
205.61
1.1
1.0
u/ml
0.8
0.3
1.73
307
631
(3018010) Neutrophils/100 leukocytes in Blood
14831
119323
1.43
196.24
6.1
5.9
%
56.2
56.5
2.71
13983
112082
(3002030) Lymphocytes/100 leukocytes in Blood
15011
121074
1.43
195.64
6.3
6.0
%
29.2
29.2
0.50
14104
113310
(3022096) Basophils/100 leukocytes in Blood
14102
112600
1.43
193.61
6.3
6.1
%
0.7
0.7
2.29
13222
105231
(3019069) Monocytes/100 leukocytes in Blood
14522
117039
1.42
186.54
6.5
6.3
%
8.4
8.3
7.62
13688
110052
(3006504) Eosinophils/100 leukocytes in Blood
14451
116395
1.42
186.11
6.3
6.0
%
3.0
2.8
24.76
13543
108765
(3019198) Lymphocytes [#/volume] in Blood
15694
128307
1.41
185.32
6.1
5.9
e9/l
1.9
2.0
1.68
13890
114333
(3000492) Spirometry study
3958
24306
1.69
184.31
1.5
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
15232
123977
1.41
183.91
6.2
5.9
e9/l
0.6
0.6
0.69
13205
108495
(3013115) Eosinophils [#/volume] in Blood
15730
128800
1.41
183.21
6.4
6.1
e9/l
0.2
0.2
16.96
13857
114417
(3006315) Basophils [#/volume] in Blood
15268
124499
1.41
181.35
6.2
5.9
e9/l
0.0
0.0
0.61
13205
108856
(3033658) Prothrombin time (PT) actual/Normal
8034
58774
1.47
171.34
3.7
3.8
%
95.0
94.1
3.02
7826
57178
(3007164) IgA [Mass/volume] in Serum or Plasma
7425
53944
1.47
162.51
1.5
1.4
g/l
2.2
2.2
0.23
4344
33421
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
273
440
6.15
157.30
1.1
1.1
u/ml
5.3
4.8
0.06
192
311
(3013650) Neutrophils [#/volume] in Blood by Automated count
17029
143561
1.37
153.96
8.6
9.0
e9/l
3.9
4.0
6.26
14765
126250
(42870588) Differential panel, method unspecified - Blood
10463
82536
1.37
138.60
6.2
6.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
14285
118612
1.34
134.36
3.1
2.9
ug/l
97.5
99.3
0.17
13425
111240
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
25574
233550
1.45
125.60
12.0
10.9
ml/min/173m2
87.0
86.7
1.19
21165
190472
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
12783
105146
1.34
124.66
2.4
2.3
nmol/l
78.9
928.1
0.50
11673
96241
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
11262
90923
1.34
124.61
2.0
1.9
pmol/l
99.9
98.2
3.08
5467
46917
(36304419) Bacteria [Presence] in Urine
7998
61295
1.38
123.18
3.1
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
10324
82372
1.35
123.13
3.7
3.5
e6/l
76.3
87.2
0.98
6760
55917
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
21480
190703
1.36
123.08
3.7
3.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
3372
21877
1.58
122.20
2.4
2.5
u/l
36.2
43.4
1.52
2878
18768
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
8223
63463
1.38
120.82
1.3
1.3
u/ml
1.5
1.6
0.20
2109
17648
(40768804) Tissue Pathology biopsy report
12463
102464
1.33
120.57
2.1
2.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
25785
236497
1.44
117.45
5.5
4.8
mu/l
2.1
2.0
0.23
24210
220433
(3013707) Erythrocyte sedimentation rate by Westergren method
20826
184683
1.34
115.77
4.3
3.9
mm/h
10.6
11.0
6.44
19524
172166
(3021589) Normoblasts [#/volume] in Blood
13244
110359
1.32
114.38
8.8
8.9
e9/l
0.0
0.0
1.64
10616
90809
(3037522) Nuclear Ab [Titer] in Serum
5116
36728
1.44
113.15
1.4
1.4
titre
562.2
552.8
0.12
1035
7411
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
27406
254763
1.53
113.04
13.4
12.1
mg/l
20.2
21.2
5.69
21537
197398
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
22695
204324
1.35
110.82
4.6
4.2
pmol/l
14.5
14.6
11.53
21025
188292
(3009542) Hematocrit [Volume Fraction] of Blood
26105
240528
1.44
110.77
15.1
12.9
%
40.4
39.9
27.24
21550
184992
(40758558) Short blood count panel - Blood
7979
62024
1.36
109.87
6.7
6.8
—
—
—
0
0
(4010399)
2607
16371
1.62
107.57
1.5
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
7944
62047
1.35
105.09
3.1
3.0
e6/l
0.3
0.4
2.91
5750
45953
(40768797) Stomach Pathology biopsy report
4592
32710
1.45
105.04
1.2
1.2
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
166
244
6.73
104.68
1.0
1.0
u/ml
3.8
3.2
0.08
125
182
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
4848
34918
1.43
104.38
2.8
2.7
e6/l
3.5
3.9
1.16
2401
18309
(3002385) Erythrocyte distribution width [Ratio]
23805
216695
1.36
102.19
16.2
14.6
%
13.5
13.6
3.72
23440
212234
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
321
849
3.75
101.94
1.0
1.0
u/ml
13.5
9.7
0.72
57
98
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
163
245
6.58
100.65
1.0
1.1
u/ml
2.9
0.6
0.93
123
182
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
5104
37554
1.40
96.58
2.7
2.6
e6/l
1.0
1.2
1.27
2636
20827
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
504
1837
2.73
93.66
1.4
1.3
u/ml
1.2
1.0
0.25
230
743
(3048689) Calprotectin [Mass/mass] in Stool
4814
35349
1.40
91.62
2.5
2.4
ug/g
103.9
125.1
5.06
3840
27662
(3002582) Erythrocytes [#/volume] in Urine
8469
67847
1.31
91.30
3.2
3.0
e6/l
77.9
67.5
0.25
6197
51173
(3037467) Urinalysis macro (dipstick) panel - Urine
19280
171640
1.28
89.52
4.6
4.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
9612
78538
1.30
88.94
3.2
3.3
mmol/l
2.4
2.4
0.11
8356
69343
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
159
271
5.80
86.67
1.0
1.0
u/ml
0.3
0.2
0.33
97
160
(3031040) Bacteria [#/volume] in Urine by Automated count
18428
163680
1.27
84.39
4.7
4.2
e6/l
2122.3
1651.6
0.39
184
2016
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
155
266
5.76
83.90
1.0
1.1
u/ml
0.2
2.5
0.96
83
140
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5299
40073
1.36
83.34
2.8
2.8
mmol/l
2.4
2.4
2.48
4588
35033
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
6054
46773
1.34
82.64
1.3
1.3
iu/ml
36.6
31.6
0.33
1837
14636
(1002224) Polysomnography panel
1795
11012
1.64
80.54
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
5762
44357
1.34
80.25
1.3
1.3
u/ml
9.1
11.1
1.66
2147
17789
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
6920
55041
1.31
75.84
1.8
1.8
mg/l
1.0
1.1
0.78
5126
41159
(3011897) Casein IgE Ab [Units/volume] in Serum
196
456
4.25
74.38
1.3
1.2
u/ml
25.1
2.0
1.53
48
95
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
146
267
5.40
73.88
1.0
1.1
u/ml
0.1
0.7
1.61
76
150
(3000494) Fungus identified in Specimen by Culture
3767
27429
1.40
73.80
1.5
1.4
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
117
173
6.68
73.45
1.0
1.0
u/ml
0.5
1.2
0.52
80
110
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
113
162
6.89
73.01
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7520
60746
1.29
72.68
1.7
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
18251
163356
1.24
71.52
3.5
3.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
1645
10172
1.62
71.29
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
8197
67099
1.28
70.91
3.7
3.9
ph
7.4
7.4
0.95
1347
12799
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
20412
185090
1.25
70.68
7.3
7.1
u/l
74.6
76.4
9.70
19250
174520
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
134
246
5.38
67.56
1.0
1.1
u/ml
0.4
0.5
0.14
75
137
(3027231) Wheat IgE Ab [Units/volume] in Serum
210
558
3.72
66.41
1.1
1.1
u/ml
2.9
2.1
—
10
18
(40761511) CBC panel - Blood by Automated count
28165
267238
1.43
64.40
11.5
11.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
415
1655
2.49
64.33
1.1
1.0
u/ml
0.9
0.7
0.20
92
208
(3020564) Creatinine [Moles/volume] in Serum or Plasma
28163
267271
1.42
63.78
14.5
13.5
umol/l
71.6
71.8
0.61
28155
267137
(3022145) Colonoscopy Study observation
3607
26666
1.37
63.74
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
28342
269312
1.44
63.38
10.4
9.5
u/l
26.2
25.9
0.84
27604
260719
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
11813
101749
1.23
63.15
5.4
5.6
mmol/l
1.2
1.2
0.34
10730
92394
(3007853) Bacteria identified in Skin by Aerobe culture
3736
27898
1.36
61.83
1.8
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
19289
174920
1.23
61.45
3.0
2.9
u/l
40.4
41.7
1.43
18216
165193
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
1012
5756
1.75
59.95
1.2
1.2
u/ml
50.1
41.8
0.70
97
573
(3014599) Egg white IgE Ab [Units/volume] in Serum
435
1833
2.35
59.75
1.1
1.0
u/ml
10.0
1.9
1.25
166
432
(3015171) Extractable nuclear Ab [Units/volume] in Serum
1679
10881
1.55
59.30
1.3
1.3
u/ml
1.1
0.8
0.30
111
952
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
99
154
6.34
59.26
1.0
1.0
u/ml
1.0
1.5
0.26
69
124
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
1246
7534
1.65
58.87
1.3
1.3
u/ml
33.7
36.6
0.17
88
454
(3007461) Platelets [#/volume] in Blood
29795
286546
1.68
58.51
19.7
17.9
e9/l
260.7
260.0
1.11
29205
279732
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
2534
17895
1.43
58.27
2.4
2.3
au/ml
24.1
23.0
0.20
190
1152
(36660697) Celiac disease serology panel - Serum
3100
22673
1.38
58.16
1.2
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
29827
286960
1.69
58.14
19.8
18.0
g/l
135.3
135.1
2.12
29555
283510
(3024731) MCV [Entitic volume]
29815
286824
1.69
58.00
19.6
17.8
fl
90.5
90.4
3.42
29540
283332
(3024891) Influenza virus A+B Ag [Presence] in Specimen
1132
6704
1.69
57.91
1.2
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
29816
286860
1.68
57.66
19.6
17.9
e12/l
4.5
4.5
1.34
29163
279414
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
4332
33415
1.32
57.20
1.5
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
437
1883
2.30
57.03
1.1
1.1
u/ml
8.9
1.0
1.65
187
510
(3035941) MCH [Entitic mass]
29806
286805
1.67
56.72
19.6
17.8
pg
30.2
30.1
4.33
29534
283317
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
2345
16425
1.44
56.32
1.3
1.3
au/ml
50.1
45.9
0.32
92
629
(3012494) Peanut IgE Ab [Units/volume] in Serum
255
849
2.97
56.23
1.1
1.1
u/ml
13.7
3.7
0.45
172
478
(3010813) Leukocytes [#/volume] in Blood
29812
286934
1.67
55.92
19.7
17.9
e9/l
6.6
6.6
2.87
29166
279442
(3026493) Urate [Moles/volume] in Serum or Plasma
7046
58040
1.25
54.99
2.4
2.4
umol/l
4119.6
3546.3
0.62
6168
50938
(3024561) Albumin [Mass/volume] in Serum or Plasma
11326
98236
1.21
53.61
4.4
4.7
g/l
36.5
36.2
8.87
10485
91239
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
23638
220147
1.24
53.19
5.2
5.0
mmol/mol
38.3
38.7
10.49
22112
205805
(3001019) Free T4 and TSH panel - Serum or Plasma
2404
17094
1.42
52.97
1.8
1.7
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
92
149
6.09
52.96
1.0
1.0
u/ml
0.7
0.5
0.19
79
137
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
12847
112894
1.21
52.74
5.9
6.3
mmol/l
1.2
1.2
0.49
11036
95206
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
91
152
5.91
50.79
1.0
1.0
u/ml
28.0
14.4
1.28
76
121
(3026782) Osmolality of Urine
5401
43494
1.27
50.51
2.6
2.7
mosm/kgh2o
521.8
534.0
3.26
4514
36950
(3023103) Potassium [Moles/volume] in Serum or Plasma
26718
252870
1.30
49.93
14.3
13.3
mmol/l
3.9
3.9
51.42
26051
245776
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
1250
7922
1.58
48.59
1.9
1.8
g/l
0.2
0.2
0.61
1182
7511
(3019550) Sodium [Moles/volume] in Serum or Plasma
26633
252147
1.29
48.27
14.1
13.2
mmol/l
139.6
139.7
10.33
26027
245584
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
333
1379
2.39
47.67
2.3
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
5760
47016
1.25
47.61
2.5
2.5
e6/l
5.9
7.0
6.55
4948
40868
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
6943
57889
1.23
47.20
2.3
2.2
mg/l
2.7
2.9
8.99
5882
49818
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
844
4879
1.72
47.18
2.0
2.1
g/l
0.0
0.0
0.54
755
4456
(3003327) Ova and parasites identified in Stool by Light microscopy
1465
9685
1.51
47.00
1.7
1.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
835
4818
1.73
46.99
2.0
2.1
g/l
0.0
0.0
0.00
755
4445
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
26341
249224
1.27
46.67
4.6
4.3
mmol/l
2.8
2.9
9.18
24619
232486
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
1268
8153
1.55
46.23
1.9
1.7
g/l
1.2
1.2
0.26
1203
7760
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
895
5317
1.68
45.22
1.9
2.1
g/l
0.0
0.0
1.41
804
4877
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
90
168
5.28
44.67
1.1
1.1
u/ml
13.9
5.9
1.85
70
114
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
5037
40802
1.26
44.07
3.6
3.3
ng/l
275.3
405.3
1.94
3435
27569
(3003338) MCHC [Mass/volume]
23918
224378
1.22
42.93
17.0
15.3
g/l
332.6
332.4
1.64
23767
222723
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
767
4433
1.72
42.92
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
3496
27151
1.30
42.87
2.4
2.7
umol/l
6.8
7.5
1.14
2975
23184
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
767
4435
1.72
42.85
1.3
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
972
5979
1.62
42.81
2.0
2.3
g/l
0.8
0.7
0.22
840
5169
(3021960) Folate [Moles/volume] in Serum or Plasma
6016
49903
1.23
42.17
1.6
1.5
nmol/l
22.0
20.7
7.20
5204
43157
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
898
5474
1.63
41.03
1.9
2.0
g/l
38.6
38.1
1.39
783
4702
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
7751
66110
1.21
40.82
2.1
2.1
u/l
172.4
194.2
1.49
7281
62117
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
25807
244315
1.24
40.74
4.1
3.9
mmol/l
1.5
1.5
0.01
24149
228565
(42529406) Shigella sp [Presence] in Stool by Culture
1170
7606
1.53
40.55
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
1085
6955
1.55
40.08
1.3
1.3
u/ml
7.7
8.9
0.24
158
1134
(3014765) Yersinia sp identified in Stool by Organism specific culture
1165
7586
1.53
40.07
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
1068
6852
1.55
39.30
1.3
1.3
u/ml
6.4
6.3
0.02
109
730
(3023323) Follitropin [Units/volume] in Serum or Plasma
2360
17544
1.35
39.19
1.4
1.3
iu/l
26.8
27.1
0.17
2043
15135
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
1151
7517
1.53
39.05
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
7305
62227
1.20
38.57
1.6
1.6
mmol/l
1.4
1.4
0.17
6355
53055
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
24930
235474
1.22
38.39
3.7
3.6
mmol/l
1.3
1.3
0.63
23132
219363
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
25935
246040
1.23
37.82
4.2
4.0
mmol/l
4.8
4.8
7.50
24361
230938
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1037
6670
1.55
37.72
1.9
2.2
g/l
3.0
3.0
1.09
838
5167
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
25115
237521
1.22
37.49
4.3
4.0
mmol/l
5.7
5.8
9.12
23329
219795
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
13516
121635
1.17
36.62
5.4
5.8
umol/l
10.7
10.6
0.46
12735
114808
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1441
9983
1.44
36.35
4.2
4.5
mmol/l
24.2
24.2
0.01
1324
9007
(3003740) Influenza virus B Ag [Presence] in Specimen
786
4797
1.63
35.77
1.1
1.1
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
78
157
4.90
35.61
1.3
1.2
u/ml
16.5
2.0
1.11
69
129
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
352
1688
2.06
35.32
4.1
4.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
784
4798
1.62
35.28
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
1201
8082
1.48
35.24
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
1445
10085
1.43
35.00
1.7
1.7
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
313
1444
2.14
34.77
1.3
1.5
ug/l
6.1
7.7
1.94
290
1295
(3036481) Cortisol [Moles/volume] in Serum or Plasma
3022
23677
1.28
34.14
2.2
2.1
nmol/l
359.0
376.4
5.59
2781
21785
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1006
6582
1.52
33.84
1.9
2.1
g/l
10.1
10.1
0.03
854
5502
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6671
56918
1.20
33.81
1.5
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1113
7438
1.49
33.81
1.2
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
2397
18287
1.31
33.08
3.2
3.3
pmol/l
4.5
4.5
0.48
2128
16368
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1059
7048
1.50
32.83
1.9
2.1
g/l
3.7
3.8
0.40
809
5024
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1059
7054
1.49
32.69
1.9
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1060
7065
1.49
32.62
1.9
2.1
g/l
7.2
7.4
2.41
858
5286
(3022948) Iron [Moles/volume] in Serum or Plasma
4290
35171
1.23
32.61
2.3
2.4
umol/l
14.0
13.6
3.05
3983
32669
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
804
5070
1.58
31.94
1.5
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
729
4495
1.61
31.85
1.1
1.1
au/ml
7.7
11.8
1.39
53
290
(3015736) pH of Urine
10743
95776
1.16
31.20
3.2
3.3
ph
5.8
5.8
—
8
42
(3023420) DNA double strand Ab [Units/volume] in Serum
518
2938
1.75
31.11
1.7
1.6
iu/ml
33.3
36.4
0.22
36
132
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
2067
15592
1.33
30.86
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
1017
6812
1.49
30.55
2.9
2.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2397
18584
1.29
29.20
2.9
2.7
ug/l
0.7
0.7
0.92
1393
10965
(3020961) Endomysium IgA Ab [Titer] in Serum
1878
14092
1.33
29.04
1.1
1.1
titre
208.2
187.6
0.12
30
367
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
924
6133
1.50
29.04
1.4
1.4
iu/ml
17.9
14.5
0.21
18
152
(3016031) Almond IgE Ab [Units/volume] in Serum
80
195
4.05
28.81
1.0
1.1
u/ml
0.8
0.5
0.55
48
106
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2844
22621
1.26
28.11
1.8
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
413
2265
1.81
27.88
2.9
2.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
1318
9423
1.39
27.77
1.4
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
9300
82562
1.16
27.69
3.0
3.2
u/l
30.2
32.1
3.30
8809
78489
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
842
5556
1.51
27.24
1.2
1.3
u/ml
5.0
5.5
0.06
62
422
(3002256) Pathology report gross observation
3819
31471
1.22
27.20
1.3
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
4283
35701
1.21
27.15
3.0
3.4
mmol/l
0.8
0.8
0.02
3945
33371
(3021601) Nitrite [Presence] in Urine by Test strip
13588
123964
1.14
27.04
4.9
4.7
estimate
0.0
0.0
0.50
2599
23880
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
3590
29428
1.23
26.91
2.4
2.5
%
23.5
23.0
1.31
3209
25218
(3004789) Transferrin [Mass/volume] in Serum or Plasma
3886
32113
1.22
26.89
2.3
2.4
g/l
2.4
2.4
0.01
3596
29718
(3014111) Lactate [Moles/volume] in Serum or Plasma
2263
17646
1.28
26.27
6.9
6.9
mmol/l
1.3
1.3
0.85
2180
17030
(4094501)
853
5697
1.49
26.03
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7182
62790
1.16
25.91
2.0
2.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
649
4091
1.57
25.90
1.7
1.5
g/l
0.6
0.7
0.54
531
3097
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
817
5425
1.50
25.66
1.2
1.2
u/ml
7.6
18.1
0.80
12
84
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
3273
26697
1.23
25.65
2.0
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
686
4390
1.55
25.62
1.1
1.1
u/ml
3.0
2.8
0.15
342
2210
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1363
9942
1.37
25.39
9.1
9.4
mmol/l
24.3
24.3
0.12
1275
9349
(3009261) Glucose [Presence] in Urine by Test strip
13674
125137
1.14
25.25
3.6
3.5
estimate
0.0
0.0
0.19
2523
23471
(3011397) Hemoglobin [Presence] in Urine by Test strip
6580
57250
1.17
25.14
3.5
3.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
1534
11420
1.34
25.00
1.1
1.1
u/ml
1.2
8.5
1.61
15
187
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
1409
10356
1.36
25.00
2.0
2.0
u/l
39.2
39.8
0.56
1272
9361
(3005719) IgG [Mass/volume] in Serum or Plasma
2391
18905
1.27
24.73
2.7
2.7
g/l
10.3
10.4
1.09
2190
17327
(4062490)
449
2618
1.70
24.52
1.6
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
4509
38166
1.19
23.90
1.7
1.7
nmol/l
1142.9
1182.0
2.15
3343
29195
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
943
6535
1.43
23.76
2.1
2.1
mg/l
10.5
10.6
0.06
873
6119
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
2668
21470
1.24
23.62
1.2
1.2
iu/ml
144.0
147.6
0.15
991
8237
(3000570) Elastase.pancreatic [Mass/mass] in Stool
948
6591
1.43
23.47
1.4
1.4
ug/g
287.9
285.9
0.11
550
3673
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2818
22834
1.24
23.41
1.8
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6558
57309
1.16
23.38
2.2
2.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
444
2615
1.68
23.38
1.6
1.3
g/l
0.3
0.4
3.25
344
1817
(3028192) IgG subclass 2 [Mass/volume] in Serum
444
2616
1.68
23.34
1.6
1.3
g/l
2.8
2.9
0.46
346
1816
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1693
12913
1.31
23.23
2.4
2.1
nmol/l
12.2
11.8
1.18
1511
11534
(3018677) aPTT in Platelet poor plasma by Coagulation assay
3865
32362
1.20
23.05
2.1
2.2
s
29.6
29.5
0.44
3735
31387
(3035350) Ketones [Presence] in Urine by Test strip
13453
123474
1.13
22.77
3.6
3.5
estimate
0.0
0.0
0.26
2523
23279
(3027135) IgG subclass 1 [Mass/volume] in Serum
442
2621
1.67
22.69
1.6
1.3
g/l
6.4
6.7
1.41
343
1818
(3039162) Centromere protein B Ab [Units/volume] in Serum
548
3440
1.58
22.33
1.2
1.3
u/ml
45.0
54.7
0.37
32
231
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
3271
27096
1.21
21.78
1.7
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1533
11654
1.31
21.54
1.7
1.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
370
2125
1.72
21.42
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
1995
15702
1.27
21.37
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
373
2149
1.72
21.35
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
369
2123
1.72
21.24
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5179
44740
1.17
21.19
2.3
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
8531
76356
1.14
21.16
2.2
2.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
368
2120
1.72
21.08
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
2152
17125
1.25
20.98
8.3
8.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
2234
17858
1.25
20.93
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
626
4107
1.51
20.92
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
371
2147
1.71
20.91
1.2
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
200
949
2.08
20.89
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
694
4656
1.48
20.79
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
370
2146
1.71
20.69
1.2
1.2
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
64
170
3.71
20.56
1.1
1.1
u/ml
1.4
1.0
0.25
44
122
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
155
669
2.29
20.52
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
2594
21168
1.22
20.02
1.9
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
1855
14597
1.27
19.89
1.9
1.8
g/l
1.3
1.3
0.20
1693
13399
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
2028
16184
1.25
19.26
1.7
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1626
12646
1.28
19.19
2.1
2.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
3702
31426
1.18
18.60
1.9
2.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
577
3824
1.49
18.42
2.0
1.8
pmol/l
193.4
189.0
0.44
554
3646
(3045683) HLA typing for celiac disease panel - Blood or Tissue
316
1816
1.72
18.34
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
616
4150
1.47
18.12
1.3
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
833
5941
1.39
17.90
1.9
1.7
nmol/l
40.8
40.9
0.01
819
5821
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
1414
10921
1.29
17.63
1.7
1.6
mg/l
3.3
3.4
0.25
989
7517
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1007
7426
1.35
17.53
2.3
2.6
%
171.1
179.3
2.43
937
7024
(3019150) Specific gravity of Urine by Refractometry
4963
54855
0.87
17.26
3.9
3.8
kg/l
1.0
1.0
0.06
656
8311
(3024928) Oxygen saturation in Venous blood
611
4162
1.45
17.01
3.2
3.6
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
63
189
3.28
16.91
1.0
1.0
u/ml
0.4
1.3
0.46
28
63
(40760892) CBC W Ordered Manual Differential panel - Blood
6620
59039
1.13
16.60
4.1
4.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
326
1942
1.66
16.60
1.2
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1264
9700
1.29
16.58
1.4
1.6
u/ml
9.6
14.1
0.54
24
282
(3036489) Thrombin time
1228
9392
1.30
16.53
1.9
2.2
s
21.0
21.2
1.13
1065
8006
(3021387) Prolactin [Units/volume] in Serum or Plasma
1564
12334
1.26
16.46
1.6
1.6
mu/l
315.8
318.2
0.07
1427
11042
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
4642
40470
1.15
16.35
2.1
2.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
695
9457
0.72
16.32
3.2
3.4
mmol/l
25.2
25.3
0.18
682
9156
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
6019
53447
1.13
16.10
2.7
2.8
ng/l
990.5
1116.2
1.39
4942
44754
(3020630) Protein [Mass/volume] in Serum or Plasma
1952
15820
1.23
16.04
2.3
2.5
g/l
67.0
66.6
1.30
1767
14444
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
1101
8351
1.31
15.78
2.0
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
1347
10505
1.27
15.56
1.8
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1494
11801
1.26
15.51
1.4
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
90
347
2.56
15.39
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
581
4001
1.44
15.31
1.4
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
2679
22495
1.19
15.16
1.5
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
306
1844
1.64
14.95
1.1
1.1
iu/ml
6.3
8.3
1.04
78
484
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
221
1219
1.79
14.91
1.2
1.3
titre
31.4
397.4
—
7
74
(1761868) Lipid panel - Serum or Plasma
10331
94952
1.11
14.77
2.5
2.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
14555
136072
1.10
14.66
4.4
4.3
mmol/l
6.4
6.5
8.07
13543
125235
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
2242
18586
1.20
14.62
1.4
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
876
6505
1.33
14.62
1.3
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
1020
7752
1.30
14.43
1.5
1.6
titre
240.6
298.0
0.29
32
332
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3901
33883
1.15
14.34
1.8
1.8
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
213
1186
1.77
13.96
1.2
1.3
titre
33.3
72.1
2.04
15
105
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1604
12939
1.23
13.79
6.3
7.1
mmol/l
24.9
24.8
0.26
1598
12825
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
237
1366
1.71
13.76
1.7
1.9
%
127.1
134.7
0.93
226
1281
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1427
11422
1.24
13.20
2.3
2.4
—
—
—
0
0
(44813793)
335
2129
1.55
13.17
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
2015
16706
1.20
13.12
3.5
3.8
ng/l
77.8
84.7
3.81
1752
14572
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
182
988
1.82
13.02
1.7
1.9
%
143.8
152.8
0.57
171
930
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
3871
33820
1.14
13.00
1.7
1.7
%
1.3
1.4
3.12
3425
30273
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
95
407
2.30
12.99
1.0
1.1
u/ml
0.1
0.3
0.61
62
240
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
175
940
1.84
12.96
1.2
1.2
%
110.9
111.0
0.01
157
833
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
30
64
4.62
12.95
1.0
1.0
u/ml
0.4
1.1
0.79
24
42
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
418
2803
1.47
12.75
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
346
5101
0.66
12.74
4.2
4.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
235
1381
1.68
12.74
1.4
1.5
u/ml
23.1
21.7
0.13
40
250
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
241
1431
1.66
12.57
1.4
1.5
u/l
5.2
5.8
1.58
194
1200
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
124
600
2.04
12.52
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
143
731
1.93
12.36
1.4
1.4
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
228
1341
1.68
12.34
1.1
1.1
u/ml
12.9
10.1
0.58
74
202
(3017143) Hepatitis C virus Ab [Presence] in Serum
4029
35438
1.14
12.17
1.6
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2450
20819
1.17
11.96
2.3
2.3
g/l
0.2
0.2
2.94
2261
19495
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
183
1022
1.77
11.95
1.2
1.2
g/l
0.3
0.3
0.23
150
807
(3004616) Nuclear Ab [Presence] in Serum
456
3154
1.43
11.85
1.4
1.3
—
—
—
0
0
(3003843) Paprika IgE Ab [Units/volume] in Serum
30
69
4.28
11.83
1.0
1.0
u/ml
0.1
0.1
0.31
25
51
(3020717) Zinc [Moles/volume] in Serum or Plasma
233
1399
1.64
11.68
1.4
1.5
umol/l
27.0
25.2
0.39
221
1331
(3013005) Retinol [Moles/volume] in Serum or Plasma
202
1170
1.70
11.61
1.8
1.9
umol/l
2.0
1.9
1.79
191
1094
(3041806) Other cells [#/volume] in Blood by Manual count
240
1461
1.62
11.40
1.6
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
1064
8394
1.26
11.25
1.1
1.1
u/ml
4.0
5.5
0.96
168
1160
(3023368) Bacteria identified in Blood by Culture
6103
55266
1.11
11.03
4.3
4.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
2911
25229
1.15
10.91
7.2
6.9
mmol/l
104.5
104.5
0.18
2866
24694
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1050
8304
1.25
10.87
1.6
1.6
iu/ml
0.2
5.9
1.38
228
1671
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1010
12345
0.80
10.85
6.9
6.8
mmol/l
24.8
24.6
0.97
943
11480
(3049717) Cytology report of Urine Cyto stain
775
5915
1.30
10.73
2.3
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
1326
10770
1.22
10.72
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
493
3523
1.38
10.67
1.2
1.3
nmol/l
0.6
1.4
1.14
477
3390
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
26
58
4.41
10.66
1.0
1.0
u/ml
9.4
12.1
0.28
21
43
(3038515) Glucose [Moles/volume] in Venous blood
259
3898
0.65
10.64
3.0
3.1
mmol/l
7.2
7.4
0.42
254
3822
(3018851) Theophylline [Moles/volume] in Serum or Plasma
45
147
3.02
10.63
1.9
1.9
umol/l
48.2
47.5
0.04
45
147
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
314
2069
1.50
10.55
1.2
1.2
titre
175.9
208.2
0.29
46
365
(3023410) Appearance of Cerebral spinal fluid
388
2665
1.44
10.54
1.5
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
2542
21875
1.16
10.51
2.3
2.7
%
1.7
1.8
2.11
2220
19461
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
115
579
1.96
10.47
1.1
1.1
%
70.1
76.6
0.42
19
136
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
722
5479
1.30
10.45
1.5
1.4
nmol/l
0.4
0.4
0.12
595
4284
(4034850)
608
7874
0.76
10.42
9.3
8.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
143
776
1.82
10.36
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
668
5023
1.32
10.35
1.7
1.7
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
312
2062
1.49
10.34
1.2
1.2
titre
193.3
203.4
—
9
71
(3009508) Creatinine [Moles/volume] in Urine
7443
68279
1.10
10.20
3.2
3.2
mmol/l
7.4
7.7
0.78
6325
58144
(3044290) Cell count panel - Cerebral spinal fluid
700
5310
1.30
10.18
1.4
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
114
580
1.94
10.09
1.1
1.1
%
90.9
87.9
0.16
19
142
(3007930) Methemoglobin/Hemoglobin.total in Blood
626
8038
0.76
10.08
4.4
4.9
%
0.9
0.9
0.18
582
7538
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
68
283
2.37
10.04
1.1
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
264
1696
1.54
10.02
1.3
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
487
3521
1.37
9.85
1.2
1.3
nmol/l
0.3
0.2
0.52
19
205
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
445
3176
1.38
9.75
1.2
1.3
—
—
—
0
0
(3009754) Celery IgE Ab [Units/volume] in Serum
17
28
5.98
9.70
1.0
1.0
u/ml
0.3
0.2
0.19
17
21
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
641
8151
0.77
9.61
4.4
4.8
%
1.7
1.7
0.08
591
7637
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
75
333
2.22
9.56
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
3560
31539
1.13
9.46
1.9
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
535
3963
1.33
9.26
1.6
1.5
—
—
—
0
0
(4015189)
97
482
1.98
9.23
2.6
2.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
115
612
1.85
8.94
1.0
1.2
%
111.3
107.7
0.55
108
575
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
163
964
1.67
8.80
1.1
1.1
%
96.3
94.9
0.17
59
458
(3008037) Lactate [Moles/volume] in Venous blood
295
4164
0.69
8.80
2.8
3.0
mmol/l
1.4
1.5
0.85
290
4073
(3000330) Specific gravity of Urine by Test strip
915
11038
0.81
8.76
3.2
3.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
452
5949
0.74
8.75
1.6
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
394
2812
1.38
8.69
1.4
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
96
486
1.95
8.69
1.3
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
59
247
2.35
8.66
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
1097
8945
1.21
8.60
1.5
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
221
1417
1.54
8.55
1.1
1.1
nmol/l
7.2
4.9
0.28
51
265
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1839
15694
1.16
8.52
2.5
2.7
ng/l
158.3
162.4
0.16
1604
14149
(3005033) Fetal Nuchal fold Thickness US
1071
8723
1.22
8.50
1.4
1.4
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
165
989
1.65
8.48
1.1
1.1
%
95.8
93.5
0.43
60
463
(3020934) Sesame Seed IgE Ab [Units/volume] in Serum
15
25
5.91
8.46
1.0
1.0
u/ml
1.4
5.6
—
8
11
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
168
1014
1.63
8.41
1.1
1.1
%
116.8
110.0
1.55
152
907
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2920
25743
1.13
8.39
3.8
3.7
%
22.2
21.7
0.65
1100
10730
(3047352) Trisomy 18 risk [Likelihood] in Fetus
1071
8739
1.21
8.35
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
505
3774
1.32
8.28
1.7
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
139
2264
0.60
8.21
2.1
2.2
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
24
62
3.81
8.18
1.0
1.0
u/ml
0.6
0.0
0.62
14
38
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
55
230
2.36
8.12
1.2
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
137
803
1.68
7.72
1.0
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
27
79
3.37
7.70
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
892
7212
1.22
7.66
1.9
1.9
iu/l
73.5
12.5
0.50
334
2797
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
1279
10720
1.18
7.46
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
276
1907
1.43
7.42
1.4
1.9
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
214
1408
1.50
7.41
1.2
1.2
u/l
18.3
22.0
0.48
188
1214
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
1282
10758
1.18
7.38
1.4
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
534
6704
0.78
7.34
5.1
5.4
mmol/l
1.3
1.3
0.01
466
5922
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
1283
10776
1.18
7.31
1.4
1.4
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
173
1091
1.56
7.28
1.1
1.1
iu/ml
3.7
4.0
0.20
12
77
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
635
7800
0.80
7.26
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
1283
10783
1.18
7.25
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
3634
32691
1.11
7.25
4.6
4.2
ug/l
1.9
2.6
3.08
3277
29558
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5678
52147
1.09
7.25
1.7
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
139
834
1.64
7.20
1.1
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
797
6415
1.23
7.17
1.4
1.4
mg/l
435.1
504.9
4.40
764
6116
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
1355
11451
1.17
7.16
1.5
1.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
217
1445
1.48
7.10
1.2
1.2
u/l
74.0
87.3
1.61
193
1273
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
162
1014
1.58
7.06
2.2
2.0
mg/l
9.2
9.4
0.17
133
816
(3035933) Granulocytes/100 leukocytes in Blood
132
787
1.65
7.02
1.4
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2603
23042
1.12
6.99
3.8
4.2
u/l
237.7
239.2
0.14
2438
21842
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
290
2047
1.40
6.94
1.3
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
918
7525
1.21
6.90
2.5
2.8
g/l
3.6
3.6
0.04
870
7157
(3011985) Renin [Units/volume] in Plasma
439
3315
1.31
6.77
1.6
1.6
mu/l
60.1
57.2
0.14
388
2987
(3048929) Epstein Barr virus Ab [Presence] in Serum
1189
9999
1.18
6.70
1.2
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
980
8106
1.20
6.69
2.1
2.4
%
94.2
93.9
0.16
916
7492
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
347
2542
1.35
6.62
1.2
1.2
u/l
65.3
61.5
0.32
247
1719
(3004716) Salmonella sp identified in Stool by Organism specific culture
1808
15721
1.14
6.49
1.4
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
94
523
1.77
6.46
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
6400
59318
1.08
6.41
3.2
3.3
mg/l
505.7
441.9
0.41
3751
36333
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
537
4199
1.26
6.33
1.2
1.3
u/ml
3.5
4.1
0.61
242
1853
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
702
5659
1.23
6.29
1.3
1.3
mmol/l
3.7
3.7
0.29
657
5318
(3007542) Rye IgE Ab [Units/volume] in Serum
38
152
2.46
6.26
1.1
1.0
u/ml
0.9
14.3
0.47
22
63
(21494755) Public health laboratory ask at order entry panel
3466
31330
1.10
6.26
1.3
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
552
4344
1.26
6.17
1.2
1.3
u/ml
2.3
3.6
1.78
181
1462
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
705
5704
1.22
6.10
1.4
1.5
e6/l
577.7
2117.4
1.55
553
4632
(3032080) INR in Blood by Coagulation assay
8990
84502
1.07
5.95
6.7
7.1
inr
1.1
1.2
2.16
2601
25932
(3035637) Corticotropin [Mass/volume] in Plasma
410
3127
1.29
5.94
1.5
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
770
6306
1.21
5.91
2.9
3.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
566
6869
0.81
5.88
4.2
4.0
mmol/l
1.3
1.4
0.42
561
6751
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
702
5701
1.22
5.87
1.4
1.4
e6/l
19.9
30.0
0.77
523
4409
(3030313) Adrenal Ab [Titer] in Serum
60
300
1.97
5.78
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
213
1475
1.42
5.78
1.6
1.6
u/l
5.9
6.2
0.10
118
698
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
607
7292
0.82
5.73
2.0
2.0
ug/l
1.5
2.3
1.12
528
6445
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
130
816
1.57
5.70
1.9
1.7
au/ml
83.8
148.6
1.00
17
107
(21494815) CD4 cells/100 lymphocytes in Specimen
293
2148
1.35
5.64
2.0
2.3
%
45.1
42.8
0.41
42
287
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
186
1262
1.45
5.64
1.2
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
254
1822
1.37
5.62
3.0
2.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
486
5961
0.80
5.59
4.6
4.2
mmol/l
3.8
3.8
2.12
459
5610
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1404
12133
1.15
5.57
9.6
9.0
%
0.6
0.7
4.44
1398
12064
(3009214) Lutropin [Units/volume] in Serum or Plasma
1056
8937
1.17
5.57
1.4
1.4
u/l
10.5
10.5
0.02
869
7324
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1032
8721
1.17
5.55
1.8
1.8
g/l
1.5
1.5
0.11
886
7504
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
896
10354
0.85
5.54
1.5
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
253
1823
1.37
5.46
1.4
1.4
umol/l
10.4
11.5
1.66
239
1733
(3038026) Centromere Ab [Units/volume] in Serum
275
2008
1.35
5.45
1.3
1.2
u/ml
29.7
53.4
0.91
16
94
(3020891) Body temperature
677
7997
0.83
5.40
4.7
4.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
358
4532
0.77
5.39
5.9
6.5
mmol/l
104.7
105.2
1.39
318
4078
(3039000) Anion gap in Blood
358
4531
0.77
5.38
5.9
6.5
mmol/l
11.2
11.2
0.00
318
4077
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1404
12164
1.14
5.38
9.5
9.0
%
1.3
1.4
3.88
1399
12088
(3019060) Gas panel - Arterial blood
1116
12643
0.86
5.36
4.4
4.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
311
2320
1.32
5.35
3.5
3.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
547
4379
1.23
5.31
1.3
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
3084
27961
1.09
5.22
5.1
5.8
mmol/l
1.0
1.0
0.04
2868
26150
(3011288) Drugs identified in Urine by Screen method
1177
10096
1.15
5.22
3.0
3.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
53
264
1.98
5.20
1.6
1.7
mg/l
0.9
1.9
1.54
40
165
(3026008) Bacteria identified in Urine by Culture
7751
72804
1.06
5.11
3.1
2.9
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
126
1868
0.66
5.08
14.5
13.2
nmol/l
871.8
1107.2
0.38
121
1808
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
266
1958
1.34
5.04
1.3
1.2
u/ml
56.8
65.5
0.28
19
100
(3051387) C reactive protein [Mass/volume] in Capillary blood
408
5039
0.79
5.04
3.8
3.2
mg/l
22.2
25.2
1.15
215
3098
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
161
1089
1.46
5.02
1.1
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
215
1533
1.38
4.99
1.4
1.3
pmol/l
89.6
85.1
0.06
62
445
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
229
1650
1.37
4.99
1.3
1.3
g/l
1.2
1.5
—
9
92
(3027008) Opiates [Presence] in Urine
1687
14866
1.12
4.96
2.1
2.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
306
2304
1.31
4.96
2.1
2.3
nmol/l
20.5
20.2
0.22
296
2190
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
520
4177
1.23
4.92
1.1
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
155
1046
1.46
4.90
1.9
1.9
umol/l
30.3
28.9
1.08
150
1011
(3028300) Cannabinoids [Presence] in Urine
1689
14902
1.12
4.87
2.2
2.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
136
896
1.50
4.85
1.1
1.1
—
—
—
0
0
(3017958) Strawberry IgE Ab [Units/volume] in Serum
25
93
2.65
4.83
1.0
1.0
u/ml
0.2
0.0
0.56
17
50
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
1.5
2.1
0.48
41
181
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
4.5
3.8
0.26
35
155
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
3.2
2.6
0.30
39
168
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
0.4
1.0
1.80
41
163
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
1.3
1.9
0.87
34
149
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
3.2
2.5
0.29
37
176
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
1.1
2.4
1.84
34
162
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
1.0
1.8
2.11
45
170
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
51
258
1.95
4.82
1.6
1.6
mg/l
0.8
1.2
0.59
37
151
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
265
1965
1.33
4.80
1.3
1.2
u/ml
72.1
43.1
0.94
21
163
(3002179) Metamyelocytes/100 leukocytes in Blood
2046
18265
1.11
4.77
3.9
4.0
%
0.5
0.6
1.11
369
3779
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
162
1109
1.44
4.76
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
438
3470
1.25
4.73
1.4
1.4
mmol/l
58.1
64.5
2.71
355
2744
(3019832) Treponema pallidum Ab [Presence] in Serum
4090
37677
1.08
4.73
1.7
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
859
7257
1.17
4.70
1.2
1.3
titre
154.1
124.2
0.31
74
673
(3027944) Amphetamines [Presence] in Urine
1657
14635
1.12
4.70
2.1
2.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
226
1642
1.36
4.70
1.6
2.2
%
104.1
97.9
1.91
209
1508
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
393
3080
1.26
4.67
1.4
1.4
pmol/l
317.6
321.3
0.05
313
2412
(3020911) Cortisol [Moles/time] in 24 hour Urine
16
47
3.35
4.61
1.1
1.1
nmol/24h
112.2
97.7
0.22
16
47
(3034274) Bile acid [Moles/volume] in Serum --fasting
608
5002
1.20
4.55
1.9
2.2
umol/l
5.4
6.1
0.70
448
3641
(3016879) Cocaine [Presence] in Urine
1556
13728
1.12
4.51
2.2
2.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
253
1883
1.32
4.50
1.3
1.2
u/ml
7.1
10.3
0.26
21
150
(1001926) Buprenorphine [Presence] in Urine by Screen method
1316
11498
1.13
4.49
2.3
2.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
89
544
1.61
4.46
1.2
1.2
pmol/l
277.5
371.5
1.52
68
397
(3022621) pH of Urine by Test strip
1460
16045
0.89
4.46
2.8
2.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
1667
14780
1.12
4.44
2.1
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
2124
19079
1.10
4.41
4.2
4.2
%
0.1
0.1
0.12
451
4847
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
648
5390
1.19
4.32
3.1
3.2
ratio
2.2
3.4
0.42
51
440
(3017732) Neutrophils [#/volume] in Blood
1995
17887
1.10
4.30
2.3
2.7
e9/l
4.2
4.1
0.88
1566
14274
(3025159) Blasts/100 leukocytes in Blood
2025
18173
1.10
4.29
4.2
4.3
%
0.2
0.2
0.10
396
4118
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
488
3957
1.22
4.28
1.5
1.5
—
—
—
0
0
(3025296) Carrot IgE Ab [Units/volume] in Serum
18
60
2.95
4.26
1.1
1.0
u/ml
3.3
0.3
0.71
13
32
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
368
2901
1.25
4.21
1.1
1.1
%
96.6
94.5
0.84
345
2721
(3036603) Volume of Urine
206
1506
1.35
4.17
1.6
1.6
ml
2339.5
1921.2
0.52
15
343
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
282
2155
1.29
4.17
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
827
9380
0.86
4.13
1.8
1.8
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
125
841
1.46
4.09
2.0
2.2
e6/l
221.3
270.8
0.39
76
459
(3041096) Erythrocytes [Presence] in Urine by Automated
7352
69342
1.06
4.08
3.1
3.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
200
1461
1.35
4.08
1.1
1.2
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
61
348
1.73
4.01
1.6
1.5
nmol/l
233338.7
284539.1
0.10
51
278
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
660
5542
1.18
3.97
3.1
3.3
mg/l
47.4
42.5
0.16
525
4498
(40761535) Cells panel - Urine sediment
1684
18232
0.90
3.93
3.8
3.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
108
712
1.49
3.93
1.0
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
211
1564
1.33
3.92
2.6
3.1
nmol/l
94.5
118.9
1.06
206
1529
(3034860) Kappa light chains.free [Mass/volume] in Serum
660
5553
1.17
3.88
3.1
3.3
mg/l
49.6
65.8
0.59
521
4507
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
813
6953
1.15
3.87
2.3
2.3
ug/l
608.9
491.6
0.29
751
6404
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
126
860
1.44
3.85
1.2
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
26
111
2.31
3.84
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
411
3317
1.22
3.82
1.5
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
311
2436
1.26
3.81
2.8
3.2
nmol/l
4.4
7.2
0.60
303
2348
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
730
6204
1.16
3.79
2.5
2.6
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
160
1144
1.38
3.77
1.8
2.0
u/l
195.1
198.9
0.34
160
1136
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
65
385
1.66
3.75
1.0
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
833
7156
1.15
3.74
1.2
1.3
titre
1405.7
897.5
0.94
23
229
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
547
4548
1.19
3.72
2.1
3.0
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
92
594
1.53
3.71
1.3
1.3
nmol/l
179.1
119.2
0.98
66
431
(4268621)
361
2885
1.23
3.71
2.2
2.3
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
29
132
2.16
3.70
1.7
1.2
u/ml
16.6
20.2
—
5
25
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
346
4186
0.81
3.66
1.4
1.4
mmol/l
6.7
7.0
1.18
252
3022
(3021447) Carbon dioxide [Partial pressure] in Venous blood
2072
18768
1.09
3.64
4.0
4.0
kpa
5.8
5.8
0.13
2006
18202
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
76
472
1.59
3.64
1.5
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
644
5442
1.17
3.62
1.3
1.3
ug/l
3.5
3.7
0.29
585
4887
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
336
2675
1.24
3.59
4.0
4.6
u/ml
74.9
114.1
1.00
111
819
(3028679) Herpes simplex virus Ab [Presence] in Serum
222
1681
1.30
3.58
1.2
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
66
398
1.63
3.57
1.6
1.6
—
—
—
0
0
(3012544) pH of Venous blood
2133
19372
1.09
3.54
4.0
4.0
ph
7.4
7.4
—
5
106
(3021661) Pineapple IgE Ab [Units/volume] in Serum
13
40
3.20
3.52
1.0
1.1
u/ml
0.4
0.2
—
5
21
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
1096
12055
0.89
3.47
1.4
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
184
1364
1.33
3.47
3.9
3.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
447
3677
1.20
3.46
1.6
1.7
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
34
170
1.97
3.42
1.0
1.1
—
2.5
—
0
8
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
233
1788
1.28
3.42
2.3
2.7
e6/l
815.7
740.0
0.49
89
740
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
520
4343
1.18
3.40
1.1
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
238
1835
1.28
3.37
1.4
1.3
umol/l
4.8
5.3
1.25
215
1698
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
60
359
1.65
3.37
1.7
1.6
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
66
1017
0.64
3.35
2.4
2.3
nmol/l
154.3
152.3
0.06
60
887
(3002032) Base excess in Venous blood by calculation
2058
18710
1.09
3.35
4.0
4.1
mmol/l
1.7
1.9
1.41
1713
15304
(3011648) Oxygen content in Venous blood
217
1655
1.29
3.35
2.2
3.0
%
11.4
11.1
0.38
217
1655
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
129
910
1.40
3.34
1.2
1.2
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
27
125
2.13
3.33
1.0
1.0
u/ml
0.0
0.1
—
10
51
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
484
4034
1.18
3.26
1.1
1.1
%
121.2
119.3
0.71
435
3648
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
162
1191
1.34
3.26
2.3
2.2
ug/l
41.7
107.9
0.94
154
1129
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
677
5794
1.15
3.26
1.2
1.3
—
—
—
0
0
(4212803)
31
153
1.99
3.25
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
1001
11017
0.89
3.23
1.8
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
2191
20006
1.08
3.22
4.1
4.2
%
0.9
0.9
0.12
477
5231
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
8571
81625
1.05
3.13
3.2
3.1
ng/l
34.6
54.9
1.53
4628
47421
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
12182
116908
1.04
3.11
3.7
3.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1706
15439
1.09
3.11
3.3
3.5
kpa
4.6
4.7
0.61
1641
14937
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
231
1795
1.27
3.11
2.4
2.6
e9/l
0.2
0.2
0.70
193
1525
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
134
965
1.37
3.10
1.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
76
492
1.52
3.10
1.4
1.3
mu/l
75.6
84.8
0.14
60
370
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
161
1194
1.33
3.08
1.4
1.4
mu/l
626.0
529.3
0.57
154
1138
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
130
933
1.37
3.07
1.9
2.0
ug/min
66.6
93.7
0.29
30
192
(3020682) Albumin/Creatinine [Ratio] in Urine
6572
62228
1.05
3.06
4.0
4.0
mg/mmol
8.8
9.0
0.13
3872
38383
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
85
566
1.48
3.04
1.6
1.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
72
463
1.53
3.03
1.2
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
155
2012
0.76
3.02
3.2
2.9
mg/l
51.9
54.0
0.05
112
1413
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
18
73
2.43
3.01
1.3
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
402
4691
0.84
2.99
2.3
2.4
ug/min
78.8
101.3
0.63
237
2820
(3016038) Potassium [Moles/volume] in Urine
179
1354
1.30
2.99
1.3
1.3
mmol/l
33.5
33.8
0.07
155
1165
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
117
831
1.39
2.96
2.5
3.0
umol/l
26.6
28.5
1.21
87
620
(44816559) Phosphatidylethanol [Mass/volume] in Blood
605
5178
1.15
2.95
1.4
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
526
4461
1.16
2.91
1.1
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
376
3103
1.19
2.88
1.1
1.1
iu/ml
3.0
1.5
—
10
43
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2632
27577
0.93
2.88
6.3
6.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
151
1122
1.33
2.88
2.4
2.7
au/ml
213.4
141.9
0.90
24
156
(3051101) Glucose [Moles/volume] in Cord blood
13
315
0.41
2.86
3.7
5.6
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
27
134
1.98
2.82
1.0
1.0
u/ml
1.4
12.1
0.43
20
61
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
263
3173
0.81
2.81
1.6
1.6
mmol/l
7.6
7.5
0.06
159
1902
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
316
2574
1.21
2.80
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
54
332
1.60
2.79
1.1
1.2
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
162
1223
1.31
2.77
1.4
1.4
%
73.5
72.9
0.21
155
1167
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
143
1061
1.33
2.77
2.1
2.2
%
27.6
28.7
0.57
137
1009
(3023520) Reticulocytes [#/volume] in Blood
1746
15905
1.09
2.77
2.3
2.7
e9/l
70.1
71.1
0.47
1173
11920
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
7911
75399
1.04
2.74
2.5
2.5
u/l
58.1
57.3
0.41
7230
69675
(42529582) MDA5 Ab [Presence] in Serum by Line blot
83
563
1.45
2.74
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
83
563
1.45
2.74
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
83
563
1.45
2.74
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
83
563
1.45
2.74
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
6530
66602
0.96
2.73
4.1
3.9
estimate
0.0
0.0
0.26
2580
23360
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
23
109
2.08
2.72
1.0
1.0
u/ml
0.0
0.1
—
7
40
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
633
5470
1.14
2.72
1.2
1.3
u/ml
257.2
258.5
0.04
403
3529
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
283
2288
1.22
2.72
1.6
1.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
233
1846
1.24
2.71
2.4
2.5
e6/l
477.4
514.0
0.79
192
1524
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
12
42
2.81
2.66
1.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
298
2430
1.21
2.64
1.7
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
243
1942
1.23
2.62
1.2
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
283
2298
1.21
2.62
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
178
1373
1.28
2.61
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
144
1080
1.31
2.61
1.5
1.5
%
2.2
4.3
1.80
38
241
(3004775) Volume in Urine collected for unspecified duration
115
1520
0.74
2.61
2.0
2.3
ml
686.5
651.8
0.31
78
1085
(3006270) Folate [Moles/volume] in Blood
236
1884
1.23
2.58
1.2
1.1
nmol/l
401.7
380.1
0.96
228
1641
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
443
3748
1.17
2.57
1.3
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
546
4694
1.15
2.55
3.7
3.6
u/ml
30.8
38.6
0.90
519
4527
(3050794) Legionella sp Ab [Presence] in Serum
32
175
1.80
2.54
1.2
1.1
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
9
25
3.54
2.53
1.7
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
204
1609
1.25
2.50
1.1
1.1
u/l
1.0
1.1
1.60
81
706
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
175
1357
1.27
2.48
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
126
935
1.33
2.48
1.5
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
126
935
1.33
2.48
1.5
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1176
10597
1.10
2.43
9.3
9.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
596
5177
1.14
2.41
1.6
1.7
e6/l
10565.4
12024.2
0.35
417
3784
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
29
157
1.82
2.39
1.0
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
255
2076
1.21
2.34
3.5
3.2
mu/l
27.0
27.4
0.06
244
1958
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
346
2899
1.18
2.31
1.3
1.3
nmol/l
27.8
27.4
—
5
25
(3006245) CD3-CD19+ cells/100 cells in Blood
144
1102
1.29
2.29
2.1
2.3
%
9.9
10.2
0.15
137
1032
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
70
978
0.70
2.29
3.1
3.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
301
2495
1.19
2.28
2.2
2.4
e9/l
1.3
1.2
1.54
174
1484
(3008295) Osmolality of Serum or Plasma
267
2190
1.20
2.28
1.6
1.5
mosm/kgh2o
279.6
280.3
0.19
190
1714
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
348
4000
0.85
2.26
3.1
3.4
u/ml
154.9
713.4
3.04
322
3623
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
635
5566
1.13
2.25
1.3
1.4
u/ml
26.1
19.3
0.32
11
108
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
41
250
1.61
2.25
1.7
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
127
959
1.30
2.24
1.1
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1043
11209
0.91
2.23
2.5
2.5
e6/l
0.3
0.3
0.04
990
10830
(4306422)
488
4215
1.14
2.19
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
230
1869
1.21
2.18
2.0
2.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
5027
47671
1.05
2.18
1.6
1.6
pmol/l
36260813.7
36834419.8
0.02
4225
40164
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
855
9259
0.91
2.16
2.1
2.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
808
7201
1.11
2.14
3.2
3.5
u/ml
1875.5
2306.0
0.11
669
6127
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
158
1237
1.26
2.12
3.3
3.2
mg/l
8.5
8.2
0.25
124
996
(3030905) Polymorphonuclear cells [#/volume] in Blood
588
5153
1.13
2.11
3.2
3.3
e9/l
4.0
4.0
0.03
588
5144
(21494567) Legionella sp IgM Ab [Presence] in Serum
25
135
1.82
2.11
1.0
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2385
22216
1.06
2.08
7.4
7.1
kpa
5.1
5.1
0.33
2275
21240
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
96
706
1.34
2.07
1.5
1.6
ug/l
9.4
8.7
0.76
96
706
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
139
1727
0.79
2.05
1.5
1.4
mmol/l
5.5
5.5
0.09
130
1635
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
591
5194
1.12
2.04
1.3
1.5
u/ml
108.0
110.8
0.20
106
1185
(3049233) Organic acids panel - Urine
9
31
2.86
2.03
1.1
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
156
1230
1.25
2.00
1.5
1.6
mmol/24h
6.6
5.5
0.55
14
107
(3027801) Oxygen [Partial pressure] in Arterial blood
2381
22208
1.06
2.00
7.4
7.1
kpa
12.9
13.0
0.28
2266
21227
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
272
2268
1.18
1.98
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
671
5951
1.11
1.98
1.3
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1127
11996
0.92
1.97
3.3
3.4
g/l
131.0
129.4
1.59
1100
11719
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
18
89
1.99
1.97
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
258
2144
1.19
1.96
1.2
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
24
132
1.79
1.93
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
238
1971
1.19
1.89
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
2380
22243
1.06
1.88
7.4
7.1
mmol/l
0.8
1.0
2.74
1907
17427
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2261
21102
1.06
1.87
3.4
3.9
ug/l
13.2
22.5
1.26
1660
16444
(3013336) Amino acids [Identifier] in Serum or Plasma
14
64
2.15
1.87
1.4
3.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
632
5610
1.11
1.86
1.3
1.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
88
1141
0.76
1.85
31.1
37.0
ug/l
7.0
7.4
0.90
80
1051
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
278
2338
1.17
1.85
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
37
233
1.56
1.83
1.1
1.1
—
—
—
0
0
(4035726)
2178
20320
1.06
1.83
1.4
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
119
922
1.27
1.80
1.1
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1871
17398
1.06
1.77
6.4
7.7
mmol/l
8.4
8.7
1.48
1786
16628
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
154
1232
1.23
1.77
1.1
1.1
iu/ml
172.7
187.9
0.32
154
1221
(3013466) aPTT in Blood by Coagulation assay
31
189
1.61
1.76
1.1
1.1
s
35.2
36.6
0.73
24
157
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
161
1297
1.22
1.74
1.7
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
782
8400
0.91
1.74
1.9
1.8
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
33
500
0.65
1.72
1.1
1.2
mg/l
96.4
60.6
0.14
24
359
(3022217) INR in Platelet poor plasma by Coagulation assay
2642
24834
1.05
1.70
21.8
19.4
inr
1.2
1.2
0.07
331
3846
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
5
13
3.79
1.69
1.0
1.0
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
55
384
1.41
1.68
1.6
1.9
pmol/l
56.1
45.2
0.23
50
324
(40768793) Breast Pathology biopsy report
755
6803
1.09
1.67
1.3
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
28
169
1.63
1.67
1.4
1.2
—
—
—
0
0
(4027681)
227
1898
1.18
1.66
1.2
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
151
1216
1.22
1.65
1.0
1.0
ng/l
42.0
42.8
0.08
108
864
(3020123) Porphyrins [Interpretation] in Serum or Plasma
27
162
1.64
1.65
1.1
1.1
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
196
1620
1.19
1.64
1.7
1.9
mg/l
3.4
3.5
0.20
181
1546
(3008536) Aspergillus sp Ab [Presence] in Serum
57
403
1.39
1.63
1.6
2.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
33
209
1.55
1.62
1.3
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
129
0.38
1.62
5.4
3.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
274
2333
1.16
1.60
1.1
1.1
mg/l
221.5
245.7
1.16
246
2042
(3042517) Benzodiazepines panel - Urine
60
430
1.37
1.59
3.2
2.9
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
256
2170
1.16
1.59
1.5
1.3
nmol/l
32.6
31.3
0.32
236
1987
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
150
1214
1.22
1.58
1.0
1.0
ng/l
689.9
751.2
0.92
105
848
(4146454)
238
2009
1.17
1.57
2.9
2.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
38
251
1.49
1.56
1.1
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
75
559
1.32
1.56
1.1
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
466
5101
0.90
1.55
2.7
3.0
mmol/l
24.8
24.7
0.35
421
4479
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
281
2405
1.15
1.55
1.1
1.2
mg/l
33.4
41.6
3.50
236
2001
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
75
560
1.32
1.54
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
75
560
1.32
1.54
1.1
1.1
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
47
325
1.42
1.54
1.9
1.7
mg/l
2.0
1.6
1.05
40
281
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
617
5534
1.10
1.54
1.4
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
150
1219
1.21
1.53
1.2
1.1
u/l
81.1
82.5
0.08
129
978
(3016750) Collection duration of Urine
94
1172
0.79
1.52
2.0
2.2
min
502.7
501.7
0.04
68
905
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
235
1988
1.16
1.52
2.0
2.1
%
12.7
13.5
0.63
136
986
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
150
1220
1.21
1.52
1.2
1.1
u/l
24.4
21.8
0.20
126
946
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
664
5982
1.09
1.51
2.8
3.4
u/ml
0.4
0.4
0.07
334
3408
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
61
443
1.36
1.51
1.0
1.0
ug/l
89.8
79.2
1.17
51
371
(3022475) Manganese [Moles/volume] in Blood
28
174
1.58
1.51
1.4
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
892
8142
1.08
1.49
3.8
3.7
mmol/l
24.9
24.8
0.39
823
7574
(3034092) Cytoplasmic Ig cells/100 cells in Blood
23
364
0.62
1.49
12.5
7.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
170
1402
1.19
1.49
1.5
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
68
504
1.33
1.48
1.1
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
148
1206
1.21
1.48
1.0
1.0
ng/l
321.1
345.7
0.28
108
874
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
102
799
1.26
1.47
1.3
1.3
%
17.9
19.5
0.06
13
146
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
342
2982
1.13
1.45
1.3
1.2
u/l
28.9
36.2
0.82
291
2610
(3013293) Extractable nuclear Ab [Presence] in Serum
59
430
1.35
1.44
1.6
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
38
256
1.46
1.44
1.3
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
86
1075
0.79
1.44
2.7
2.6
ph
7.4
7.4
0.13
31
354
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
35
232
1.49
1.43
1.1
1.2
mg/l
42.9
44.0
—
6
68
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
40
273
1.44
1.42
1.8
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
313
2718
1.13
1.42
2.2
2.0
mg/l
23.2
24.6
0.18
78
745
(40760888) Immunoglobulin light chains.free panel - Serum
472
4207
1.11
1.37
3.0
3.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
203
1716
1.17
1.36
1.2
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
236
2019
1.15
1.35
2.0
2.1
%
75.1
73.5
1.28
229
1942
(3004809) Band form neutrophils/100 leukocytes in Blood
311
3449
0.89
1.34
3.4
3.1
%
1.0
1.4
1.84
235
2677
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
684
6210
1.09
1.34
1.7
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
85
660
1.27
1.34
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
268
2318
1.14
1.32
1.5
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
193
1630
1.17
1.32
1.4
1.4
e6/l
49216.7
46806.0
0.05
118
942
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
84
1038
0.80
1.30
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
2312
21828
1.05
1.30
4.0
3.9
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
29
420
0.68
1.29
1.8
2.7
mmol/l
1.2
1.2
0.12
29
399
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
122
992
1.21
1.28
1.1
1.1
ng/l
220.5
492.6
0.69
24
219
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
379
3354
1.11
1.28
1.7
1.7
titre
4880.0
2979.2
0.24
15
100
(40768800) Prostate Pathology biopsy report
203
1726
1.16
1.28
1.2
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
12
61
1.94
1.27
1.3
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
47
624
0.74
1.26
3.2
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
47
624
0.74
1.26
3.2
2.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
25
159
1.55
1.26
1.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
720
7633
0.93
1.26
1.4
1.4
pmol/l
97.5
124.5
1.63
707
7437
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
377
3342
1.11
1.25
1.0
1.1
g/l
1.5
1.5
0.50
340
3032
(3022313) Gas panel - Capillary blood
985
9108
1.07
1.21
3.6
3.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1786
16795
1.05
1.21
2.8
3.2
u/ml
51.7
48.1
0.08
1733
16224
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
197
2231
0.87
1.20
1.3
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
213
2398
0.87
1.20
3.2
8.4
mmol/l
6.7
7.3
1.72
192
1947
(3013166) Neutrophils/100 leukocytes in Synovial fluid
50
651
0.76
1.19
1.3
1.4
%
47.7
50.9
0.23
41
563
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
183
1555
1.16
1.19
1.7
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
100
805
1.22
1.18
4.2
3.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
69
533
1.27
1.17
1.1
1.1
—
—
—
0
0
(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum
15
85
1.74
1.17
1.1
1.0
u/ml
0.1
0.2
—
8
12
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
68
525
1.28
1.16
1.2
1.1
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
31
211
1.45
1.16
1.1
1.1
u/ml
13.9
34.8
—
6
44
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
31
211
1.45
1.16
1.1
1.1
u/ml
14.9
26.1
—
5
40
(3017704) Immunofixation for Urine
118
970
1.20
1.14
1.3
1.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
100
809
1.22
1.14
7.4
6.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
100
810
1.22
1.13
3.7
3.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
54
407
1.31
1.11
3.2
4.8
u/l
39.6
60.2
0.99
15
167
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
223
1935
1.14
1.10
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
114
940
1.19
1.08
1.8
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
308
2730
1.11
1.07
1.6
1.6
%
51.0
53.9
0.61
196
1709
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
22
321
0.67
1.06
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
221
1925
1.13
1.04
1.2
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
249
2186
1.12
1.03
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
194
1678
1.14
1.02
5.7
6.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
30
209
1.41
1.02
1.0
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
472
5034
0.92
1.02
2.9
3.4
kpa
8.9
8.6
1.95
441
4690
(3004446) Plasmodium sp identified in Blood by Light microscopy
43
319
1.33
1.01
2.6
2.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
336
3637
0.91
1.01
2.5
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
264
2331
1.12
1.00
1.7
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
460
4173
1.09
1.00
2.5
2.9
umol/l
33.7
34.1
0.13
384
3583
(3010144) Erythrocytes [#/volume] in Synovial fluid
179
2007
0.88
1.00
1.5
1.4
e6/l
100569.0
95712.6
0.04
127
1365
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
21
305
0.68
1.00
5.7
7.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
9
48
1.85
0.99
1.1
1.4
mmol/24h
2.3
1.9
—
9
48
(3037121) Protein [Mass/volume] in Urine
827
7669
1.06
0.98
3.1
3.2
g/l
0.3
0.3
0.24
320
3255
(3036005) Urine sediment comments by Light microscopy Narrative
0
28
0.00
0.97
0.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
10
53
1.86
0.97
1.3
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
233
2048
1.12
0.96
1.5
1.6
%
35.7
33.9
0.29
133
1257
(3017461) Flecainide [Moles/volume] in Serum or Plasma
18
114
1.55
0.96
1.8
1.7
umol/l
0.8
0.7
0.42
13
87
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
585
5368
1.07
0.96
1.4
1.4
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
74
594
1.23
0.95
1.3
1.6
ug/l
0.4
0.4
0.09
50
392
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
7
36
1.91
0.95
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
72
866
0.82
0.95
2.5
2.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
12
195
0.61
0.95
3.7
2.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
177
1532
1.14
0.94
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
62
756
0.81
0.93
7.1
8.8
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
167
1870
0.88
0.93
10.7
12.0
mmol/l
0.6
0.6
0.27
150
1726
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
44
559
0.77
0.93
1.2
1.3
%
41.5
40.4
0.08
33
375
(3024522) Salmonella sp identified in Specimen by Organism specific culture
348
3133
1.09
0.92
1.4
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
47
590
0.78
0.91
1.1
1.2
—
—
—
0
0
(3013512) EKG study
6196
62099
0.98
0.90
3.5
3.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
219
1928
1.12
0.90
1.4
1.3
nmol/l
1.4
1.5
0.16
195
1737
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
86
1010
0.84
0.90
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
347
3129
1.09
0.89
1.4
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
532
4883
1.07
0.89
3.0
3.8
mmol/l
2.4
2.5
0.37
339
3267
(3013290) Carbon dioxide [Partial pressure] in Blood
532
4885
1.07
0.88
3.0
3.8
kpa
5.0
5.0
0.77
525
4774
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
24
166
1.42
0.87
1.4
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
178
1553
1.13
0.86
1.4
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
214
1888
1.12
0.86
2.8
2.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
403
3666
1.08
0.86
1.1
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
36
268
1.32
0.86
1.1
1.1
umol/24h
1.5
1.7
0.71
36
268
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
149
1286
1.14
0.85
1.6
1.6
nmol/l
3.1
9.0
0.70
124
1059
(3023511) Choriogonadotropin [Units/volume] in Urine
878
8202
1.06
0.85
1.4
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
535
5627
0.93
0.84
1.5
1.3
u/l
23.6
26.3
1.20
432
4647
(3027315) Oxygen [Partial pressure] in Blood
534
4914
1.07
0.84
3.0
3.8
kpa
8.9
8.8
0.49
527
4802
(3025315) Body weight
25
176
1.40
0.83
4.4
4.2
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
10
56
1.76
0.83
1.1
1.2
mg/l
28.1
28.1
—
10
48
(3023199) Leukocytes [#/volume] in Pleural fluid
206
1818
1.12
0.83
1.4
1.4
e6/l
1983.8
3361.8
1.65
145
1312
(3044007) Cell count panel - Peritoneal fluid
43
538
0.79
0.83
1.8
1.9
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
55
668
0.81
0.82
1.5
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
47
581
0.80
0.82
2.3
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
236
2100
1.11
0.82
1.7
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
195
1718
1.12
0.82
1.4
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
75
882
0.84
0.82
2.4
2.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
24
325
0.73
0.81
1.1
1.1
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
28
370
0.74
0.81
4.8
5.0
ug/min
28.9
39.0
0.70
18
276
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
14
210
0.66
0.81
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
342
3100
1.09
0.81
1.4
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
431
4558
0.93
0.80
2.6
2.4
%
13.1
13.1
0.97
423
4506
(3010421) pH of Blood
614
5689
1.06
0.80
2.8
3.7
ph
7.4
7.4
1.64
525
4775
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
106
898
1.16
0.80
2.4
2.9
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
87
1006
0.85
0.79
2.2
2.1
ug/l
3.1
2.5
0.28
73
856
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
344
3124
1.08
0.79
2.5
2.7
u/ml
202.6
560.0
0.53
328
2928
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
150
1305
1.13
0.78
1.3
1.3
%
65.9
67.1
0.05
14
160
(3042733) HLA Ab [Presence] in Serum
72
845
0.84
0.78
4.2
5.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
232
2071
1.10
0.77
1.7
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
391
3572
1.08
0.77
1.7
1.7
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
12
73
1.62
0.77
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
40
308
1.28
0.77
1.3
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
291
3119
0.92
0.77
1.4
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
46
564
0.80
0.77
1.2
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
61
494
1.22
0.76
1.3
1.4
nmol/l
0.2
0.3
0.46
43
351
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
81
1.58
0.76
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
46
361
1.25
0.76
1.1
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
67
548
1.20
0.76
1.1
1.1
umol/24h
0.6
0.8
0.95
36
269
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
352
3205
1.08
0.76
1.4
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
283
2553
1.09
0.76
5.3
6.5
mg/l
11.4
11.4
0.00
262
2345
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
33
421
0.77
0.76
2.4
2.6
mg/l
19.7
41.9
—
9
73
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
13
194
0.66
0.75
1.5
1.4
%
83.0
70.5
1.61
13
161
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
92
776
1.17
0.75
1.2
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
50
398
1.24
0.74
1.2
1.3
titre
9.7
144.1
—
7
45
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
341
3106
1.08
0.74
1.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
531
4914
1.06
0.74
4.8
5.7
iu/ml
1463.9
1296.2
0.07
54
706
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
2159
20633
1.03
0.74
1.5
1.5
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
23
307
0.74
0.73
1.3
1.2
mmol/l
1.8
1.9
0.05
15
181
(3042010) Triglyceride [Moles/volume] in Pleural fluid
18
250
0.71
0.72
1.3
1.2
mmol/l
4.1
1.4
—
10
162
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
100
852
1.16
0.72
2.0
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
100
852
1.16
0.72
2.0
2.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
40
312
1.26
0.71
1.3
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
91
772
1.16
0.70
2.8
3.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
58
473
1.21
0.70
1.1
1.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
47
375
1.23
0.69
1.1
1.4
ng/l
43.8
67.5
0.95
28
229
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
121
1349
0.88
0.69
1.1
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
57
674
0.83
0.69
2.4
1.9
e6/l
3937.7
3041.9
0.12
42
439
(3005988) Vibrio sp identified in Specimen by Organism specific culture
340
3110
1.08
0.68
1.4
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
19
133
1.41
0.68
1.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
15
100
1.48
0.68
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
33
253
1.28
0.68
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
272
2467
1.09
0.67
2.8
2.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
44
350
1.24
0.67
1.1
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
31
390
0.78
0.66
1.2
1.1
pmol/l
5.0
3.4
—
5
56
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
406
3743
1.07
0.66
2.9
2.9
u/ml
27236.6
4311.5
0.41
21
190
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
101
869
1.14
0.66
2.0
2.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1924
18400
1.03
0.65
8.3
7.9
g/l
121.6
121.2
0.35
1868
17723
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
36
281
1.26
0.65
1.0
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
65
541
1.18
0.64
1.7
1.8
u/l
49.7
30.3
0.36
57
484
(3049242) von Willebrand panel - Platelet poor plasma
12
77
1.53
0.64
1.7
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
529
4924
1.06
0.64
1.9
2.1
g/l
132.8
130.4
1.32
328
3627
(43055514) Macroprolactin [Presence] in Serum or Plasma
107
927
1.14
0.64
1.4
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
28
212
1.30
0.64
1.1
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
25
187
1.32
0.62
2.0
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
198
1780
1.10
0.62
1.2
1.2
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
11
162
0.67
0.62
1.3
1.8
%
63.8
58.1
—
5
97
(4024509)
212
2274
0.92
0.62
1.6
1.6
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
19
136
1.38
0.61
1.1
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
24
308
0.77
0.61
10.2
7.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
16
111
1.42
0.61
1.1
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
10
149
0.66
0.60
1.0
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
21
154
1.34
0.59
11.5
7.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
222
2012
1.09
0.59
1.3
1.3
mmol/l
1.9
2.0
0.70
202
1876
(3001186) Copper [Moles/volume] in Serum or Plasma
80
684
1.15
0.59
1.4
1.3
umol/l
17.1
17.1
0.01
73
609
(3020491) Glucose [Moles/volume] in Blood
208
1881
1.09
0.58
1.7
1.8
mmol/l
6.6
6.4
0.38
166
1395
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
6
34
1.74
0.58
1.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
6
34
1.74
0.58
1.0
1.0
—
—
—
0
0
(3045759) Histamine [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
39
467
0.82
0.57
7.8
5.9
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
6
35
1.69
0.57
1.0
1.0
—
10417.9
—
0
13
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
157
1404
1.10
0.56
1.7
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
126
1114
1.11
0.56
1.9
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
126
1114
1.11
0.56
1.9
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
126
1114
1.11
0.56
1.9
1.9
—
—
—
0
0
(44806071)
45
368
1.20
0.56
1.1
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
29
226
1.26
0.55
2.4
3.0
mg/l
0.9
1.3
0.87
19
147
(3002621) Streptococcal DNAse B [Units/volume] in Serum
30
235
1.26
0.55
1.1
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
14
97
1.42
0.55
9.4
8.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
93
1033
0.89
0.55
2.1
2.0
ug/l
5.0
3.8
0.32
77
915
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
78
876
0.88
0.54
2.4
2.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
158
1703
0.91
0.54
1.5
1.4
umol/l
67.2
67.9
0.05
12
141
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
126
1118
1.11
0.54
1.9
1.9
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
53
443
1.18
0.53
1.1
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
432
4030
1.06
0.52
2.1
1.9
titre
7.0
7.3
0.04
11
77
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
147
1317
1.10
0.52
1.3
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
161
1449
1.09
0.52
2.1
1.9
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
6
39
1.51
0.52
1.2
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
52
599
0.85
0.51
2.2
1.8
e6/l
37952.8
8283.7
0.46
33
296
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
99
0.60
0.51
1.3
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
194
2066
0.92
0.51
1.6
1.5
promille
1.6
1.4
1.06
157
1554
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
17
222
0.75
0.51
2.2
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
237
2171
1.07
0.51
1.5
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
54
619
0.86
0.51
1.5
1.7
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
9
64
1.38
0.50
1.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
42
490
0.84
0.49
1.6
1.4
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
87
761
1.13
0.49
2.7
2.5
ng/l
94.2
113.3
0.70
54
413
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
121
1079
1.10
0.49
3.1
2.4
umol/l
52.0
52.8
0.11
98
909
(3052592) Norovirus Ag [Presence] in Stool
35
415
0.83
0.49
1.3
1.3
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
7
107
0.64
0.48
2.1
2.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
107
0.64
0.48
1.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
348
3621
0.95
0.48
1.3
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
38
312
1.20
0.47
2.1
1.8
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
24
187
1.26
0.47
1.5
1.4
umol/l
0.1
0.2
—
5
62
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2307
22248
1.02
0.47
3.2
3.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
229
2105
1.07
0.46
1.3
1.3
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
38
313
1.19
0.46
3.2
2.7
mmol/l
1.9
1.2
0.48
28
225
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
28
337
0.82
0.46
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
454
4263
1.05
0.45
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
531
5005
1.04
0.45
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
403
4164
0.95
0.44
1.7
1.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
140
1265
1.09
0.44
1.7
1.7
u/field
3.6
2.3
0.46
99
910
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
124
1115
1.09
0.44
5.8
5.6
u/ml
26463.8
962.1
0.52
26
199
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
17
128
1.31
0.43
5.2
5.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
246
2275
1.06
0.43
4.0
3.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
75
827
0.89
0.43
1.1
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
5
31
1.59
0.42
1.8
1.2
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
5
31
1.59
0.42
1.8
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
650
6167
1.04
0.42
1.2
1.3
—
—
—
0
0
(3013762) Body weight Measured
6
93
0.63
0.42
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
103
921
1.10
0.42
1.1
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
103
1.34
0.41
1.0
1.1
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
8
57
1.38
0.41
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
22
268
0.81
0.41
2.0
1.9
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
15
0.00
0.41
0.0
1.0
—
21.8
—
0
15
(3017937) Magnesium [Moles/time] in 24 hour Urine
10
69
1.43
0.41
1.1
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
32
374
0.84
0.40
1.6
1.4
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.1
—
27.1
—
0
17
(3020650) Glucose [Presence] in Urine
82
726
1.11
0.40
1.5
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
107
961
1.10
0.40
2.7
4.2
mg/l
4529.4
2272.2
0.31
75
693
(3038071) Oxygen [Partial pressure] in Mixed venous blood
36
416
0.85
0.40
6.8
8.5
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
17
130
1.29
0.40
1.8
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
331
3421
0.95
0.39
2.5
2.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1909
18422
1.02
0.39
3.1
3.7
mmol/l
1.2
1.2
0.76
1655
16077
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
162
1484
1.07
0.39
1.3
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
60
665
0.89
0.38
5.6
6.2
mmol/l
24.8
25.1
0.28
54
620
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
5
35
1.41
0.38
1.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
5
35
1.41
0.38
1.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
5
35
1.41
0.38
2.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
5
35
1.41
0.38
2.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
5
35
1.41
0.38
1.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
5
35
1.41
0.38
1.8
2.0
—
—
—
0
0
(44806420)
41
466
0.87
0.38
1.7
2.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
517
4898
1.04
0.38
1.6
1.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
19
149
1.26
0.37
1.1
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
5
36
1.37
0.37
1.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
23
275
0.82
0.37
1.2
1.3
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
113
0.70
0.37
6.1
3.5
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
68
600
1.12
0.37
1.2
1.3
g/l
39.9
39.4
0.13
40
320
(40768795) Lymph node Pathology biopsy report
231
2404
0.95
0.36
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
196
1814
1.06
0.36
2.1
2.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
11
144
0.75
0.36
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
150
1.25
0.36
1.3
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
172
1586
1.07
0.36
1.5
1.5
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
24
284
0.83
0.36
9.0
5.1
g/mol
144.5
56.3
0.46
19
261
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
61
671
0.89
0.36
1.2
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
452
4278
1.04
0.35
1.4
1.5
—
—
—
0
0
(3024316) Viscosity of Plasma
14
106
1.30
0.35
1.6
1.4
mpas
1.7
1.5
—
7
58
(3024471) HLA-A [Type]
78
846
0.91
0.35
1.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
77
834
0.91
0.34
1.2
1.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
21
169
1.22
0.34
1.5
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
10
131
0.75
0.33
1.7
2.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
136
1434
0.93
0.33
1.1
1.2
u/ml
28.6
13.0
0.25
15
149
(3017569) Oxygen content in Arterial blood
78
841
0.91
0.32
1.8
2.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
34
386
0.87
0.32
1.2
1.3
ug/l
783.6
290.2
0.30
18
221
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
90
1.31
0.32
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
55
484
1.12
0.32
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
174
1613
1.06
0.32
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
185
1719
1.06
0.32
1.4
1.5
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
41
458
0.88
0.32
1.4
1.4
g/l
14.5
13.8
0.17
34
339
(3020356) Listeria sp identified in Specimen by Organism specific culture
29
244
1.17
0.31
1.1
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
216
2018
1.05
0.31
1.1
1.1
mg/l
293.7
440.4
0.50
192
1814
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
460
4372
1.04
0.31
1.2
1.2
titre
68.0
156.0
—
5
91
(3048879) Bone marrow aspiration report
57
505
1.11
0.30
2.1
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
99
902
1.08
0.30
1.4
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
2256
21886
1.02
0.29
4.2
3.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
36
403
0.88
0.29
1.9
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
1609
16107
0.98
0.29
2.5
2.3
u/l
5625.3
6150.8
0.29
622
6451
(3046904) Somatotropin [Units/volume] in Serum or Plasma
7
55
1.25
0.29
2.6
1.9
mu/l
0.7
2.5
—
7
55
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1644
15909
1.02
0.29
2.1
2.2
ug/l
7.6
6.7
0.56
1376
13815
(3014271) Vancomycin [Susceptibility]
94
857
1.08
0.29
3.0
2.9
—
—
—
0
0
(3022670) pH of Venous cord blood
7
56
1.23
0.29
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
84
763
1.08
0.28
1.1
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
117
1077
1.07
0.28
1.4
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
11
138
0.78
0.28
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
186
1738
1.05
0.28
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
25
286
0.86
0.27
1.9
2.3
u/field
0.8
0.8
0.07
25
286
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
43
378
1.12
0.27
1.4
1.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
37
322
1.13
0.27
3.2
6.3
%
68.3
69.3
0.07
26
251
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
9
117
0.76
0.27
5.7
3.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
187
1750
1.05
0.27
1.0
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
19
156
1.20
0.27
1.6
1.5
umol/24h
344.3
320.2
0.21
19
156
(3029396) Erythrocyte agglutination [Presence] in Blood
120
1108
1.07
0.27
3.0
3.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
60
538
1.10
0.27
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
112
1032
1.07
0.27
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
300
2840
1.04
0.27
1.4
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
118
1237
0.94
0.27
2.0
1.7
nmol/l
1.3
1.3
0.10
92
985
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
466
4448
1.03
0.26
2.3
2.4
nmol/l
0.9
0.8
0.65
378
3752
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
112
1033
1.07
0.26
1.4
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
1323
12795
1.02
0.26
3.5
3.5
ph
7.4
7.4
0.34
175
1662
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
115
1062
1.07
0.26
1.4
1.5
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
5
74
0.66
0.25
1.2
1.2
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
11
136
0.80
0.25
1.0
1.1
u/field
1.4
1.3
—
5
87
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
257
2632
0.96
0.25
1.3
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
42
459
0.90
0.25
8.9
8.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
120
1113
1.06
0.24
1.6
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
1377
13767
0.98
0.24
1.4
1.4
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
12
95
1.24
0.23
1.1
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
51
458
1.10
0.23
2.2
2.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1300
12997
0.98
0.23
1.5
1.5
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
5
38
1.29
0.23
1.0
2.2
ng/l
23.2
19.3
—
5
30
(3044009) aPTT.lupus sensitive (LA screen)
24
270
0.87
0.22
1.2
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
92
964
0.94
0.22
1.7
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
1169
11320
1.02
0.22
1.8
1.8
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
40
1.23
0.22
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
529
5080
1.03
0.22
1.6
1.6
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
12
96
1.23
0.22
9.2
13.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
172
1768
0.96
0.21
2.1
2.0
u/field
2.1
2.3
0.17
85
804
(3008896) Cortisol [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(36304079) Mucus [Presence] in Urine sediment
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
5
42
1.17
0.21
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1335
12950
1.02
0.21
3.5
3.5
kpa
5.2
5.2
0.57
1231
12015
(3017354) Segmented neutrophils/100 leukocytes in Blood
206
2107
0.96
0.21
3.5
3.1
%
60.3
57.1
1.35
141
1335
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1275
12366
1.02
0.20
3.5
3.4
mmol/l
1.6
1.7
0.44
958
9064
(3013945) Hepatitis B virus e Ab [Presence] in Serum
19
161
1.16
0.20
1.5
1.4
—
—
—
0
0
(4133840)
76
700
1.07
0.20
1.1
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
48
1.23
0.20
1.0
1.1
%
2.7
2.6
—
6
48
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
50
1.18
0.19
1.2
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
132
1360
0.95
0.19
1.4
1.3
u/l
429.1
399.5
0.21
125
1294
(3010375) cycloSPORINE [Mass/volume] in Blood
102
1058
0.95
0.19
26.9
26.9
ug/l
112.6
119.7
0.53
86
879
(3006462) Nitrate [Presence] in Urine
120
1239
0.95
0.19
3.1
2.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
428
4112
1.02
0.19
1.2
1.2
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
6
52
1.14
0.18
1.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
12
98
1.21
0.18
1.4
1.3
—
—
—
0
0
(4211845)
132
1358
0.96
0.18
3.1
2.8
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
11
89
1.22
0.18
1.1
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9766
96483
0.99
0.18
3.7
3.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
312
3156
0.97
0.18
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
1159
11251
1.01
0.18
1.3
1.3
miu/ml
223.3
225.4
0.07
576
5445
(3018738) Hemoglobin F/Hemoglobin.total in Blood
19
213
0.88
0.18
2.5
2.9
%
20.6
9.5
—
8
54
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
37
333
1.09
0.17
3.5
2.9
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
12
99
1.19
0.17
1.2
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
24
211
1.12
0.17
1.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
55
579
0.93
0.17
1.1
1.2
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
69
0.71
0.16
1.2
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
84
784
1.05
0.16
2.4
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
475
4770
0.98
0.16
2.9
3.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
29
259
1.10
0.16
1.1
1.2
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
8
70
1.12
0.16
4.8
5.5
mmol/l
0.4
0.2
—
8
70
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
190
1810
1.03
0.16
1.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
190
1810
1.03
0.16
1.7
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
190
1810
1.03
0.16
1.7
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
452
4359
1.02
0.16
1.5
1.7
—
—
—
0
0
(3001729) Color of Synovial fluid
14
159
0.87
0.15
1.5
1.7
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
12
100
1.18
0.15
1.4
1.3
nmol/l
389.8
487.6
0.39
12
100
(3037692) Legionella sp identified in Specimen by Organism specific culture
74
691
1.05
0.15
1.5
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
200
1911
1.03
0.14
1.1
1.1
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
13
110
1.16
0.14
1.4
1.6
u/l
0.3
0.0
—
6
33
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
26
281
0.91
0.14
4.1
3.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
402
3878
1.02
0.14
1.1
1.1
iu/ml
83.3
2919.4
0.65
97
952
(3036782) Glucose [Moles/volume] in Pleural fluid
159
1514
1.03
0.14
1.3
1.3
mmol/l
6.1
6.3
0.65
144
1406
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
78
805
0.95
0.14
1.4
1.8
u/ml
286688.4
9274.0
—
8
108
(40760409) HLA-A [Type] by High resolution
8
97
0.81
0.13
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
8
97
0.81
0.13
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
8
97
0.81
0.13
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
8
97
0.81
0.13
1.0
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
117
1195
0.96
0.13
3.5
2.0
umol/l
102.6
154.5
1.68
65
604
(3013862) HLA-DP [Type]
8
99
0.80
0.13
1.0
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
2016
19684
1.01
0.13
8.1
7.5
%
95.8
96.0
0.72
1957
18924
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
16
139
1.13
0.13
7.4
5.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
259
2489
1.02
0.13
1.1
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
295
2840
1.02
0.13
1.5
1.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
9
106
0.84
0.13
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
313
3017
1.02
0.13
3.1
3.1
nmol/l
0.8
0.8
0.94
249
2325
(3001556) Androgen free Index in Serum or Plasma
36
379
0.93
0.12
1.4
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
138
1318
1.03
0.11
2.5
2.8
%
37.9
40.9
0.67
40
462
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
148
1498
0.97
0.11
1.1
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
29
307
0.93
0.11
2.4
2.3
ug/l
3.5
3.9
—
8
118
(40758292) HTLV I+II Ab panel - Serum
44
409
1.06
0.11
1.3
1.4
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
17
185
0.90
0.11
1.0
1.0
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
23
208
1.09
0.10
1.3
1.3
mg/24h
168.6
249.2
—
5
29
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
39
407
0.94
0.10
2.3
2.2
mmol/l
6.7
7.4
0.88
20
233
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
107
1087
0.97
0.10
1.2
1.2
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
12
104
1.14
0.10
1.0
1.0
u/ml
1.6
0.1
—
6
52
(40758358) Immune stain study
14
123
1.12
0.10
1.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
95
966
0.97
0.10
1.8
2.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
5
44
1.12
0.10
1.0
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
17
152
1.10
0.09
6.2
4.6
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
38
395
0.95
0.09
1.6
1.4
g/l
29.0
27.2
0.25
30
305
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
63
645
0.96
0.09
1.2
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
16
143
1.10
0.09
1.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
12
132
0.89
0.09
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
571
5559
1.01
0.09
2.2
2.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
299
2898
1.02
0.08
1.4
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
32
297
1.06
0.08
10.2
9.8
mmol/l
5.2
5.2
0.00
32
297
(3009466) Valproate [Moles/volume] in Serum or Plasma
379
3681
1.01
0.08
4.8
5.4
umol/l
354.6
376.1
2.17
325
3243
(40765089) Chromosome analysis panel - Blood by G-banded
119
1142
1.03
0.08
1.0
1.0
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
17
182
0.92
0.08
1.4
1.5
%
46.4
35.2
—
8
128
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
5
64
0.77
0.08
1.2
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
47
483
0.96
0.08
1.2
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
121
1162
1.02
0.08
2.0
2.2
ml
2213.9
1957.7
1.93
110
1053
(4281824)
303
3024
0.99
0.08
1.1
1.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
7
67
1.03
0.07
2.1
3.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
6
69
0.86
0.07
1.5
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
70
0.84
0.07
1.2
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
170
1705
0.98
0.07
1.2
1.2
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
8
75
1.05
0.07
1.0
1.1
nmol/l
235.8
258.7
—
8
75
(3032352) Blasts [#/volume] in Cerebral spinal fluid
26
241
1.06
0.07
2.7
2.8
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
39
367
1.05
0.07
1.1
1.2
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
11
97
1.12
0.07
1.0
1.0
u/ml
1.9
0.1
—
6
43
(3035611) Eosinophils/100 leukocytes in Synovial fluid
12
130
0.91
0.06
1.6
1.8
%
0.7
0.5
—
6
101
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
56
570
0.97
0.06
1.3
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
138
1332
1.02
0.06
1.1
1.1
%
98.3
95.6
0.55
106
1060
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
28
261
1.06
0.06
1.2
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
94
903
1.02
0.06
1.7
2.6
mmol/l
8.8
9.2
0.73
73
664
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
15
160
0.92
0.06
1.3
1.6
%
9.7
13.0
—
9
122
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
17
155
1.08
0.06
1.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
25
260
0.95
0.06
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
74
748
0.97
0.06
1.5
2.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
56
534
1.03
0.06
1.1
1.2
—
—
—
0
0
(44790047)
248
2470
0.99
0.05
1.5
1.5
—
—
—
0
0
(44790048)
248
2470
0.99
0.05
1.5
1.5
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
15
159
0.93
0.05
1.1
1.3
—
—
—
0
0
(44806118)
248
2469
0.99
0.05
1.5
1.5
—
—
—
0
0
(44790049)
248
2469
0.99
0.05
1.5
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
643
6287
1.01
0.05
3.5
4.2
mg/l
1.4
1.4
1.30
587
5852
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
12
108
1.09
0.05
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1868
18447
1.00
0.05
2.2
2.5
ml/min/173m2
74.3
69.6
5.42
725
7099
(3020876) Protein [Mass/time] in 24 hour Urine
167
1667
0.99
0.05
1.9
2.0
g/24h
0.7
1.2
—
8
105
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
371
3681
0.99
0.05
1.4
1.4
—
—
—
0
0
(4038314)
24
248
0.95
0.05
1.2
1.2
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
17
178
0.94
0.04
1.1
1.1
u/l
27.9
22.6
—
9
125
(3017315) Amylase [Enzymatic activity/volume] in Urine
135
1309
1.01
0.04
1.6
1.2
u/l
197.6
302.6
2.02
129
1220
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
65
655
0.98
0.04
1.2
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
36
367
0.97
0.04
1.1
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
18
167
1.06
0.04
1.0
1.1
u/l
7.4
10.2
0.56
18
167
(40757494) Bilirubin.total [Moles/volume] in Blood
108
1080
0.98
0.04
2.3
2.2
umol/l
16.7
24.8
—
8
109
(40767503) Oxygen content in Capillary blood by calculation
455
4506
0.99
0.04
2.3
2.4
%
17.3
16.6
3.57
226
2262
(46235168) Fasting glucose [Moles/volume] in Blood
30
284
1.04
0.04
1.0
1.3
mmol/l
5.8
7.8
3.07
13
83
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
138
1376
0.99
0.04
1.4
1.4
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
17
177
0.95
0.04
1.1
1.3
ml/s/173m2
1.4
1.8
0.38
11
115
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
36
343
1.03
0.03
1.4
2.4
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
13
137
0.93
0.03
1.1
1.2
ug/l
46.4
108.0
—
5
83
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
107
1039
1.01
0.03
1.3
1.4
pmol/l
14.7
14.6
0.14
94
878
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
54
543
0.98
0.03
1.9
1.9
ug/l
2.7
3.5
0.29
31
342
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
114
1136
0.99
0.03
1.2
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
19
196
0.95
0.03
1.3
1.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
24
227
1.04
0.03
1.1
1.2
mmol/l
5.3
5.7
0.18
14
114
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
120
1194
0.99
0.02
1.4
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
110
1094
0.99
0.02
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
61
610
0.98
0.02
1.2
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
187
1828
1.01
0.02
1.9
2.7
—
0.7
—
0
13
(3000012) Reticulocyte production index
107
1063
0.99
0.02
1.3
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
188
1839
1.01
0.01
1.1
1.1
ratio
1.1
1.1
0.20
63
661
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
88
875
0.99
0.01
1.3
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
10
105
0.94
0.01
1.1
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
38
381
0.98
0.01
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
44
440
0.98
0.01
2.9
2.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
925
9092
1.00
0.01
3.0
3.0
%
0.6
0.7
1.99
887
8723
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
66
656
0.99
0.00
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
137
1355
0.99
0.00
1.4
1.4
—
—
—
0
0
(3033942) Copper [Moles/time] in 24 hour Urine
14
132
1.04
0.00
1.3
1.2
umol/24h
1.3
0.7
—
9
55
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
10
104
0.95
0.00
1.1
1.1
kpa
7.4
7.0
—
10
99
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
2815
27695
1.00
0.00
4.4
4.1
%
32.3
32.4
0.28
1882
19642
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
276
2722
1.00
0.00
1.4
1.4
mmol/l
10.7
11.6
0.86
75
521
(40763480) Human metapneumovirus Ag [Presence] in Specimen
12
114
1.04
0.00
1.1
1.3
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
10
99
0.99
0.00
1.1
1.1
kpa
3.0
4.5
—
10
91
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
31
307
0.99
0.00
1.2
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
16
162
0.97
0.00
1.1
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
57
561
1.00
0.00
1.2
1.3
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
13
133
0.96
0.00
1.2
1.4
%
0.4
1.2
—
7
94
(40768441) Liver Pathology biopsy report
184
1812
1.00
0.00
1.2
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
23
229
0.99
0.00
1.3
1.2
nmol/l
18.0
15.4
—
8
58
(4198724)
165
1625
1.00
0.00
2.4
2.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
33
325
1.00
0.00
1.1
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
142
1401
1.00
0.00
1.0
1.1
miu/ml
1327.8
1513.9
1.45
142
1401
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
15
152
0.97
0.00
3.7
2.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
45
442
1.00
0.00
1.5
1.8
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
26
259
0.99
0.00
1.5
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
160
1574
1.00
0.00
1.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
310
3046
1.00
0.00
1.6
1.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
205
2018
1.00
0.00
1.4
1.4
g/l
34.7
33.8
0.50
182
1845
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
14
133
1.04
0.00
1.1
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
7730
76067
1.00
0.00
1.6
1.6
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
22
215
1.01
0.00
1.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
33
327
0.99
0.00
1.3
1.4
%
57.3
54.6
0.09
12
170
(3017509) Phencyclidine [Presence] in Urine
41
403
1.00
0.00
1.4
2.0
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
20
202
0.97
0.00
2.6
2.8
pmol/l
47.0
474.1
—
7
55
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
66
652
1.00
0.00
1.2
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
17
172
0.97
0.00
1.1
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
10
95
1.04
0.00
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
25
251
0.98
0.00
1.4
1.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
5
52
0.95
0.00
1.0
1.2
—
—
—
0
0
(3020071) Venlafaxine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
5
58
0.85
0.00
2.0
2.2
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
5
53
0.93
0.00
1.0
1.2
—
—
—
0
0
(3027114) Cholesterol [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763791) Oxygen content in Venous blood by calculation
6
67
0.88
0.00
5.0
7.2
ml/dl
10.5
12.7
—
6
55
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
7
73
0.94
0.00
1.3
1.4
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
7
75
0.92
0.00
4.7
2.1
—
—
—
0
0
(3030703) Everolimus [Mass/volume] in Blood
0
7
0.00
0.00
0.0
18.6
—
5.2
—
0
7
(3019529) Immunofixation for Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
4.2
—
140.4
—
0
5
(3005117) Influenza virus A Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015057) Respiratory syncytial virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006407) Chromogranin A [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
58.8
—
0
5
(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032642) Schistosoma sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
8
78
1.01
0.00
1.1
1.0
—
—
—
0
0
(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012864) Amino acids [Identifier] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
8.6
—
—
—
0
0
(3009179) Lactate [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.1
—
2.1
—
0
9
(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025311) HLA-B [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003220) Varicella zoster virus IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
764.2
—
0
6
(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003195) risperiDONE [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
6
62
0.95
0.00
1.0
1.1
mmol/l
—
—
—
0
0
(3017501) Neutrophils [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H7_ALLERGICCONJUNCTIVITIS and mortality.

Females

Parameter HR [95% CI] p-value
H7_ALLERGICCONJUNCTIVITIS 0.723 [0.67, 0.78] < 0.001
Birth year 0.992 [0.98, 1.0] 0.053

During the follow-up period (1.1.1998 — 31.12.2019), 5773 out of 104020 females with H7_ALLERGICCONJUNCTIVITIS died.

Males

Parameter HR [95% CI] p-value
H7_ALLERGICCONJUNCTIVITIS 0.752 [0.68, 0.84] < 0.001
Birth year 0.99 [0.98, 1.0] 0.038

During the follow-up period (1.1.1998 — 31.12.2019), 2587 out of 62896 males with H7_ALLERGICCONJUNCTIVITIS died.

Mortality risk

Mortality risk for people of age

years, who have H7_ALLERGICCONJUNCTIVITIS.

N-year risk Females Males
1 0.066% 0.117%
5 0.388% 0.932%
10 1.061% 2.47%
15 1.998% 4.814%
20 3.401% 8.358%

Relationships between endpoints

Index endpoint: H7_ALLERGICCONJUNCTIVITIS – Allergic conjunctivitis

GWS hits: 28

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data